Genomic_Coordinate(ENIGMA),Comment_on_clinical_significance(ENIGMA),Submitter(ClinVar),Origin_of_variant(LOVD),Functional_analysis_result(LOVD),Functional_analysis_technique(LOVD),Variant_frequency(LOVD),Variant_haplotype(LOVD),Minor_allele_frequency(ESP),polyPhen2_result(ESP),EUR_Allele_frequency(1000_Genomes),AFR_Allele_frequency(1000_Genomes),AMR_Allele_frequency(1000_Genomes),EAS_Allele_frequency(1000_Genomes),SAS_Allele_frequency(1000_Genomes),Patient_nationality(BIC),Number_of_family_member_carrying_mutation(BIC),Ethnicity(BIC),Mutation_type(BIC),IARC_class(exLOVD),Segregation_LR(exLOVD),Co_occurrence_LR(exLOVD),Sum_family_LR(exLOVD),Posterior_probability(exLOVD),Missense_analysis_prior_probability(exLOVD),Combined_prior_probablility(exLOVD),Consequence(VEP),IMPACT(VEP),EXON(VEP),INTRON(VEP),STRAND(VEP),TSL(VEP),SIFT(VEP),PolyPhen(VEP),SOMATIC(VEP),PHENO(VEP),Allele_frequency(1000g_exac),labels
chr13:32387053:C>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 1 (Asian)| 0.9 (African)| 1 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32353757:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1661 (Asian)| 0.3516 (African)| 0.3206 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3082,0.3177,0.3386,0.1657,0.2965,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.283946,benign
chr13:32340217:TT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-53),benign(0-005),,,,pathogenic
chr13:32337423:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32341018:->AAAG,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,,,pathogenic
chr13:32326497:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,4/1658,,,,,,,,,Western Europe|-|American,,Western European|-|None Specified|Italian/English/Dutch?Welsh/Irish/French,Splice|IVS,,,,,,,,splice_acceptor_variant,HIGH,,6/26,1,,,,,1&1,,pathogenic
chr17:43071149:GA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1,,pathogenic
chr13:32399160:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0,0.0,0.006,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.00119808,benign
chr17:43093955:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32326556:AT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43093176:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32379495:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1&1,,pathogenic
chr13:32334688:G>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (Asian)| 0.02 (African)| 0.02 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,1,1,,benign
chr17:43100560:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| 0.2602 (African)| 0.02507 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,,benign
chr13:32332934:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43092242:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0),probably_damaging(0-999),,1,,pathogenic
chr17:43093008:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.236e-06,benign
chr17:43092169:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32362658:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,17/27,,1,,,,,1,,benign
chr13:32398381:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43093220:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3536 (European)| derived from 1000 genomes (2012-04-30).,Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,32.3721|18.7699|27.7641,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1,1&1,,benign
chr13:32379850:TA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1,1&1,,pathogenic
chr13:32380146:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1,,pathogenic
chr13:32380146:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1,,pathogenic
chr17:43104166:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1,,benign
chr13:32368453:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0008,0.0,0.0407,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00898562,benign
chr17:43039999:->AT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.22 (African)| 0.36 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32379872:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,Not Specified|-,,Western European|-|Asian,N,,,,,,,,stop_gained,HIGH,,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32340286:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32337148:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43094724:C>T,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0|0.0908|0.0308,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43067626:G>GG,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/22,,-1,,,,,,,pathogenic
chr13:32319433:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,1,,benign
chr13:32356418:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,1,,benign
chr17:43089373:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2195 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3588,0.2179,0.3746,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.353435,benign
chr13:32371049:A>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,20/27,,1,,,,,1,,pathogenic
chr13:32339932:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,pathogenic
chr17:43091623:A>AA,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32380141:AACA>TT,,Sharing_Clinical_Reports_Project_(SCRP)|Curoverse|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&splice_region_variant,HIGH,,,1,,,,,1,,pathogenic
chr17:43098661:->T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.32 (Asian)| 0.22 (African)| 0.35 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,benign
chr17:43082509:AC>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,pathogenic
chr13:32338356:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,2,,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32367579:->GATGGCTTG,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.51 (Asian)| 0.44 (African)| 0.5 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32337312:A>AA,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32363510:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,0&1&1,0&1&1,,pathogenic
chr13:32392545:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32362594:G>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,17/27,,1,,,,,1,,pathogenic
chr17:43093512:T>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,25/27,,1,,,,,,,pathogenic
chr17:43043076:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32340218:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,1,,pathogenic
chr13:32332892:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43074658:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2846 (African)| 0.3668 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43081192:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,benign
chr17:43094343:A>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-331),,,,pathogenic
chr13:32326104:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43126899:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.71 (African)| 0.36 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,,,,,0&1,,benign
chr13:32340817:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43104865:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,4/21,-1,,,,,,,pathogenic
chr13:32327943:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05285 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.056,0.0072,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.0157748,benign
chr17:43092046:T>-,,GeneDx|Invitae|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Curoverse|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,pathogenic
chr17:43070706:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3322 (Asian)| 0.1301 (African)| 0.3588 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,66/1658,,,,0.3579,0.1619,0.3646,0.372,0.499,,,,IVS,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.33746,benign
chr17:43094794:A>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(1),,,,pathogenic
chr13:32337681:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),possibly_damaging(0-526),,1,,pathogenic
chr13:32363191:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,benign
chr17:43045780:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,pathogenic
chr17:43103085:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,benign
chr17:43121520:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3287 (Asian)| 0.2175 (African)| 0.3562 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43092245:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1&1,,pathogenic
chr17:43092770:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43092245:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-14),benign(0-007),,1,,pathogenic
chr13:32356757:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03659 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,,benign
chr17:43094130:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32338632:C>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32338986:A>AA,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32337086:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32350055:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0542 (Asian)| 0.1332 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.1213,0.0015,0.0591,0.0635,0.0787,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.0611022,benign
chr13:32398189:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,pathogenic
chr13:32378309:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0277 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0278,0.0,0.0043,0.001,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.00678914,benign
chr17:43094223:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43104856:T>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,,,benign
chr13:32339793:T>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,,pathogenic
chr17:43092897:T>C,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32337855:TA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-001),,,,pathogenic
chr13:32340323:GA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-001),,,,pathogenic
chr13:32326166:A>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/26,1,,,,,,,benign
chr13:32332616:A>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43057601:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04065 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0492,0.0,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.0131789,benign
chr17:43045803:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,21/21,-1,,,,,1,,pathogenic
chr17:43063876:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,21/21,-1,,,,,1,,pathogenic
chr17:43092576:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,pathogenic
chr13:32340399:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32380424:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.5386 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32340728:A>AA,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32347225:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr17:43063353:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/23,,-1,,,,0&0&1,1&1&1,,pathogenic
chr13:32340981:TA>TATA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,0&1,,pathogenic
chr17:43074397:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,pathogenic
chr17:43091516:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32340388:TT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32327154:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,benign
chr17:43070978:C>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,8/27,,1,,,,,1&1,,pathogenic
chr17:43094019:A>AA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32349323:->C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr17:43091012:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1,,pathogenic
chr17:43091564:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Western-European|-,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1&1,8.236e-06,pathogenic
chr17:43117298:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr13:32363516:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/27,,1,,,,,1&1,,pathogenic
chr17:43092758:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43092238:AG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,pathogenic
chr13:32356535:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/27,,1,,,,,1,,pathogenic
chr13:32371062:T>TT,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,20/27,,1,,,,,,,pathogenic
chr13:32340630:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-27),benign(0-217),,1,,pathogenic
chr17:43093803:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32338494:TT>TTTT,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32335141:CAAG>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-38),benign(0-06),,1,,benign
chr13:32385099:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05277 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43106453:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),as wildtype control|predicted deleterious|-|as variant control|deletion 22 nt from 3' end exon 5,Splicing reporter minigene|mRNA analysis (RT-PCR)|-|Multifactorial likelihood-ratio model|splicing reporter minigene/patient RNA analysis,,,,,,,,,,French?|German|Belgian|-|Belgian?,1|2|-,-|Caucasian|Native American|caucasian,IVS,5 - Definitely pathogenic,1.0,1.32,1100.0,1.0,,0.97,splice_region_variant&intron_variant,LOW,,4/22,-1,,,,,1&1,,pathogenic
chr13:32352880:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.09763 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32338933:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43093330:TTCTC>-,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Division_of_Human_Genetics_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43091490:TCTT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43106535:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,3/22,-1,,,,,1,,pathogenic
chr13:32337664:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43091437:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,,pathogenic
chr13:32339620:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32386560:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03862 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43094002:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32332739:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1&1,,pathogenic
chr17:43092212:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43078507:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1626 (Asian)| 0.122 (African)| 0.2731 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr13:32371097:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,20/27,,1,,,,,1,,pathogenic
chr17:43093420:TT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,20/27,,1,,,,,1,,pathogenic
chr17:43106929:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.378 (African)| 0.01715 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr13:32376717:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,pathogenic
chr17:43093579:T>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,pathogenic
chr17:43098010:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.313 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,benign
chr17:43052344:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr17:43085427:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01187 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr13:32358855:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02098 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr17:43093460:TT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-3),benign(0-076),,1,,pathogenic
chr17:43093647:ACTG>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,pathogenic
chr17:43076103:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04878 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/21,-1,,,,,,,benign
chr13:32362691:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,17/27,,1,,,,,1,,pathogenic
chr13:32339845:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43122772:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06098 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43106514:G>T,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1,,benign
chr17:43093578:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43091827:TTTAC>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32330918:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,,1,,,,,1,,pathogenic
chr13:32346892:TTTCG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,pathogenic
chr13:32316496:T>TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,1,,,,,1,,pathogenic
chr13:32330657:T>TT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32332532:T>TT,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43074016:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01399 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0,0.0,0.0079,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.00159744,benign
chr13:32394413:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01055 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0109,0.0008,0.0029,0.0,0.0092,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00459265,benign
chr17:43092616:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,3/27,,1,,,,,,,pathogenic
chr13:32333264:G>C,,CSER_CC_NCGL._University_of_Washington_Medical_Center|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0465|0.0227|0.0385,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),possibly_damaging(0-864),,1&1,,benign
chr17:43091006:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),possibly_damaging(0-864),,1&1,,pathogenic
chr17:43092973:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43094681:GTAATGA>GTAATGAGTAATGA,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43118338:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03455 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr13:32336991:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,pathogenic
chr17:43091765:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32336563:A>G,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0|0.0454|0.0154,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43093054:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,25/26,1,,,,,1&1,,pathogenic
chr17:43051050:C>A,,Invitae,,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,benign
chr13:32378476:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,benign
chr13:32339535:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-19),benign(0-01),,,,pathogenic
chr17:43063873:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,, Western European|Western European|-Western-European|Western-European,IVS,,,,,,,,splice_donor_variant,HIGH,,17/22,-1,,,,,1&1,,pathogenic
chr17:43049685:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.1301 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,benign
chr17:43063873:C>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,In vitro (cloned)|Unknown,predicted deleterious|-,-|Multifactorial likelihood-ratio model,-|3/1658,,,,,,,,,,B217|-,Western-European|-|None Specified,IVS,5 - Definitely pathogenic,12.87,1.15,,1.0,,0.97,splice_donor_variant,HIGH,,17/22,-1,,,,,1&1,,pathogenic
chr13:32338175:AAGA>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,17/22,-1,,,,,1&1,,pathogenic
chr13:32332100:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,,benign
chr17:43063873:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,Czech,,central Europe,IVS,,,,,,,,splice_donor_variant,HIGH,,17/22,-1,,,,,1&1,,pathogenic
chr13:32389701:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04881 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0606,0.0008,0.0144,0.0,0.0082,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.0159744,benign
chr17:43105441:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,,benign
chr13:32340748:ATTA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,16/27,,1,,,,,,,pathogenic
chr13:32363231:G>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1&1&1,,pathogenic
chr17:43059936:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.002,0.0212,0.0058,0.0,0.0317,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.0129792,benign
chr13:32336967:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1&1,,pathogenic
chr17:43109088:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02639 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr17:43053755:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2134 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3588,0.2186,0.2925,0.372,0.499,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.342652,benign
chr17:43094410:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,pathogenic
chr13:32337191:GA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32337185:A>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32370437:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,19/27,,1,,,,,1,,benign
chr17:43063369:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,19/27,,1,,,,,1,,pathogenic
chr17:43118425:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06504 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr13:32360774:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3864 (Asian)| 0.1585 (African)| 0.219 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr17:43057356:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0159,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.00499201,benign
chr17:43093701:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43091931:C>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Counsyl|Invitae,,,,,,0.0|0.2724|0.0923,probably-damaging:0.998|None|None|probably-damaging:0.998|probably-damaging:0.998,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,benign
chr17:43091931:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,benign
chr17:43090930:C>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,8.241e-06,benign
chr13:32332603:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr17:43093053:TG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,pathogenic
chr13:32379766:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,Canadian,,,N,,,,,,,,stop_gained,MODIFIER,,,1,,,,,1,,pathogenic
chr13:32318623:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3846 (Asian)| 0.1667 (African)| 0.281 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.2644,0.2148,0.232,0.3681,0.2526,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.265375,benign
chr17:43054039:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr13:32332606:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,pathogenic
chr13:32332974:AG>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,,pathogenic
chr13:32340277:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43091701:G>GG,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32332756:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32338631:A>AA,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43092695:TAC>G,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43092805:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32333328:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32333328:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43106501:->TC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,1&1,,pathogenic
chr17:43046985:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01979 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0189,0.0023,0.0072,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.00559105,benign
chr13:32339231:AA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,1,,pathogenic
chr17:43092063:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,benign
chr13:32355267:AA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),possibly_damaging(0-599),,1,,pathogenic
chr13:32333241:ATAA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1&1,,pathogenic
chr13:32337254:CT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,0&1,,pathogenic
chr17:43093619:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1&1&1,,pathogenic
chr17:43093172:C>CC,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43093535:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1,,pathogenic
chr17:43094515:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32326238:CCAG>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant&intron_variant,HIGH,,5/26,1,,,,,1,,pathogenic
chr13:32394792:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,1,,,,,1,,pathogenic
chr17:43087611:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3287 (Asian)| 0.2093 (African)| 0.3536 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr13:32331009:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,Western Europe,,,N,,,,,,,,stop_gained,HIGH,9/27,,1,,,,,1&1,,pathogenic
chr17:43093831:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43123065:A>AA,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3 (Asian)| 0.12 (African)| 0.32 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43093619:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,pathogenic
chr13:32332408:AT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,pathogenic
chr13:32340118:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,,,,,,pathogenic
chr17:43115797:G>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr13:32338294:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-21),benign(0-02),,1,,pathogenic
chr13:32349324:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05285 (African)| 0.01583 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr17:43094289:G>A,,Ambry_Genetics|Invitae,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32329446:GA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43121362:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32338226:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Counsyl,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43093882:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-01),possibly_damaging(0-756),,1,,pathogenic
chr13:32340680:GT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-13),benign(0-176),,,,pathogenic
chr13:32339658:TT>-,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0-01),possibly_damaging(0-453),,1,,pathogenic
chr13:32338294:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1,,pathogenic
chr13:32338294:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1,,pathogenic
chr13:32376755:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/27,,1,,,,,,,benign
chr13:32394546:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02439 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32336381:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-019),,1,,pathogenic
chr13:32343207:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,benign
chr13:32339705:AA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,pathogenic
chr13:32332753:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0|0.9773|0.3309,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr13:32385702:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.502 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.5159,0.5113,0.5375,0.5327,0.4683,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.511781,benign
chr17:43082551:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32338311:ATGA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,pathogenic
chr17:43092353:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned),,,,,,,,,,,,Not Specified|Norwegian|Sweden|-,,Western-European|Western European|-|Caucasian|Western Europe/Sweden,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43091496:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43093451:TG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,1,,pathogenic
chr13:32319771:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43063890:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,-|Irish/Scottish,1|-,Not Specified|Western European|Caucasian,N,,,,,,,,stop_gained,HIGH,17/23,,-1,,,,,1&1,,pathogenic
chr17:43066450:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0159,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.00499201,benign
chr17:43094112:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,2.471e-05,benign
chr17:43095919:CACA>-,,University_of_Washington_Center_for_Mendelian_Genomics|_University_of_Washington,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32332657:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr13:32339950:AT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32339645:TC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43093373:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,-|Venezuela,,Western European|-,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32363289:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/27,,1,,,,,1&1,,pathogenic
chr13:32332991:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-52),benign(0-023),,1,8.237e-06,benign
chr13:32333310:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1&1,,pathogenic
chr17:43045764:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/22,,-1,,,,,1&1&1&1,,pathogenic
chr13:32315655:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1836 (Asian)| 0.126 (African)| 0.1636 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,benign
chr13:32391658:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02972 (Asian)| 0.01319 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43091881:->T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43094394:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics,,,,,,0.0|0.6355|0.2153,probably-damaging:1.0|None|None|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1,,benign
chr17:43092915:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32356483:G>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,,,benign
chr13:32341421:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0136,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.00399361,benign
chr17:43053924:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2886 (African)| 0.3681 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr13:32339950:AT>C,,Curoverse,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32394784:AT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,0&1,,pathogenic
chr13:32363289:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-996),,,,pathogenic
chr17:43100559:TA>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03 (Asian)| 0.45 (African)| 0.03 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,benign
chr13:32330162:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0356,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,0.00958466,benign
chr13:32387360:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04895 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43100594:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02273 (Asian)| 0.3049 (African)| 0.02111 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,,benign
chr13:32370422:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,19/27,,1,,,,,1,,benign
chr17:43093057:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43091675:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,,pathogenic
chr13:32332877:AAGA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,,,pathogenic
chr13:32333020:G>GG,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,pathogenic
chr13:32320728:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04354 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43093330:TTCTCTTCTTTTTC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,pathogenic
chr17:43093712:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,-|British,,Western-European|None-Specified|Caucasian,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43092133:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,,,pathogenic
chr13:32330966:TGAT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,,,pathogenic
chr13:32337364:CA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,tolerated(0-34),benign(0-082),,1,,pathogenic
chr17:43104918:TCAACAAGTTG>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,0&1&1&1,1&1&1&1,,pathogenic
chr17:43094327:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,pathogenic
chr13:32340575:CAC>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43116729:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08333 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr13:32356585:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,,pathogenic
chr13:32324693:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43090931:AC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,benign
chr13:32340356:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,pathogenic
chr17:43075589:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0098,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.00259585,benign
chr17:43091711:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32346481:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.4353 (Asian)| 0.3415 (African)| 0.4683 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,benign
chr13:32318557:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.09441 (Asian)| 0.01626 (African)| 0.04617 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,benign
chr13:32332518:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-04),benign(0-245),,1,,benign
chr13:32338804:A>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-121),,,,pathogenic
chr17:43092114:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32398464:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32338040:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-27),possibly_damaging(0-744),,1&1&1,,pathogenic
chr13:32332837:A>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr13:32380111:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,1,,benign
chr13:32337751:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3846 (Asian)| 0.1646 (African)| 0.2942 (European)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,30.7397|22.6055|27.9837,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1,1&1,,benign
chr13:32354877:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,14/27,,1,,,,,1&1,,pathogenic
chr13:32336629:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,2.471e-05,benign
chr17:43094021:G>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-63),benign(0-098),,1&1&1,,pathogenic
chr13:32325741:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.8801 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,benign
chr13:32339205:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-24),benign(0-253),,1,,benign
chr17:43083089:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02622 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr17:43092928:G>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,pathogenic
chr17:43108968:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02507 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr17:43091832:T>C,,Ambry_Genetics,,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,benign
chr17:43079681:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.5 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,benign
chr17:43057032:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,8.236e-06,benign
chr13:32332703:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,1,,pathogenic
chr17:43093334:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43091832:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,0&1,,pathogenic
chr13:32370973:A>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr13:32339912:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,inframe_deletion,MODERATE,11/27,,1,,,,,,,pathogenic
chr13:32337550:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,15/22,,-1,,,,,,,pathogenic
chr17:43091948:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,15/22,,-1,,,,,,,pathogenic
chr13:32340437:GAAGA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-17),benign(0-046),,1&1&1,,pathogenic
chr13:32340728:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-17),benign(0-046),,1&1&1,,pathogenic
chr17:43092235:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,pathogenic
chr13:32338140:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32370969:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,deleterious(0-01),probably_damaging(0-999),,,,pathogenic
chr13:32346833:TAAA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Counsyl|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,25/27,,1,,,,,1&1&1,,pathogenic
chr17:43092796:T>C,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43057090:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/22,,-1,,,,,1,,pathogenic
chr13:32317748:T>TT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,benign
chr13:32331008:TCAAA>-,,GeneReviews|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,,pathogenic
chr13:32340307:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43070924:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/22,-1,,,,,1&1,,pathogenic
chr17:43093343:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43092896:C>A,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32347807:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3864 (Asian)| 0.1707 (African)| 0.2929 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32315532:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03659 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,benign
chr13:32394898:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,pathogenic
chr17:43094465:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,Spanish|Dutch,,-|Caucasian,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32339674:G>A,,Ambry_Genetics|Invitae,,,,1/1658,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,1.648e-05,benign
chr13:32379332:G>T,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,, Portuguese|Western European,N,,,,,,,,stop_gained,HIGH,22/27,,1,,,,,1,,pathogenic
chr17:43083822:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05894 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0348,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.00938498,benign
chr17:43093914:C>T,,Ambry_Genetics,,,,,,0.0|0.0454|0.0154,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43076581:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),probably_damaging(0-998),,1&1,,pathogenic
chr17:43092659:->T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43093123:CT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32371030:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,20/27,,1,,,,,,,benign
chr13:32363368:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,benign
chr13:32319226:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,3/27,,1,,,,,1,,pathogenic
chr17:43092661:TGAGA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,9/27,,1,,,,,,,pathogenic
chr17:43094175:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,pathogenic
chr13:32398431:C>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32337709:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32362573:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,17/27,,1,,,,,1&1,,pathogenic
chr13:32354950:T>TT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,,,pathogenic
chr17:43094179:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,0&0&1,1&1&1,,pathogenic
chr17:43091859:G>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-01),benign(0-001),,,,pathogenic
chr13:32337709:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1,,benign
chr17:43092666:->A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43094703:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43047106:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3821 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,,benign
chr13:32338426:A>C,,Ambry_Genetics|GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,0.0|0.227|0.0769,None,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,0.000373671,benign
chr13:32319192:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,1,8.237e-06,benign
chr13:32339594:->T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,1,,pathogenic
chr13:32357741:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,15/26,1,,,,,1&1&1,,pathogenic
chr13:32316471:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,1,,,,,1,,benign
chr13:32339989:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,,benign
chr17:43100558:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3077 (Asian)| 0.1118 (African)| 0.2929 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,,benign
chr13:32329790:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04268 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,,benign
chr13:32363376:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/27,,1,,,,,1&1,,pathogenic
chr17:43092761:TAAC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,pathogenic
chr17:43104888:TGAAAAGCACAAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,pathogenic
chr13:32370456:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,benign:0.023,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,tolerated(0-33),benign(0-184),,1,,benign
chr13:32369612:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04268 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr17:43106497:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,pathogenic
chr17:43099851:AG>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43099815:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,1,8.236e-06,benign
chr13:32330925:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,pathogenic
chr17:43115724:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western-European,IVS,,,,,,,,splice_donor_variant,HIGH,,3/22,-1,1.0,,,,1&1&1&1,,pathogenic
chr17:43064189:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| 0.08443 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr17:43115724:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Western European|None-Specified,IVS,,,,,,,,splice_donor_variant,HIGH,,3/22,-1,1.0,,,,1&1&1&1,,pathogenic
chr13:32398666:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43048520:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.2832 (Asian)| 0.185 (African)| 0.3127 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,benign
chr17:43065090:A>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr13:32332886:G>GG,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32380604:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.909 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32371053:T>TT,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,20/27,,1,,,,,1,,pathogenic
chr13:32365149:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06294 (Asian)| 0.3293 (African)| 0.2836 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32340789:ATAATCAC>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr13:32332977:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-009),0&0&1&1,1&1&1&1,,pathogenic
chr17:43126360:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.22 (African)| 0.36 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,,,,,0&1,,benign
chr13:32340510:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,1&1&1&1,1&1&1&1,,pathogenic
chr13:32357842:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,16/27,,1,,,,,,,pathogenic
chr13:32394808:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,25/27,,1,,,,,1&1&1,,pathogenic
chr13:32388181:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.5041 (African)| 0.533 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.5159,0.5106,0.536,0.5327,0.4683,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.511382,benign
chr13:32332465:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr13:32319654:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.5629 (Asian)| 0.5467 (African)| 0.5317 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr13:32326521:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),probably_damaging(1),,1&1&1,,pathogenic
chr17:43078359:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3269 (Asian)| 0.126 (African)| 0.3562 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr13:32394808:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1,,pathogenic
chr13:32379436:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/27,,1,,,,,,,benign
chr17:43092717:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0|0.6128|0.2076,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32379812:TA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,tolerated(1),possibly_damaging(0-815),,1&1&1,,pathogenic
chr13:32339791:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,tolerated(1),possibly_damaging(0-815),,1&1&1,,pathogenic
chr17:43092722:TATC>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-39),benign(0-004),,1,,pathogenic
chr13:32316528:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned),as variant control,mRNA analysis (RT-PCR),,,,,,,,,,,,Western Europe|-,IVS,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1&1,,pathogenic
chr13:32370464:TAG>AA,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,19/27,,1,,,,,1,,pathogenic
chr13:32316528:G>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,Western European,IVS,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1&1,,pathogenic
chr17:43093217:C>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,0&1,,pathogenic
chr13:32364619:T>TT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.19 (Asian)| 0.1 (African)| 0.25 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32336893:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43123134:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.126 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32394576:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01187 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),In vitro (cloned)|Unknown,predicted neutral|-,-|mRNA analysis and splicing reporter minigene,,,,,0.0109,0.0,0.0029,0.0,0.0,,,,IVS,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00259585,benign
chr13:32340564:AAAG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32363356:T>C,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0|0.0454|0.0154,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,,benign
chr13:32354859:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,13/26,1,,,,,1&1&1,,pathogenic
chr13:32340307:A>AA,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32354859:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,13/26,1,,,,,1&1&1,,pathogenic
chr17:43047680:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/22,,-1,,,,,,,benign
chr13:32326520:AT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,0&1,,pathogenic
chr13:32333333:C>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43046253:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02507 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,,benign
chr17:43106441:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,1,,benign
chr17:43115725:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,3/22,-1,1.0,,,,1&1,,pathogenic
chr17:43115725:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,3/22,-1,1.0,,,,1&1,,pathogenic
chr17:43092204:T>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000307,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Invitae,,,,,,0.0116|0.0227|0.0154,probably-damaging:0.995|None|None|probably-damaging:0.995|probably-damaging:0.995,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,1&1&1,,benign
chr13:32357762:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,16/27,,1,,,,,,,benign
chr13:32337767:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43094466:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Counsyl|Invitae,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32340414:AACA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32338639:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43070980:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-68),benign(0-002),,1,,pathogenic
chr17:43092821:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43110532:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| 0.03166 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr13:32370410:TAAC>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32326278:T>TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,6/27,,1,,,,,1,,pathogenic
chr17:43115726:TT>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-81),benign(0-023),1&1,1&1,,pathogenic
chr17:43124031:->AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr13:32337756:G>C,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-193),,1,,benign
chr17:43093857:TT>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43093567:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-08),benign(0-228),,,,pathogenic
chr17:43104195:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32337736:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,1&1,1&1,,pathogenic
chr17:43091017:->AGAT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32355232:ACAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-16),benign(0-061),,1,,pathogenic
chr17:43061103:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01748 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32379859:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,1,,benign
chr17:43058585:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01748 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr17:43082475:->C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/22,,-1,,,,,,,pathogenic
chr17:43092357:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,0&1&1,1&1&1,,pathogenic
chr17:43094530:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000271,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx,,,,,,0.0116|0.0|0.0077,possibly-damaging:0.584|None|None|possibly-damaging:0.584|possibly-damaging:0.584,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32340941:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43093142:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1&1,,pathogenic
chr13:32340121:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32371795:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1906 (Asian)| 0.09959 (African)| 0.248 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr17:43056687:G>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04 (African)| 0.03 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1&1,,benign
chr13:32362580:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,17/27,,1,,,,,1&1,,pathogenic
chr13:32333030:G>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32326498:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,6/26,1,,,,,1&0,,pathogenic
chr13:32361504:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr17:43091638:G>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,,pathogenic
chr13:32325098:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,4/27,,1,,,,,,,benign
chr13:32339881:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0),probably_damaging(0-951),,1&1,,pathogenic
chr13:32338964:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000424,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-881),,,,benign
chr13:32319275:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1,,pathogenic
chr17:43042868:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.72 (African)| 0.37 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32369206:AA>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.12 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1&1,,benign
chr13:32337647:A>-,,Faculty_of_Pharmacy|_Ain_Shams_University,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,pathogenic
chr13:32339853:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43084625:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02846 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.025,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.00658946,benign
chr17:43104952:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,benign
chr17:43051111:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,pathogenic
chr17:43071076:CT>GGC,,Strand_Center_for_Genomics_and_Personalized_Medicine|Strand_Life_Sciences_Pvt_Ltd,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,1,,pathogenic
chr13:32326144:AA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32339741:GA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-234),,1,,pathogenic
chr17:43045734:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Counsyl,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/22,,-1,,,,,1&1,,pathogenic
chr17:43094366:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,pathogenic
chr17:43093193:GA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,pathogenic
chr13:32344830:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.07343 (Asian)| 0.311 (African)| 0.2018 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,benign
chr13:32363535:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,18/26,1,,,,,1,,pathogenic
chr13:32339986:C>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,,pathogenic
chr13:32379757:GAGT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,,pathogenic
chr13:32333183:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-08),benign(0-095),,1&1&1,,pathogenic
chr17:43082422:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/22,,-1,,,,,1&1,,pathogenic
chr17:43076569:TTCTGGCTTATAG>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,1,,pathogenic
chr17:43056450:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08333 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr13:32376731:G>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/27,,1,,,,,1,,benign
chr13:32360521:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| 0.02243 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0386,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.0101837,benign
chr13:32362663:C>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43094170:CT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43090946:GA>GAGA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr13:32338993:T>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0-01),benign(0-089),,1&1,,pathogenic
chr13:32339295:CA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0-01),benign(0-089),,1&1,,pathogenic
chr13:32362688:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,17/27,,1,,,,,,,benign
chr13:32363376:GGTATGCTGTTA>TT,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,1,,pathogenic
chr13:32395918:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02273 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43060163:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32356535:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0),0&1&1,1&1&1,,pathogenic
chr17:43091772:AGAC>-,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,1.0,,,,,,pathogenic
chr13:32339986:C>T,,Ambry_Genetics,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1,,benign
chr13:32384512:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3811 (Asian)| 0.1423 (African)| 0.2177 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43074411:->GA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,pathogenic
chr13:32375396:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01187 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr13:32398566:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32381972:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06294 (Asian)| 0.3293 (African)| 0.2836 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32398593:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43092541:TT>TTTT,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43100574:->AT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.26 (Asian)| 0.16 (African)| 0.23 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,,benign
chr13:32339341:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32394470:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.502 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43102706:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01187 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0099,0.0023,0.0072,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.00419329,benign
chr17:43074584:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3588 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32333332:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,10/27,,1,,,,,1,,pathogenic
chr13:32364744:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3846 (Asian)| 0.1585 (African)| 0.219 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32333032:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr17:43092549:AC>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,5/27,,1,,,,,0&1,,pathogenic
chr13:32357803:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,5/27,,1,,,,,0&1,,pathogenic
chr17:43092845:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,5/27,,1,,,,,0&1,,pathogenic
chr17:43092202:TTTT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,pathogenic
chr17:43093006:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000043,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43108991:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0121,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.00319489,benign
chr17:43102469:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.1321 (African)| 0.3681 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,benign
chr17:43051308:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr17:43091439:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43095848:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1,,pathogenic
chr17:43106518:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-19),benign(0-081),0&0&1&1,0&1&1&1,,pathogenic
chr13:32336300:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43104895:CA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,pathogenic
chr13:32339086:ATTAGC>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43092962:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32338598:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32338330:TGCT>TGCTTGCT,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43089486:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2236 (African)| 0.3628 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43094285:GAACGTC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32338106:A>AA,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32332843:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,Prevalence in normal controls|-|?,-|56/1658,,3.677|1.9764|3.101,None,0.0348,0.0325,0.0922,0.0962,0.1329,USA|German|-|Austria|Sri Lankan|Belgian,1|0|-| -,Global|-|Caucasian|Sinhalese,Syn,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,0&1,1&1,0.06234105,benign
chr17:43124095:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,start_lost,HIGH,,,-1,1.0,deleterious(0),,,1&1&1,,pathogenic
chr13:32338447:AT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1,,pathogenic
chr17:43124095:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,start_lost,HIGH,,,-1,1.0,deleterious(0),,,1&1&1,,pathogenic
chr17:43106476:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr17:43082492:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/22,,-1,,,,1,1,,benign
chr17:43064324:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.376 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.005,0.3949,0.0274,0.0,0.0317,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.115216,benign
chr13:32340479:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,, African|Western European| Native Americ|African,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,8.237e-06,pathogenic
chr17:43067635:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/22,,-1,,,,,1&1,,pathogenic
chr13:32326615:T>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,In vitro (cloned)|Unknown|Germline (inherited),predicted deleterious|no rescue ES cell lethality|-|as variant control, RNA analysis|mRNA analysis (RT-PCR)|-|Co-segregation in families|Mouse ES cell assay,1/1658|-,-|FA FANCD1_00002,,,,,,,,,, Norwegian German|Not Specified|Western European|-|Native American| Central/Eastern Europea|Western Europe|None Specified,IVS,,,,,,,,splice_donor_variant,HIGH,,7/26,1,,,,,1&1&1&0,,pathogenic
chr13:32319271:CT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/27,,1,,,,,1&1,,pathogenic
chr13:32340077:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,pathogenic
chr13:32340946:TG>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32339981:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32316529:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1&1,,pathogenic
chr13:32316529:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1&1,,pathogenic
chr13:32319327:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,3/26,1,,,,,1,,pathogenic
chr17:43092336:->C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43092731:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,2/1658|-,,,,,,,,,Australian|-,,Turkish|None-Specified|Asian,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&1,1&1&1,,pathogenic
chr13:32340547:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32361269:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06294 (Asian)| 0.01626 (African)| 0.2836 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.2734,0.0151,0.2349,0.0704,0.1595,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.136781,benign
chr17:43091727:A>G,,Ambry_Genetics|GeneDx|Invitae,Unknown|Germline (inherited),,,,,0.0|0.0227|0.0077,None|None|None|None|None,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,0.0001121955,benign
chr17:43057056:CTGTC>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32333398:->T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,1,,benign
chr17:43104881:G>A,,Ambry_Genetics|GeneDx,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,4/22,,-1,,,,,1,,benign
chr13:32333267:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32377317:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3864 (Asian)| 0.04472 (African)| 0.219 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,benign
chr13:32316529:T>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-21),benign(0-073),1&1,1&1,,pathogenic
chr17:43094763:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,,benign
chr17:43067380:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04878 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr13:32398160:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32376978:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3811 (Asian)| 0.1402 (African)| 0.2177 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,benign
chr17:43094148:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,pathogenic
chr13:32339809:A>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,pathogenic
chr17:43066555:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3287 (Asian)| 0.128 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3569,0.1573,0.3646,0.371,0.499,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.335863,benign
chr17:43093896:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,0&1,1&1,8.237e-06,benign
chr17:43093570:T>TT,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32355131:T>A,,Ambry_Genetics|Invitae,,,,,,0.0|0.0681|0.0231,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,1,,benign
chr17:43045729:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/22,,-1,,,,,1&1,,pathogenic
chr13:32337554:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,pathogenic
chr13:32398629:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43074385:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,pathogenic
chr13:32336608:TG>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,pathogenic
chr17:43091842:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43094556:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43091660:ATTTT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32339570:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,pathogenic
chr13:32340801:TTAAA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,pathogenic
chr17:43115727:T>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0008,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,1.0,deleterious(0-01),,,1,,benign
chr17:43094087:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,1.0,deleterious(0-01),,,1,,pathogenic
chr17:43104185:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,benign
chr13:32352925:->AT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32336569:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43066690:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06504 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr17:43092159:G>A,,Ambry_Genetics,In vitro (cloned),predicted neutral|as wildtype control|as variant control,Recombination rate|Clonogenic assay|Proliferation in yeast|Homologous recombination in yeast,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,1&1,1&1,,benign
chr13:32336725:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43127865:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.22 (African)| 0.36 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32342233:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,benign
chr13:32342652:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,benign
chr17:43045677:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,3_prime_UTR_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43090961:->CT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr17:43092518:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-12),benign(0-005),0&1&1,1&1&1,,pathogenic
chr17:43039818:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32332788:AAGA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-14),benign(0-093),,1,,pathogenic
chr13:32319276:G>A,,Ambry_Genetics|GeneDx|Counsyl|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,1,,benign
chr13:32337925:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,1,,pathogenic
chr17:43091931:CT>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-631),,,,pathogenic
chr17:43091891:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Counsyl,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43106534:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,3/22,-1,,,,,1&1&1,,pathogenic
chr17:43106534:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,3/22,-1,,,,,1&1&1,,pathogenic
chr17:43051071:A>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0),possibly_damaging(0-774),,1&1&1,,pathogenic
chr17:43115746:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05769 (Asian)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,0&0&1,1&1&1,,benign
chr17:43118446:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3579,0.2163,0.3732,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.352636,benign
chr17:43082414:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,0.0,0.0,0.0,0.001,0.0,American,,Caucasian,Syn,,,,,,,,synonymous_variant,LOW,11/22,,-1,,,,,1,0.0001327855,benign
chr13:32339706:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32337039:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32339332:C>T,,Ambry_Genetics|GeneDx|Invitae,,,,1/1658|-,,0.0233|0.0|0.0154,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,0.0001154,benign
chr17:43092786:AG>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,,pathogenic
chr13:32362589:T>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,17/27,,1,,,,,1,,pathogenic
chr13:32370484:TAT>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,19/27,,1,,,,,1,,pathogenic
chr13:32339276:GAAA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr17:43127544:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.87 (African)| 0.37 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32337521:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,Latin American/Caribbean|Western European|None Specified| Asian,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43071074:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000000000703,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,0.0|0.1589|0.0538,benign:0.013|benign:0.013|benign:0.013|benign:0.013|benign:0.013,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-004),,1,,benign
chr17:43091772:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-34),benign(0-138),,,,pathogenic
chr13:32337702:->TA,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32336458:TATT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43091763:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43091000:TT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,pathogenic
chr13:32366979:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr17:43094402:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43093317:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43063920:T>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32355004:AA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-04),benign(0-014),,,,pathogenic
chr13:32339915:GT>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,pathogenic
chr13:32393874:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02439 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0257,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00678914,benign
chr17:43070922:A>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/22,-1,,,,,1&1&1,,pathogenic
chr17:43070922:A>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/22,-1,,,,,1&1&1,,pathogenic
chr17:43091484:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32339741:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43095587:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3287 (Asian)| 0.2073 (African)| 0.3443 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32325869:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01583 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,benign
chr17:43091636:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43093691:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43094266:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43094291:C>CC,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32340690:GA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,6/27,,1,,,,,1,,pathogenic
chr17:43052360:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2134 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3588,0.2194,0.2925,0.372,0.499,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.342851,benign
chr13:32364948:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0348,0.0295,0.0908,0.0962,0.1329,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.0726837,benign
chr13:32379821:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr13:32398608:->GAATTATATCT,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32358600:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr13:32355038:CTTGAT>AG,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,14/27,,1,,,,,1,,pathogenic
chr17:43092434:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,1&1&1,,pathogenic
chr13:32338228:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32397149:T>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32333278:T>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43094025:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32333278:T>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32340301:T>-,,GeneReviews|_NHGRI|Biesecker_Laboratory_-_ClinSeq_Project|Emory_Genetics_Laboratory|Ambry_Genetics|Curoverse|Counsyl|Invitae|Pathway_Genomics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43047665:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,21/22,,-1,,,,,1&1,,pathogenic
chr17:43091987:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43074522:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Counsyl,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,,-1,,,,,1&1,,pathogenic
chr13:32337849:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-16),benign(0-028),,1,8.236e-06,benign
chr13:32337365:A>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,19/27,,1,,tolerated(0-53),benign(0-01),,1,,pathogenic
chr17:43101311:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,benign
chr17:43052991:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06504 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr13:32398438:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32340845:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1,,pathogenic
chr13:32370985:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,20/27,,1,,,,,,,benign
chr13:32346312:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,benign
chr13:32338597:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43093314:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32337098:ACTTG>-,,Counsyl,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-18),possibly_damaging(0-865),,1,,pathogenic
chr13:32319095:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,pathogenic
chr13:32317629:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,benign
chr17:43124476:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32336881:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32340845:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,pathogenic
chr13:32338901:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32341188:TCTTA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43071162:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,,benign
chr13:32339410:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32338534:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,,benign
chr17:43079069:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0159,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.00499201,benign
chr13:32338236:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Italian,,Caucasion,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43091034:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr17:43097273:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,1,,benign
chr17:43091034:T>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr13:32340140:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000521,Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,benign:0.004,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-74),benign(0-03),,1&1,,benign
chr17:43076553:A>T,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,12/22,,-1,,,,,1,,benign
chr13:32337197:G>GG,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32398485:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43093088:T>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,pathogenic
chr13:32331778:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02846 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0257,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,0.00678914,benign
chr17:43094153:TT>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32337511:A>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00025883,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32326137:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,18/26,1,,,,,1&1&1,,pathogenic
chr17:43118649:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3559,0.1566,0.3631,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.335064,benign
chr17:43099856:G>GG,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr13:32379508:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,,1,,pathogenic
chr13:32337909:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,pathogenic
chr13:32356517:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/27,,1,,,,,1,,pathogenic
chr13:32336642:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,1&1,1&1,,pathogenic
chr13:32338825:A>AA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32330977:->AG,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,9/27,,1,,,,,1,,pathogenic
chr17:43074431:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,9/27,,1,,,,,1,,pathogenic
chr13:32340212:G>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,German|Not Specified|Western Europe|-|Dutch,,"White-NonHispanic| French Canadian""""|Italian/French|-|British|Unknown|French-Canadian|Western European|French Canadian|Western Europe|Caucasian|None Specified|""""Western European",N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1,8.237e-06,pathogenic
chr17:43091888:TC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1,,pathogenic
chr13:32339122:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32333046:A>G,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-09),benign(0-125),,1,,benign
chr13:32336764:T>G,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43094569:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,0&0&1,1&1&1,,pathogenic
chr17:43092207:TA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-31),benign(0-001),,,,pathogenic
chr13:32333119:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr17:43093155:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,pathogenic
chr17:43093857:T>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),probably_damaging(0-982),0&0&1,1&1&1,,pathogenic
chr13:32319160:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,deleterious(0-04),,0&1&1,1&1&1,,pathogenic
chr17:43094832:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,benign
chr17:43091614:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,pathogenic
chr13:32396903:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,,benign
chr17:43067343:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02243 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr13:32338765:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32394701:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,25/27,,1,,,,,1,,pathogenic
chr17:43070973:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,25/27,,1,,,,,1,,pathogenic
chr17:43045804:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,21/21,-1,,,,,1,,pathogenic
chr13:32335723:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0151,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.00439297,benign
chr17:43098877:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08333 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0552,0.0072,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.0155751,benign
chr13:32341058:AT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,pathogenic
chr13:32340864:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,2/22,-1,1.0,,,,,,pathogenic
chr13:32363326:T>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,,benign
chr17:43124125:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr17:43092823:->AT,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,1&1,1&1,,pathogenic
chr13:32339501:TATG>-,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,1&1,1&1,,pathogenic
chr17:43092696:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32339067:AG>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,pathogenic
chr17:43076550:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,12/22,,-1,,,,,1,,benign
chr17:43115737:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,,,benign
chr13:32336925:T>TT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43094775:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,benign
chr17:43091724:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43044897:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Counsyl,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43110084:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr13:32319207:A>G,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0349|0.0|0.0231,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,0&1&1,1&1&1,,benign
chr13:32340124:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43067683:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/22,,-1,,,,,1&1,,pathogenic
chr17:43074351:T>TT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,HIGH,,,-1,,,,,,,pathogenic
chr13:32379516:G>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1&1&1,,pathogenic
chr13:32339428:A>-,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1&1&1,,pathogenic
chr13:32333309:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1&1&1,,pathogenic
chr13:32395894:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08392 (Asian)| 0.3069 (African)| 0.285 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.2744,0.2436,0.2882,0.0804,0.1503,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.204872,benign
chr13:32337813:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43070980:->TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,1&1,,pathogenic
chr13:32338037:AATG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,pathogenic
chr13:32337580:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43047161:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1098 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,,benign
chr17:43091594:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32379516:G>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43093586:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,-|Brazilian,,Western European|Caucasian,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32338835:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43071104:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,N,,,,,,,,stop_gained,HIGH,15/23,,-1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32346896:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,13/27,,1,,deleterious(0-03),benign(0-082),,1&1&1&1&0&0,,pathogenic
chr13:32357813:C>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,1,,pathogenic
chr13:32338229:C>T,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32346896:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,13/27,,1,,tolerated(0-07),possibly_damaging(0-456),,1&1&1&1&0&0,,pathogenic
chr13:32330993:CA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,pathogenic
chr13:32341000:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32316487:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,1,,,,,,,benign
chr17:43095590:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.002,0.0015,0.0029,0.006,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.00239617,benign
chr17:43093268:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32329493:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,1/1658,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,8/26,1,,,,,1,,pathogenic
chr17:43082407:T>A,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/22,,-1,,,,,1,,pathogenic
chr13:32338466:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43093035:T>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43093268:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,pathogenic
chr17:43092968:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43067387:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr17:43092131:C>A,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,In vitro (cloned)|Unknown,-|?,-|?,-|3/1658,,,,,,,,,Danish|-,,Not Specified|Western European|-|Caucasian|Western Europe|None-Specified|None Specified,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43092342:GG>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32336667:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43094473:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned)|Unknown,-|?,-|?,,,,,,,,,,,,Not Specified|-,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32337315:A>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000741,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,Histopathology|-,,,0.0116|1.0667|0.3695,possibly-damaging:0.744,0.0,0.0076,0.0,0.0,0.0,Latin American/Caribbean|African American|-,,"| Native American""""| Latin American/Caribbean""""|Western European|-| Native Americ|""""African|African| African|African American|""""Western European| Jamaican (Africian) Scottish""""|None Specified|Trinidad",M,1 - Not pathogenic or of no clinical significance,,0.001,4.97,7e-05,0.02,0.02,missense_variant,MODERATE,11/27,,1,,,benign(0-373),,1,0.001443255,benign
chr13:32338368:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,pathogenic
chr13:32357881:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,16/27,,1,,,,,1&1,,pathogenic
chr13:32396903:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1,,pathogenic
chr13:32352517:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.02846 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32355271:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(1),benign(0-016),,1,,benign
chr17:43092667:G>T,,Pathway_Genomics|Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32338417:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43097236:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,7/21,-1,1.0,,,,,,benign
chr13:32325140:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,4/27,,1,,,,,,,benign
chr13:32340921:A>AA,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43092171:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43066598:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01748 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr13:32351120:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06469 (Asian)| 0.3191 (African)| 0.2018 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.1938,0.2723,0.2176,0.0714,0.1452,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.183706,benign
chr17:43088733:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08333 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0552,0.0086,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.0157748,benign
chr13:32341207:A>G,,GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,1,,benign
chr13:32371016:GAAG>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(0-977),,1,,pathogenic
chr13:32339745:C>-,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32340841:ACAA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,tolerated(1),benign(0),,1,,pathogenic
chr13:32332680:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,0&1&1,1&1&1,,pathogenic
chr17:43106524:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,pathogenic
chr17:43113790:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05285 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr17:43094766:C>T,,Ambry_Genetics|GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,0.0116|0.3177|0.1153,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,,benign
chr13:32338004:A>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32338277:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&0,,pathogenic
chr13:32337458:G>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,2/1658,,,,,,,,,Not Specified|-,,Western Europe|-|None Specified,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43076593:C>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,1,,pathogenic
chr13:32326614:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,7/26,1,,,,,1&1&0,,pathogenic
chr17:43072249:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02846 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,benign
chr13:32345245:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,1,,benign
chr17:43094580:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,8.236e-06,benign
chr17:43092669:T>C,,Ambry_Genetics|Invitae,,,,,,,,0.001,0.0,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.0001163155,benign
chr17:43049139:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/23,,-1,,,,,,,benign
chr17:43124016:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,-1,1.0,,,1&1,1&1,,pathogenic
chr17:43124016:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,-1,1.0,,,1&1,1&1,,pathogenic
chr17:43124016:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,-1,1.0,,,1&1,1&1,,pathogenic
chr13:32399065:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.031,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.0081869,benign
chr17:43104968:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,In vitro (cloned)|Unknown,predicted deleterious|-,mRNA analysis (RT-PCR)|-,,,,,,,,,,Not Specified|-|Western/Central/Eastern Europe|Malaysian|German|Dutch|Western Europe|Russian/German/Italian,," Ashkenazi|Chinese|Not Specified|Western European|-| Japanese""""|None-Specified|North Europe| Asian|Western-European|Western Europe|Caucasian|None Specified|""""Western European",IVS,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,1&1,,pathogenic
chr17:43094170:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32340235:T>C,,Ambry_Genetics,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43094627:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-14),benign(0-085),,1,,pathogenic
chr17:43093429:TT>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-584),,,,pathogenic
chr13:32340593:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,pathogenic
chr13:32339259:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32354879:A>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43067647:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),,0&1&1,1&1&1,,pathogenic
chr17:43093496:T>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,Not Specified|Western Europe|-|American,,"Central/Eastern Europe| Central/Eastern European""""|Western European|-|Western-European|Western Europe|None-Specified|None Specified|""""Western European",N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43094688:->CT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32394749:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Asian,N,,,,,,,,stop_gained,HIGH,25/27,,1,,,,,1&1,,pathogenic
chr17:43044346:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01187 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32337996:T>-,,Faculty_of_Pharmacy|_Ain_Shams_University,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr13:32376686:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/27,,1,,,,,,,benign
chr13:32366257:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.001,0.0265,0.0072,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.0081869,benign
chr17:43093325:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,pathogenic
chr13:32339485:TGTA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/21,-1,,,,,1,,pathogenic
chr13:32394726:C>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,25/27,,1,,,,,1&1&1,,pathogenic
chr13:32394726:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,25/27,,1,,,,,1&1&1,,pathogenic
chr13:32380142:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,,1,,pathogenic
chr17:43093141:TC>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,pathogenic
chr13:32394867:GT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,pathogenic
chr17:43124026:->T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43093614:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32372082:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr17:43111549:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2317 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr13:32336781:T>G,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43094139:G>A,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,0.0,0.0,0.0,0.002,0.0,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1&1&1,0.0002326255,benign
chr17:43104104:GAA>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,20/26,1,,,,,1,,benign
chr13:32333395:TG>-,,GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,20/26,1,,,,,1,,benign
chr13:32332396:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,1.648e-05,benign
chr13:32337008:GACA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,pathogenic
chr17:43090737:->GTGCGC,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43057137:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,18/22,-1,,,,,1&1,,pathogenic
chr17:43094237:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,1&1,1&1,,benign
chr13:32325137:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,4/27,,1,,,,,,,benign
chr17:43125443:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0159,0.0058,0.0,0.001,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,0.00519169,benign
chr13:32370433:G>A,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,Germline (inherited),,,1/238 patients,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,19/27,,1,,,,,1,,pathogenic
chr13:32319080:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43061731:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| 0.1715 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.172,0.0151,0.2262,0.001,0.0542,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.0806709,benign
chr13:32338832:GA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,pathogenic
chr13:32346895:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,13/27,,1,,tolerated(0-15),benign(0-082),0&1&1,1&1&1,,benign
chr13:32337109:C>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32337945:A>AA,,Curoverse,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32326255:->G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,6/27,,1,,,,,1,,pathogenic
chr17:43093324:T>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32357901:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,16/27,,1,,,,,1,,pathogenic
chr17:43092848:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43067606:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,15/21,-1,,,,,1,,pathogenic
chr17:43047896:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.1362 (African)| 0.3694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,benign
chr13:32355136:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,pathogenic
chr17:43074861:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02846 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32362606:AA>AAAA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,17/27,,1,,,,,,,pathogenic
chr13:32337056:C>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/27,,1,,,,,1,,pathogenic
chr13:32396969:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43094151:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32326516:A>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,7/27,,1,,,,,1,,benign
chr13:32379837:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,pathogenic
chr17:43091746:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43070082:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| 0.08443 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,benign
chr13:32379399:T>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/27,,1,,,,,1,,pathogenic
chr13:32340799:T>TT,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32337832:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32340571:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,,benign
chr17:43092180:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32337537:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43071080:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/23,,-1,,,,,,,pathogenic
chr17:43092142:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,Western Europe|-,,German|Western Europe|-,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43049181:C>T,,Ambry_Genetics|Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,21/23,,-1,,,,,1&1,,pathogenic
chr17:43091690:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&0&1,1&1&1,,pathogenic
chr13:32370848:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0098,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,0.00259585,benign
chr13:32340571:C>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,,pathogenic
chr13:32337422:AACAT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,,,pathogenic
chr13:32336611:C>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,2.471e-05,benign
chr13:32370401:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,18/26,1,,,,,1&1,,pathogenic
chr13:32372668:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3811 (Asian)| 0.04268 (African)| 0.2177 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr13:32338543:A>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,pathogenic
chr17:43091772:A>AA,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43082440:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/22,,-1,,,,,,,pathogenic
chr13:32363365:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,benign
chr13:32338249:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32356559:CT>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-09),probably_damaging(0-996),,1&1,,pathogenic
chr13:32367486:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr17:43065024:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02243 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr17:43104878:TG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,pathogenic
chr13:32357804:T>TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,16/27,,1,,,,,1&1,,pathogenic
chr13:32370491:G>A,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,19/27,,1,,,,0&1&1,1&1&1,,benign
chr13:32332771:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr13:32376673:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,21/27,,1,,,,,1,,pathogenic
chr17:43091905:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-42),benign(0-036),,1,,pathogenic
chr13:32340206:AGTT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Counsyl|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,4/26,1,,,,,1,,pathogenic
chr17:43093236:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32340118:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32388542:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1084 (Asian)| 0.04065 (African)| 0.05277 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43076025:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0,0.0014,0.006,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.00139776,benign
chr17:43100586:AT>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03 (African)| 0.03 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32369699:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01715 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0139,0.0008,0.1009,0.0,0.0153,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.0199681,benign
chr13:32319070:T>TT,,Counsyl|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,2/26,1,,,,,1,,benign
chr13:32326500:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-1),probably_damaging(0-922),,1,,pathogenic
chr13:32356501:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,1,,benign
chr13:32353468:TA>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.38 (Asian)| 0.17 (African)| 0.21 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,,,1,,benign
chr17:43092327:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32394707:ATTT>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,pathogenic
chr13:32339971:AGTAA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr13:32314943:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.14 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,benign
chr17:43091937:->AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32332537:A>G,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr17:43044391:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3339 (Asian)| 0.2114 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Counsyl,,,,46/1658,,,,0.3588,0.2179,0.2911,0.373,0.498,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,0.333126,benign
chr13:32321936:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0234,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.0061901,benign
chr13:32397288:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.911 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.999,0.9145,0.9971,1.0,1.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.976837,benign
chr13:32338492:GATTA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,13/27,,1,,deleterious(0),possibly_damaging(0-886),0&1&1,0&1&1,,pathogenic
chr13:32363269:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,tolerated(0-75),benign(0-04),,1,,pathogenic
chr17:43071171:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,1&1,,benign
chr13:32325169:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,1&1,,pathogenic
chr17:43099829:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,pathogenic
chr17:43090942:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,-1,1.0,,,,1,,pathogenic
chr13:32339355:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32341669:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.02642 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0348,0.0325,0.0922,0.0962,0.1339,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.0738818,benign
chr17:43061743:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08443 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr17:43092552:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,benign
chr17:43092419:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32331004:CA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1&1,,pathogenic
chr13:32363269:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Counsyl,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/27,,1,,,,,1&1&1&1,,pathogenic
chr17:43093179:C>T,,Ambry_Genetics|GeneDx|Counsyl|Invitae,,,,,,0.0233|0.0|0.0154,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32339623:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,4.119e-05,benign
chr13:32337772:G>A,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,,benign
chr13:32333396:GT>-,,GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32354986:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,14/27,,1,,,,,1&1,,pathogenic
chr13:32340420:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32331135:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,,benign
chr13:32354990:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,1,,benign
chr17:43076487:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned),predicted deleterious,Splicing reporter minigene,,,,,,,,,,,,Western-European|-Western-European| East Indian|Asian| Asian,IVS,,,,,,,,splice_donor_variant,HIGH,,12/21,-1,,,,0&0&0&0&1,1&1&1&1&1,,pathogenic
chr13:32339699:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-924),,1,,pathogenic
chr13:32378219:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01319 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,benign
chr13:32379914:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1&1,,pathogenic
chr13:32332654:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr13:32379914:G>A,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Division_of_Human_Genetics_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1&1,,pathogenic
chr17:43109216:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr13:32368935:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1259 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32318683:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.09441 (Asian)| 0.03252 (African)| 0.04617 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,benign
chr13:32386531:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43043694:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.22 (African)| 0.36 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43126870:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32355107:AG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,10/27,,1,,,,,,,pathogenic
chr17:43091540:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32339939:GTGA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32358468:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr13:32398701:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32342160:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1853 (Asian)| 0.1972 (African)| 0.1755 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.2008,0.1846,0.1527,0.1726,0.1196,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.168331,benign
chr13:32329463:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,8/27,,1,,,,,1,,pathogenic
chr17:43094707:CCACATGGCT>CCACATGGCTCCACATGGCT,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32398337:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43083782:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.4056 (Asian)| 0.07114 (African)| 0.3773 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3748,0.9486,0.4582,0.4435,0.5481,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.585463,benign
chr13:32379795:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,pathogenic
chr13:32398283:AAGA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32336958:C>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32357797:AG>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/21,-1,,,,,,,pathogenic
chr13:32338355:TT>-,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,possibly_damaging(0-878),,1,,pathogenic
chr13:32340999:ACTC>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr17:43124000:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32376668:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,20/26,1,,,,,1&1,,pathogenic
chr17:43092937:T>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,1,,,,,1&1&1,,pathogenic
chr17:43051076:G>GG,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,20/23,,-1,,,,,,,pathogenic
chr13:32316408:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,benign
chr13:32362547:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,17/27,,1,,,,,,,benign
chr13:32357930:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,, Greek|Central/Eastern European|African,IVS,,,,,,,,splice_donor_variant,HIGH,,16/26,1,,,,0&1&1,1&1&1,8.236e-06,pathogenic
chr13:32337985:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32332861:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr13:32340043:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32337513:T>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43093969:GC>TA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32340717:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-275),,1&1,,benign
chr17:43126708:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.5 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43124031:T>TT,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,1,,pathogenic
chr17:43079885:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.126 (African)| 0.3562 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,benign
chr13:32317661:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3864 (Asian)| 0.1707 (African)| 0.281 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,benign
chr17:43106457:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,,deleterious(0),,,1&1&1,,pathogenic
chr13:32333071:A>AA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43074461:C>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,,benign
chr13:32339976:TTAA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,,pathogenic
chr17:43094139:G>GG,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32372283:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04268 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr13:32337464:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,HKSAR|-|Italian,,Chinese|Pakistani|Asian|Chinese |Caucasian,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43110340:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr17:43104942:CTTT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,pathogenic
chr13:32332476:T>TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43092690:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32370976:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,20/27,,1,,,,,,,benign
chr13:32370967:G>A,,Ambry_Genetics,,,,,,,,0.0,0.0,0.0014,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,20/27,,1,,,,,1,0.0001039585,benign
chr13:32367304:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02972 (Asian)| 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr17:43094097:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,pathogenic
chr13:32369645:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01829 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32340830:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,0&1&1&1&1,1&1&1&1&1,,pathogenic
chr13:32332731:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,0&1&1,1&1&1,,pathogenic
chr13:32339291:GA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,probably_damaging(0-977),,1,,pathogenic
chr13:32338613:G>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Counsyl|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,pathogenic
chr13:32340380:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32336581:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32376782:TTAC>TTACTTAC,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,21/27,,1,,,,,,,pathogenic
chr17:43045257:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3322 (Asian)| 0.126 (African)| 0.3588 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,46/1658,,,,0.3569,0.1566,0.2839,0.372,0.498,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,0&1,0.3077405,benign
chr13:32399139:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06294 (Asian)| 0.3435 (African)| 0.277 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43127867:AC>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.37 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-34),benign(0-009),,1,,benign
chr17:43093290:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-001),,1,,pathogenic
chr17:43093174:AGTAACG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-001),,1,,pathogenic
chr13:32376120:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.502 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.5159,0.503,0.5375,0.5327,0.4683,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.509585,benign
chr13:32340011:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32380037:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,pathogenic
chr17:43063893:T>-,,Strand_Center_for_Genomics_and_Personalized_Medicine|Strand_Life_Sciences_Pvt_Ltd,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,pathogenic
chr13:32326520:AT>ATAT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,7/27,,1,,,,,1&1,,pathogenic
chr13:32337466:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32344085:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.03049 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0348,0.0552,0.0937,0.0962,0.1339,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.0800719,benign
chr17:43052636:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06301 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0393,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.0105831,benign
chr13:32362651:G>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32354903:C>T,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,0&1&1,1&1&1,8.236e-06,benign
chr17:43092764:CTGT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43092350:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43093374:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43091558:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32339958:ACAG>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,pathogenic
chr17:43118260:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3569,0.1573,0.3631,0.372,0.4969,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.335463,benign
chr17:43091033:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown,predicted deleterious|-,-|Multifactorial likelihood-ratio model,,,,,,,,,,,,Western European,IVS,5 - Definitely pathogenic,1.0,1.02,22.91,0.999,,0.97,splice_acceptor_variant,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr17:43076488:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Invitae|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,,deleterious(0),,,1&1&1,,pathogenic
chr17:43114335:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr13:32340059:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0116|1.8384|0.6306,benign:0.055,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-21),benign(0-072),,1,,benign
chr13:32352524:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32341186:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43092969:->GC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43104262:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,4/21,-1,,,,,1&1,,pathogenic
chr17:43104262:C>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,4/21,-1,,,,,1&1,,pathogenic
chr13:32338640:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43092919:GG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,6/21,-1,1.0,,,,1&1,,pathogenic
chr13:32332615:A>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,pathogenic
chr17:43099837:A>AA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr13:32332439:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1&1,,pathogenic
chr17:43082413:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/22,,-1,,,,,,,pathogenic
chr13:32351909:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1031 (Asian)| 0.01423 (African)| 0.0343 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32340385:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,1&1,1&1,,benign
chr13:32345631:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03846 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0008,0.0591,0.0317,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.014976,benign
chr13:32385652:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.2587 (Asian)| 0.2195 (African)| 0.2137 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32379814:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1&1,,pathogenic
chr17:43091813:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,-|1/1658,,,,,,,,,-|Central/Eastern Europe,,Western-European|Western European|-,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32356611:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,15/26,1,,,,,1&1,,pathogenic
chr17:43091901:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-06),benign(0-083),,1&1,,pathogenic
chr17:43092940:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32394812:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,25/27,,1,,,,,1,,pathogenic
chr13:32339319:A>AA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43091679:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32397570:T>TT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.55 (Asian)| 0.51 (African)| 0.54 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43082518:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43090943:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr17:43090943:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr13:32339512:TTCAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43094549:AT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,pathogenic
chr17:43097347:A>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.13 (African)| 0.35 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1,,benign
chr17:43121006:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08537 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32396296:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03455 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43045691:T>G,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,,benign(0),,1,0.036,pathogenic
chr17:43045573:ACAG>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,,,,,,pathogenic
chr17:43064188:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.1179 (African)| 0.2744 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr17:43078211:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.126 (African)| 0.3549 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr13:32397045:G>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43082397:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,11/21,-1,,,,,1,,benign
chr13:32319132:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,,,benign
chr13:32398179:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,pathogenic
chr17:43106489:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,pathogenic
chr13:32338840:C>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,1&1,1&1,,benign
chr13:32355265:CAAAGTGTGA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/22,,-1,,,,,1,,pathogenic
chr13:32336839:T>C,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,4.119e-05,benign
chr13:32316853:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr17:43047704:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,20/21,-1,,,,,1,,pathogenic
chr13:32339320:C>R,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,1&1&1&1&1,,pathogenic
chr17:43093656:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,1&1&1&1&1,,pathogenic
chr13:32336746:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43092610:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,pathogenic
chr17:43078938:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr17:43071011:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/23,,-1,,,,,1,,pathogenic
chr13:32344804:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.07343 (Asian)| 0.311 (African)| 0.2018 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,benign
chr17:43067655:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/22,,-1,,,,,,,pathogenic
chr13:32339428:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1&0,,pathogenic
chr13:32340704:T>TT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43093656:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32337632:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,,pathogenic
chr17:43074462:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,benign
chr13:32332619:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-08),benign(0-126),,1,,benign
chr17:43075066:->GGAA,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.21 (African)| 0.35 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43091456:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western Europe,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32357158:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,,benign
chr13:32349851:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32354995:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-06),benign(0-001),,,,pathogenic
chr13:32363449:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,,benign
chr13:32331024:A>AA,,Faculty_of_Pharmacy|_Ain_Shams_University,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,9/27,,1,,,,,1,,pathogenic
chr13:32382620:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.2587 (Asian)| 0.2195 (African)| 0.2137 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32339383:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43093098:G>-,,Pathway_Genomics|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,pathogenic
chr17:43091663:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32338626:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,,pathogenic
chr17:43094696:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32396999:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43073762:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,benign
chr17:43095913:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,benign
chr17:43082434:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/22,,-1,,,,0&0&0&1&1,1&1&1&1&1,,pathogenic
chr17:43071159:TG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,pathogenic
chr17:43093919:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43072816:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3417 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,benign
chr13:32340423:ACCAG>-,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32332750:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr17:43114022:C>CC,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr13:32337253:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43093742:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,Western European,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,0&1&1,1&1&1,,pathogenic
chr17:43057065:G>GG,,GeneReviews|Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/22,,-1,,,,,,,pathogenic
chr17:43063883:T>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 0.99,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),In vitro (cloned),predicted deleterious|as variant control|strong functional effect,Peptide binding ability|Bayesian statistics|Structure-based prediction (crystallography etc)|Prevalence in normal controls|transcription activation/PS/BA/BS|Multifactorial likelihood-ratio model|Proteolytic degradation|evolutionary conservation analysis,,,,,,,,,,Denmark,,,M,5 - Definitely pathogenic,1.0,1.23,36.31,0.9948,0.81,0.81,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-991),,1&1&1,,pathogenic
chr13:32364532:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04268 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0378,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.00998403,benign
chr17:43088583:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01748 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr17:43099836:CA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,pathogenic
chr13:32396972:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32347011:->TTTATAAAA,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1 (Asian)| 0.03 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32341120:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43051084:GC>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr17:43092456:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32339288:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Central/Eastern European,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43063348:TC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32370497:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,19/27,,1,,,,,,,benign
chr13:32379415:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/27,,1,,,,,,,benign
chr17:43073766:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3392 (Asian)| 0.1748 (African)| 0.4182 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,benign
chr13:32338918:A>C,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,8.237e-06,benign
chr17:43049498:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01573 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0,0.0,0.0129,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.00259585,benign
chr13:32398537:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,benign
chr17:43092423:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(0-999),,1,,pathogenic
chr17:43104867:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,4/21,-1,,,,,,8.237e-06,pathogenic
chr13:32340760:CTTAA>-,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,4/21,-1,,,,,,,pathogenic
chr13:32325762:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,benign
chr17:43090589:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32350747:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.243 (Asian)| 0.1016 (African)| 0.2836 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32338942:G>GG,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32340958:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43049347:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08443 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,benign
chr13:32340594:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32326609:C>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,7/27,,1,,,,,1,,benign
chr13:32396918:TG>AT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32340790:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,1&1,1&1,,benign
chr17:43124055:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,1,,benign
chr13:32326609:C>T,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,7/27,,1,,,,,1,,benign
chr13:32337620:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32338816:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32327292:->C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (Asian)| 0.02 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,benign
chr13:32340763:AAATGTT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,pathogenic
chr17:43094862:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,,-1,,,,,1&1,,pathogenic
chr13:32338126:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,,benign
chr17:43115747:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,probably_damaging(0-984),,1,,pathogenic
chr13:32332930:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,0&1&1,1&1&1,,benign
chr17:43094081:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32394742:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,pathogenic
chr13:32336973:T>TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32384329:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3811 (Asian)| 0.1402 (African)| 0.2177 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr17:43071113:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/23,,-1,,,,,1&1,,pathogenic
chr17:43080841:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08333 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,benign
chr13:32380145:GG>TA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant&coding_sequence_variant,HIGH,,,1,,,,,1,,pathogenic
chr13:32398763:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32338456:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1,,benign
chr17:43096467:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3536 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3529,0.1573,0.3646,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.334864,benign
chr13:32332840:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43094697:->T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32336488:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1&1,1&1&1&1,,benign
chr17:43094736:AG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0-01),possibly_damaging(0-507),,1,,pathogenic
chr13:32332434:A>AA,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32338167:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32337428:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43053354:T>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,benign
chr13:32339097:->TG,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43093910:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,-|1/1658,,,,,,,,,German|-,1|3|-,Western Europe|-|Caucasian,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32330985:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,probably_damaging(0-98),,,,pathogenic
chr13:32340373:TA>TATA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32337850:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,0.0001071,benign
chr17:43092873:AG>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,1&1,,pathogenic
chr13:32339163:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43099808:G>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-33),benign(0-015),,1,,pathogenic
chr17:43106508:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1&1,,pathogenic
chr17:43099808:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,1.0,,,,1&1&1&1,,pathogenic
chr13:32388063:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32341030:A>G,,Ambry_Genetics|GeneDx,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32340747:AATTA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr17:43067324:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1626 (Asian)| 0.1138 (African)| 0.2704 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,1,,benign
chr13:32363866:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04065 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr17:43093198:->CA,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,pathogenic
chr13:32319307:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Central/Eastern European,N,,,,,,,,stop_gained,HIGH,3/27,,1,,,,,1,,pathogenic
chr17:43106433:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06301 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),In vitro (cloned)|Unknown,no splicing defect|-,exon inclusion|-,,,0.0|3.1349|1.0625,None|None|None|None|None,0.0,0.0393,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,1,0.00687755,benign
chr17:43091760:CT>-,,Ambry_Genetics|Invitae|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr17:43098906:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.1341 (African)| 0.3654 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,benign
chr13:32337556:T>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,benign(0-108),,1,,pathogenic
chr17:43092718:GG>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43045684:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/22,,-1,,,,,1,,benign
chr13:32339200:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/22,,-1,,,,,1,,pathogenic
chr17:43094051:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43094031:ATTT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32371400:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06294 (Asian)| 0.2012 (African)| 0.2836 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr13:32337236:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32338648:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32376803:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,benign
chr17:43100609:->AT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.15 (Asian)| 0.12 (African)| 0.17 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,,benign
chr13:32344544:A>T,,Invitae,,,,,,0.012|0.0|0.0079,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,1,,benign
chr13:32338192:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,0&1&1,,pathogenic
chr17:43094697:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,1.647e-05,benign
chr13:32333077:TG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-04),probably_damaging(0-999),0&1&1,1&1&1,,pathogenic
chr17:43115033:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3562 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3539,0.2171,0.3775,0.371,0.5061,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.354233,benign
chr13:32337013:TG>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,pathogenic
chr13:32398144:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43093571:T>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,pathogenic
chr17:43104225:TTAT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43093317:A>AA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43045708:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/22,,-1,,,,,,,benign
chr13:32340622:GCAT>GCATGCAT,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32335919:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1031 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,benign
chr13:32337188:->TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32394706:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43111432:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03322 (Asian)| 0.04472 (African)| 0.02902 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr17:43063808:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3615 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,1&1,,benign
chr13:32398437:C>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,In vitro (cloned)|Unknown,-|inconclusive|as variant control,Cell viability (in BRCA-/- cells)|Homology-directed repair assay|-|Nuclear foci formation BRCA2/BRC3 domain - Rad51,2/1658|-,,,,,,,,,Western Europe|-,,"Latin American/Caribbean| Central/Eastern European""""|Western European|-| Irish & German""""|Western Europe| M & P|None Specified|""""Western European",N,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,1.647e-05,pathogenic
chr17:43052188:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr17:43093234:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-033),,1,,pathogenic
chr13:32355272:TG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-033),,1,,pathogenic
chr17:43115796:G>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr13:32340036:A>AA,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32356610:G>A,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,In vitro (cloned)|Unknown,Aberrant splicing|-| skip exon 15,-|cDNA analysis,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,15/26,1,,,,,1&1&1,,pathogenic
chr17:43092263:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32332296:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43115968:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0159,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.00499201,benign
chr13:32371076:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,20/27,,1,,,,0&1&1,1&1&1,,pathogenic
chr17:43063340:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,pathogenic
chr13:32355088:->G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,14/27,,1,,,,,1,,pathogenic
chr13:32339390:A>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,,pathogenic
chr13:32332849:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr17:43093575:TTTC>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,pathogenic
chr13:32379251:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.502 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,35/1658|-,,,,0.5159,0.5113,0.536,0.5327,0.4683,South African|-|Austria,12|-|1|0|3|2,Global|White South African|-|Caucasian,IVS,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,1,0.511581,benign
chr13:32382599:G>GG,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr17:43057086:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,pathogenic
chr17:43092108:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43069579:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05285 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,benign
chr17:43093784:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43127820:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.13 (African)| 0.35 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43045764:CTCGGGTCACC>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,22/22,,-1,,,,,1,,pathogenic
chr13:32332507:A>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,pathogenic
chr13:32379745:AACA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43124331:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43093426:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Latin American/Caribbean,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43092522:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32339924:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1,,pathogenic
chr17:43071198:AGAGA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,pathogenic
chr17:43113156:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02846 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr17:43104263:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,4/21,-1,,,,,1&1,,pathogenic
chr17:43104263:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,4/21,-1,,,,,1&1,,pathogenic
chr13:32333367:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32338986:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43093110:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43090967:GA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-687),,1,,pathogenic
chr13:32321537:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.09615 (Asian)| 0.01626 (African)| 0.04617 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43124010:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,1.0,,,,1,8.237e-06,benign
chr13:32393238:C>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.23 (Asian)| 0.02 (African)| 0.21 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,1&1&1,,benign
chr13:32337141:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000741,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,Histopathology|-,,,0.0116|1.0894|0.3769,benign:0.091,0.0,0.0076,0.0,0.0,0.0,Latin American/Caribbean|African American|-,," Native American""""| Latin American/Caribbean""""|Western European|-| Native Americ|""""African|African| African|African American|""""Western European| Jamaican (Africian) Scottish""""|None Specified|Trinidad",M,1 - Not pathogenic or of no clinical significance,,0.001,4.97,7e-05,0.02,0.02,missense_variant,MODERATE,11/27,,1,,,,,1&1&1,0.001447305,benign
chr13:32379774:C>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,1,,,,,1&1&1,,pathogenic
chr13:32325166:A>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,pathogenic
chr17:43092726:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,pathogenic
chr17:43079499:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3588 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3579,0.2194,0.3746,0.371,0.4969,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.353435,benign
chr13:32325185:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,4/26,1,,,,,1,,pathogenic
chr17:43092854:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43104263:T>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43094722:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/27,,1,,deleterious(0),probably_damaging(1),,1,,pathogenic
chr13:32320840:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05285 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0582,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.0157748,benign
chr13:32357726:TGTT>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32336973:TA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,pathogenic
chr17:43110694:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05285 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr17:43091565:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/22,,-1,,deleterious(0),probably_damaging(0-912),,1&1,,pathogenic
chr13:32363642:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32338566:CAAAT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,9/27,,1,,,,,,,pathogenic
chr17:43093277:AC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,9/27,,1,,,,,,,pathogenic
chr13:32387908:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.5061 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43072015:T>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43093658:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32338482:GAAA>-,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,pathogenic
chr17:43090963:CT>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,,pathogenic
chr17:43091752:->T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,0&1,,pathogenic
chr13:32391514:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.909 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32364848:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04268 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32379883:G>A,,Ambry_Genetics|GeneDx|Invitae,In vitro (cloned)|Unknown,no splicing defect|-,splicing reporter minigene|-,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,1,4.943e-05,benign
chr17:43104234:T>TT,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,6/23,,-1,,,,,,,pathogenic
chr17:43118212:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr13:32319337:A>G,,GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,1,,benign
chr13:32394810:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,25/27,,1,,,,,,,benign
chr13:32346848:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,13/27,,1,,,,,1&1,,pathogenic
chr13:32338726:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,8.239e-06,benign
chr13:32339997:AATC>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,1&1&1&1,,pathogenic
chr17:43049196:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,19/21,-1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32363286:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43091951:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,benign(0-001),,1,,pathogenic
chr17:43110292:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr17:43077761:T>TT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.98 (Asian)| 0.96 (African)| 0.98 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr13:32340409:T>C,,Invitae,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,0.000103959,benign
chr17:43094459:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,pathogenic
chr13:32332645:G>A,,Ambry_Genetics|Invitae,,,,,,0.0|0.023|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,4.946e-05,benign
chr17:43063932:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,17/23,,-1,,,,,1,4.118e-05,benign
chr13:32340212:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,pathogenic
chr13:32341836:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,benign
chr13:32340979:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43092338:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43106455:C>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43066316:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr17:43094001:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,25/26,1,,,,,,,pathogenic
chr17:43092986:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43106455:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,4/22,-1,,,,,1&1&1,,pathogenic
chr17:43104173:G>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,Asian,N,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,8.236e-06,pathogenic
chr13:32385401:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02243 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43106455:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,4/22,-1,,,,,1&1&1,,pathogenic
chr17:43094316:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43106455:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,4/22,-1,,,,,1&1&1,,pathogenic
chr13:32385062:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.502 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.5159,0.5113,0.536,0.5327,0.4683,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.511581,benign
chr13:32338624:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32336641:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43092302:CT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Counsyl|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,,pathogenic
chr17:43092801:TTGAT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,pathogenic
chr17:43078319:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3234 (Asian)| 0.128 (African)| 0.3522 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr17:43057124:T>-,,Faculty_of_Pharmacy|_Ain_Shams_University,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,pathogenic
chr13:32398389:G>A,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32372278:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.909 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr17:43091818:GGTATATT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,pathogenic
chr17:43094515:T>TT,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Curoverse,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43092669:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43090832:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.285 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32332504:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr13:32319285:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,3/27,,1,,,,,1,,pathogenic
chr17:43091460:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32339706:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32397453:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0129,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.00339457,benign
chr13:32370558:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,19/26,1,,,,,1&1,,pathogenic
chr13:32337153:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,pathogenic
chr13:32330949:G>T,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,Germline (inherited),,,1/238 patients|-,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,pathogenic
chr13:32337106:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,8.237e-06,benign
chr13:32338361:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,,,pathogenic
chr13:32370558:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,19/26,1,,,,,1&1,,pathogenic
chr13:32332697:C>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,16/27,,1,,,,,1&1,,pathogenic
chr17:43052001:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr17:43092069:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32371474:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr17:43098205:T>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-82),benign(0-004),,1&1,,benign
chr17:43092662:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32394672:T>TT,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32356550:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,-|1/1658,,0.0116|0.0|0.0077,None,,,,,,Not Specified|Malaysian|-,,"Latin American/Caribbean|Native American| Central/Eastern European""""|Chinese|Central/Eastern Europe|Not Specified|Western European|-| Ashkenazi""""|Asian|English|Western Europe|""""Western European|White|None Specified|Central/Eastern European",N,,,,,,,,stop_gained,HIGH,15/27,,1,,,,,1&1,2.471e-05,pathogenic
chr17:43055445:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05145 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0586,0.003,0.0461,0.0,0.0133,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.0215655,benign
chr13:32329469:GT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-11),benign(0-056),,1,,pathogenic
chr13:32333277:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-25),benign(0-009),,1,,pathogenic
chr13:32379334:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/27,,1,,,,,,,benign
chr17:43106131:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1463 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,,benign
chr17:43069161:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04878 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,benign
chr17:43124028:CT>CTCT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr13:32394864:TG>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-22),benign(0-006),,,,pathogenic
chr17:43092845:TT>-,,Pathway_Genomics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,6/21,-1,1.0,,,,1&1,,pathogenic
chr13:32359789:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3864 (Asian)| 0.1606 (African)| 0.219 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.2087,0.208,0.1988,0.369,0.1748,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.232827,benign
chr13:32394887:AG>AGAG,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,25/27,,1,,,,,,,pathogenic
chr17:43084026:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02846 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr13:32333122:G>A,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr17:43092465:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,benign(0-003),,1,,pathogenic
chr13:32336941:AAATCAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,pathogenic
chr17:43093705:TTCT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Counsyl|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,pathogenic
chr13:32342540:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02622 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,benign
chr17:43092535:AG>TA,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32336446:A>AA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32330970:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,9/27,,1,,,,,1,,pathogenic
chr17:43097307:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,9/27,,1,,,,,1,,benign
chr13:32339291:GAAA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,pathogenic
chr13:32347169:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr17:43091567:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43060152:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32341093:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32325083:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,4/27,,1,,,,,1,8.237e-06,benign
chr17:43115721:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,3/22,-1,1.0,,,,,,pathogenic
chr17:43115721:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,3/22,-1,1.0,,,,,,pathogenic
chr17:43090065:A>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04 (Asian)| 0.05 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,3/22,-1,1.0,,,,,,benign
chr13:32398734:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43045658:G>A,,GeneDx,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,3_prime_UTR_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43039471:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43063953:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,15/21,-1,,,,,1&1&1,,pathogenic
chr17:43056288:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr13:32381563:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr17:43074331:C>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,,,,,1&1,,pathogenic
chr17:43079204:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3536 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3569,0.1573,0.3646,0.371,0.4969,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.335463,benign
chr17:43074331:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,,,,,1&1,,pathogenic
chr13:32332667:->TTAG,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,10/27,,1,,,,,,,pathogenic
chr17:43104959:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,"""""Latin American/Caribbean| Hispanic Columbia""""",IVS,,,,,,,,splice_region_variant&intron_variant,LOW,,4/22,-1,,,,,1,,pathogenic
chr13:32379437:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/27,,1,,,,,,,pathogenic
chr13:32336805:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/27,,1,,,,,,,pathogenic
chr13:32341112:CT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/27,,1,,,,,,,pathogenic
chr13:32363439:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43074348:AAGT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,pathogenic
chr13:32364036:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0348,0.0295,0.0908,0.0962,0.1329,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.0726837,benign
chr13:32336222:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0|0.9777|0.3311,None,0.0,0.0227,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.00359271,benign
chr13:32338270:T>-,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32337531:TG>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,pathogenic
chr17:43092919:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&0&0&1,1&1&1&1&1,,benign
chr13:32363332:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&0&0&1,1&1&1&1&1,,pathogenic
chr13:32394828:A>G,,Ambry_Genetics|Invitae,,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,25/27,,1,,,,,1,0.0001080755,benign
chr13:32318598:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.7063 (Asian)| 0.5183 (African)| 0.7084 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,benign
chr13:32340566:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,pathogenic
chr17:43104148:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr13:32332840:A>G,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,0.0,0.0,0.0,0.0069,0.0,Malaysian,,Chinese,Syn,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1&1,0.00084713,benign
chr13:32319298:G>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,3/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32338760:GACAT>-,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),0&0&0&1&1,1&1&1&1&1,,pathogenic
chr13:32340283:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32347584:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02902 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr17:43092853:TTTA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43111593:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr13:32336482:G>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,8.237e-05,benign
chr17:43115711:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr13:32332696:C>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr13:32326575:TAGC>AGG,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,HIGH,7/27,,1,,,,,,,pathogenic
chr17:43093232:T>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,pathogenic
chr13:32339572:TTTAAGT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr17:43089551:->C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.13 (African)| 0.35 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32339514:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43091489:CT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,20/27,,1,,,,,,,pathogenic
chr13:32339765:GT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,12/27,,1,,deleterious(0),probably_damaging(1),,1,,pathogenic
chr13:32357845:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,None Specified,N,,,,,,,,stop_gained,HIGH,16/27,,1,,,,,1,,pathogenic
chr13:32339514:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32388406:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05894 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43067677:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,pathogenic
chr13:32319259:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,3/27,,1,,,,,1&1,,pathogenic
chr17:43063332:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,18/22,-1,,,,,1,,pathogenic
chr17:43063332:C>A,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,18/22,-1,,,,,1,,pathogenic
chr13:32379431:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/27,,1,,,,,1&1,,pathogenic
chr17:43063332:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,18/22,-1,,,,,1,,pathogenic
chr17:43092089:C>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43115163:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0076,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.00199681,benign
chr17:43052761:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05081 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr13:32363525:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,1,,pathogenic
chr17:43063928:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,pathogenic
chr13:32319061:T>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43094756:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,pathogenic
chr17:43121231:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1484 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.003,0.149,0.0187,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.0425319,benign
chr17:43049140:G>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,21/23,,-1,,,,,1,,pathogenic
chr17:43071147:A>C,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,1,,benign
chr13:32332297:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr17:43120979:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01319 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0129,0.0015,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.00379393,benign
chr13:32355251:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,,,benign
chr17:43092671:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43091759:CC>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32379894:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,,,1,,,,0&1&1,1&1&1,,pathogenic
chr13:32356588:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,1,,benign
chr13:32380776:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0507 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr17:43104136:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,In vitro (cloned)|Unknown|Germline (inherited),as wildtype control|-,Recombination rate|-,-|6/1658,,,,,,,,,Not Specified|Western Europe|-,," Native American|Irish| Central/Eastern European""""|White-NonHispanic|-Italy|Western European|-|None-Specified|-Irish|Unknown|Western-European|Western Europe|""""Western European|Central/Eastern-European|Caucasian|None Specified| Ashkenazi""""",N,,,,,,,,stop_gained,HIGH,,,-1,,,,0&0&1&1&1,1&1&1&1&1,,pathogenic
chr17:43092621:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32340175:GAAAGTTTCTAAAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr17:43074380:AG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr13:32371114:T>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,1,,benign
chr13:32333320:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43091759:CC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0-04),,,1&1,,pathogenic
chr17:43092501:AG>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0-04),,,1&1,,pathogenic
chr17:43094317:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32356588:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,1,,benign
chr17:43094317:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32354968:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,14/27,,1,,,,,1,,pathogenic
chr13:32382007:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32339773:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Emory_Genetics_Laboratory|Counsyl|Invitae,,,,,,0.0|2.4512|0.8304,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43111828:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr17:43093772:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-27),benign(0-295),,1,,pathogenic
chr13:32390367:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.229 (Asian)| 0.01626 (African)| 0.2111 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43063946:C>A,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,17/23,,-1,,,,,1&1&1&1,,pathogenic
chr13:32369919:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3811 (Asian)| 0.1402 (African)| 0.2177 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr17:43092261:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr13:32338369:->GG,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,1&1,1&1,,pathogenic
chr13:32319283:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,3/27,,1,,,,,1,,pathogenic
chr13:32340000:C>A,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,0&0&0&1&1,1&1&1&1&1,,pathogenic
chr17:43124076:G>A,,Ambry_Genetics|Emory_Genetics_Laboratory|GeneDx|Counsyl|Invitae,,,,,,0.0|0.4995|0.1692,None|None|None|None|None,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,0&1&1,1&1&1,0.00105817,benign
chr13:32362638:GAATTT>AG,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,17/27,,1,,,,,1,,pathogenic
chr17:43113759:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr13:32384860:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0507 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32339185:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32380071:T>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,pathogenic
chr13:32336723:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43091958:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32346885:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,13/27,,1,,,,,1&1&1,1.648e-05,benign
chr13:32337022:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43092040:CTAGTATCTTC>-,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32330937:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43092092:AACA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32399167:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05691 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.002,0.0598,0.0029,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.0165735,benign
chr13:32338948:A>AA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32337153:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,1,,pathogenic
chr17:43092805:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,1,,pathogenic
chr13:32333719:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.1203,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,0.0323482,benign
chr13:32351783:->ATTTT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32340148:A>G,,Ambry_Genetics,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,4.118e-05,benign
chr17:43086485:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr17:43091631:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr13:32340078:TAGAT>-,,Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32355041:G>A,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,1,7.413e-05,benign
chr13:32355041:G>T,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-38),possibly_damaging(0-731),,1,1.647e-05,benign
chr13:32339331:->G,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,,,pathogenic
chr13:32362509:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.5507 (Asian)| 0.5589 (African)| 0.5409 (European)| derived from 1000 genomes (2012-04-30).,Ambry_Genetics|Emory_Genetics_Laboratory|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Counsyl,,,,,,49.6279|44.7751|47.9849,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,0&1,,benign
chr13:32370413:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,0&1,,pathogenic
chr13:32359800:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.9065 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr13:32376704:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/27,,1,,,,,,,benign
chr17:43092791:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43099491:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.2236 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,benign
chr17:43093025:C>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,1,,,,,1,,pathogenic
chr13:32330992:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr17:43074452:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,benign
chr17:43091459:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32341057:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,0&1,,pathogenic
chr13:32339572:TTTA>-,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32355095:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3864 (Asian)| 0.1585 (African)| 0.219 (European)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,21.3256|20.7671|21.1364,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,0&1,1&1,,benign
chr13:32396995:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32337191:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32340425:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Central/Eastern European| Greek,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43091783:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&0&0&1&1,1&1&1&1&1,,pathogenic
chr17:43071240:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,13/21,-1,,,,,1,,pathogenic
chr17:43093107:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,13/21,-1,,,,,1,,pathogenic
chr13:32339420:GC>AAA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32354065:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06993 (Asian)| 0.3232 (African)| 0.2836 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.2724,0.2799,0.2478,0.0754,0.1595,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.209265,benign
chr17:43102743:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,benign
chr17:43091783:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000204,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0349|0.0227|0.0308,possibly-damaging:0.84|None|None|possibly-damaging:0.84|possibly-damaging:0.84,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&0&0&1&1,1&1&1&1&1,,benign
chr17:43092532:T>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,,pathogenic
chr17:43063923:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32338035:TG>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,pathogenic
chr13:32339572:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1&1&1&1,8.239e-06,benign
chr13:32338603:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32340800:AT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43060745:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3801 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr17:43074380:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,,benign
chr13:32340366:AAGATAG>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,,pathogenic
chr13:32379853:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,,pathogenic
chr17:43119205:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr17:43101650:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08333 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,benign
chr13:32370972:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,20/27,,1,,,,0&0&1&1&0,1&1&1&1&0,,pathogenic
chr17:43063941:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32325148:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32359302:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02622 (Asian)| 0.02902 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr17:43099791:A>AA,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr17:43074454:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr17:43049141:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32363436:TGAC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),possibly_damaging(0-772),,1,,pathogenic
chr17:43049193:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,21/23,,-1,,,,,1,,benign
chr13:32338063:A>AA,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43126716:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32337619:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1&0,,pathogenic
chr17:43124135:->AT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32336579:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Latin American/Caribbean|Latin American/Caribbean/Western Europe,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,8.236e-06,pathogenic
chr17:43093759:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr17:43094204:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43063854:A>T,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0233|0.0|0.0154,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/22,-1,,,,,1,,benign
chr13:32373717:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr17:43090959:GTCA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,5_prime_UTR_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43071150:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,1&1&1,,benign
chr17:43093013:TG>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-21),benign(0-072),,1,,pathogenic
chr17:43092633:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32355154:A>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43067543:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3322 (Asian)| 0.1402 (African)| 0.2744 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,6/1658,,,,0.2744,0.1611,0.3084,0.372,0.4693,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,1,0.306909,benign
chr13:32340469:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43090981:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,1.0,,,,1,,pathogenic
chr17:43094132:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32340592:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32357805:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,16/27,,1,,,,,1,,pathogenic
chr13:32394688:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,24/26,1,,,,,1&1&1,,pathogenic
chr13:32375245:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.5407 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr17:43112322:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr13:32396957:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32380559:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08333 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32363244:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,pathogenic
chr13:32356420:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,14/26,1,,,,,1,,benign
chr13:32346876:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,13/27,,1,,,,,1,,benign
chr17:43044565:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32371062:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,20/27,,1,,,,,1,,pathogenic
chr13:32337525:AGAAA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1,,pathogenic
chr17:43059636:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32379837:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,pathogenic
chr17:43063374:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,17/22,-1,,,,0&0&0&1&1,1&1&1&1&1,,pathogenic
chr13:32370957:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,20/27,,1,,,,,1,,pathogenic
chr17:43063374:C>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,17/22,-1,,,,0&0&0&1&1,1&1&1&1&1,,pathogenic
chr13:32336685:A>AA,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32339380:T>C,,Ambry_Genetics,,,,,,0.0117|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32331431:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0257,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,0.00678914,benign
chr17:43091912:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43117163:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02111 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0278,0.0023,0.0202,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.00958466,benign
chr13:32363272:TT>TTTT,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,,,pathogenic
chr13:32337334:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43107539:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr17:43082539:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/22,,-1,,,,,1&1,,pathogenic
chr17:43126099:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.72 (African)| 0.37 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,0&1,,benign
chr13:32340057:AG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,1,,,,,1&1&1,,pathogenic
chr17:43078027:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02111 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0298,0.0023,0.0216,0.0,0.0041,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.0103834,benign
chr17:43047719:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,1,,benign
chr17:43057060:->G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,18/22,,-1,,,,,,,pathogenic
chr17:43120293:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr13:32341165:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32363407:CC>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,pathogenic
chr13:32380005:A>G,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned)|Unknown,-|?|as variant control,mRNA analysis (RT-PCR)|-|?,,,,,,,,,,Czech|-,,Finland|Caucasian,IVS,,,,,,,,splice_acceptor_variant,HIGH,,,1,,,,0&0&1&1,1&1&1&1,3.295e-05,pathogenic
chr13:32348194:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0542 (Asian)| 0.1319 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32332522:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr13:32338392:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,pathogenic
chr17:43092191:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western European,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32316546:T>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,,benign
chr13:32371040:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,20/27,,1,,,,,1&1,,pathogenic
chr13:32340340:C>T,,Ambry_Genetics|Invitae,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,,benign
chr17:43074388:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr13:32333291:A>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr13:32339550:T>-,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr13:32333251:TTAT>-,,Invitae|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr13:32339002:AGAG>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,pathogenic
chr13:32333291:A>AA,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1&0,,pathogenic
chr13:32398251:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32338485:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,,,pathogenic
chr13:32362694:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Western European|Chinese,IVS,,,,,,,,splice_donor_variant,HIGH,,17/26,1,,,,,1&1,,pathogenic
chr17:43092641:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,6/26,1,,,,,,,pathogenic
chr17:43063346:TTTC>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),benign(0-047),,1&1&1,,pathogenic
chr13:32338573:AGAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,1&0,,pathogenic
chr17:43106477:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1,,pathogenic
chr17:43124033:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,pathogenic
chr17:43091821:A>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,pathogenic
chr13:32355079:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-29),benign(0-132),,1,,pathogenic
chr13:32357492:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,,benign
chr17:43092801:TTGA>-,,Ambry_Genetics|Invitae|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32330993:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,9/27,,1,,,,,1,,benign
chr13:32338849:T>A,,Ambry_Genetics,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32345500:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3829 (Asian)| 0.1728 (African)| 0.2942 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,benign
chr17:43051091:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-009),,,,pathogenic
chr13:32344637:A>G,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,12/27,,1,,,,,1,,benign
chr13:32338680:C>G,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,0&1&1,1&1&1,,pathogenic
chr13:32396963:C>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32338680:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,0&1&1,1&1&1,,pathogenic
chr13:32333386:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr17:43045698:T>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000697,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),In vitro (cloned),predicted neutral,Multifactorial likelihood-ratio model,,,,,,,,,,,,,,1 - Not pathogenic or of no clinical significance,1.0,0.00316,0.724,7e-05,0.03,0.03,missense_variant,MODERATE,22/22,,-1,,,benign(0-014),,1,5.767e-05,benign
chr17:43093734:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32371043:C>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43094408:GTG>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32371043:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,Western European,N,,,,,,,,stop_gained,HIGH,20/27,,1,,,,,1&1&1&1,,pathogenic
chr13:32339924:GAAAC>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43098424:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,benign
chr13:32322152:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02846 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43123815:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43041407:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43051091:G>A,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0|0.0454|0.0154,None|None|None|None|None,0.0,0.0023,0.0,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,20/23,,-1,,,,,1&1,0.000311876,benign
chr13:32329444:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,8/27,,1,,,,,,,benign
chr13:32335478:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,benign
chr17:43093719:T>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-43),benign(0-05),,1,,pathogenic
chr13:32353602:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr17:43093200:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32340154:CCAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43067652:GTTAA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/27,,1,,tolerated(0-41),benign(0-039),,1&1,,pathogenic
chr17:43070943:C>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,,benign
chr17:43112129:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3322 (Asian)| 0.1321 (African)| 0.3536 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr17:43070943:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,,benign
chr13:32340571:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,,benign
chr13:32324101:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr13:32340245:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,pathogenic
chr13:32376795:A>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,21/26,1,,,,,1&1,,pathogenic
chr13:32347999:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1941 (Asian)| 0.1972 (African)| 0.1794 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32380085:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1&1&0,,pathogenic
chr13:32338918:A>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-359),,1,,benign
chr13:32340798:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,1,,pathogenic
chr17:43099828:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr17:43045760:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,Czech|-|French,2|-,Western European|-|Caucasian,N,,,,,,,,stop_gained,HIGH,22/22,,-1,,,,,1&1&1,,pathogenic
chr13:32340752:T>TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32340007:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43092511:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43066409:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01055 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr17:43094256:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43052373:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2134 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr17:43071063:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,,benign
chr13:32333233:GAAAA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,,,,1,,pathogenic
chr13:32320347:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05769 (Asian)| 0.0343 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr13:32336449:A>G,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1,8.237e-06,benign
chr17:43092202:T>TT,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43080327:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.8706 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,1.0,1.0,0.9986,0.9077,0.9949,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.980232,benign
chr13:32340998:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-913),,1&1,,pathogenic
chr13:32346841:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),Unknown|Germline (inherited),,,1/1658|-,,,,,,,,,Sweden|-,,Not Specified|-|Asian|None Specified,N,,,,,,,,stop_gained,HIGH,13/27,,1,,,,,1&1,,pathogenic
chr17:43124096:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Emory_Genetics_Laboratory|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,start_lost,HIGH,,,-1,1.0,deleterious(0),,0&0&1,1&1&1,,pathogenic
chr17:43091016:C>T,,Ambry_Genetics|GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,0.0|0.3631|0.123,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,1&1,,benign
chr17:43093315:->AG,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32340619:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43057052:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,18/22,,-1,,,,,1,,pathogenic
chr17:43094069:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32338211:AAAA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/22,,-1,,deleterious(0),probably_damaging(0-919),,1&1,,pathogenic
chr17:43091016:C>-,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Division_of_Human_Genetics_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-08),benign(0-38),,1,,pathogenic
chr17:43051067:G>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,20/23,,-1,,,,,1,,benign
chr17:43062193:AA>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.13 (African)| 0.36 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43047666:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,21/22,,-1,,,,,1&1,,pathogenic
chr17:43091538:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr13:32354878:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43092372:->C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32338906:AGAA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/22,,-1,,,,,,,pathogenic
chr13:32326613:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),In vitro (cloned)|Unknown,as wildtype control|predicted deleterious|-|major exon skipping,splicing reporter minigene|Radiation sensitivity|-|cDNA analysis|mRNA analysis (RT-PCR),,,,,,,,,,Not Specified|-|Italian,,Central/Eastern European|Western European|-|Western Europe|Caucasian|None Specified,M,,,,,,,,missense_variant&splice_region_variant,MODERATE,7/27,,1,,,,,1&1&1,,pathogenic
chr13:32336872:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43049182:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,21/23,,-1,,,,,1&1,,pathogenic
chr13:32340000:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,0&0&0&1&1,1&1&1&1&1,,pathogenic
chr13:32340722:GAAA>GAAAGAAA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32327293:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1084 (Asian)| 0.02236 (African)| 0.04354 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,benign
chr17:43055643:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05691 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr17:43071225:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/23,,-1,,,,,1&1,,pathogenic
chr13:32367646:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02236 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr17:43092877:A>AA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32339851:T>TT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32340626:A>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-3),benign(0-059),,1,8.237e-06,benign
chr13:32333137:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr17:43091559:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,1&1,1&1,,pathogenic
chr13:32394840:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,pathogenic
chr17:43091012:C>A,,Ambry_Genetics|Invitae|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr17:43094513:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr13:32340908:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32398675:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32376791:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,21/27,,1,,,,,1,,pathogenic
chr13:32370465:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,pathogenic
chr13:32356297:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,,benign
chr17:43067643:ATTAG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32338220:AAAT>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43060996:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06504 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32338266:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32393166:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04268 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0378,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00998403,benign
chr13:32339641:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43045767:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Children's_Hospital_of_Philadelphia|Ambry_Genetics|GeneDx|Counsyl|Invitae|Division_of_Human_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,14/1658|-,,,,,,,,,Not Specified|-|Dutch?|German|Dutch|Western Europe,1|3|-,White-NonHispanic|Western Europe/Central-Eastern Europe| Central/Eastern Europe|Not Specified|Western European|Philippines|-|None-Specified|German|Ashkenazi|Unknown|Western-European|Western Europe|Caucasian|None Specified,N,,,,,,,,stop_gained,HIGH,22/22,,-1,,,,0&0&0&0&1&1,1&1&1&1&1&1,,pathogenic
chr17:43053704:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.4919 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr13:32332379:G>GG,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,pathogenic
chr17:43093942:TCAGGAG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-044),,1,,pathogenic
chr17:43076624:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Counsyl|Invitae,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,co-occurrence with deleterious variant|-|?,,,,,0.0,0.0008,0.0014,0.0,0.0,Not Specified|Western Europe|-,,"-Sephardi|-Near-Eastern|Mexican|Central/Eastern Europe| Latin American/Caribbean""""|Western European|-|Latin-American/Caribbean|-Central/Eastern-Europe|Croatia|Ashkenazi/Western Europe|Western-European|-Greek|Central/Eastern-European|None-Specified|None Specified|""""Western European",IVS,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,1,0.0003149805,benign
chr17:43092128:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32363198:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/27,,1,,,,,1,,pathogenic
chr13:32331128:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.8902 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.999,0.9039,0.9971,1.0,1.0,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,0.974042,benign
chr13:32337751:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-04),probably_damaging(0-982),0&1,1&1,,benign
chr13:32369041:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01847 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32340663:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32340663:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32320601:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.09441 (Asian)| 0.01626 (African)| 0.04617 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr13:32398417:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43092028:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr17:43094544:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,7.413e-05,benign
chr17:43091769:->AA,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32394172:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02972 (Asian)| 0.126 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.003,0.1188,0.0605,0.0208,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.0449281,benign
chr17:43057069:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,-|French,3|2|-,Western Europe/Latin American/Caribbean|South Loire River,N,,,,,,,,stop_gained,HIGH,18/22,,-1,,,,,1,,pathogenic
chr17:43050878:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02439 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,benign
chr17:43076509:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,pathogenic
chr13:32340088:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32333132:T>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,1,,pathogenic
chr17:43091763:TG>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,1,,pathogenic
chr13:32340509:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32340813:C>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32363203:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,benign
chr17:43093262:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,pathogenic
chr17:43092423:A>AA,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32338134:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32339032:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43092174:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43082575:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,11/22,,-1,,,,,1&1,,pathogenic
chr13:32348993:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32379784:ATA>TT,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,1,,,,,1,,pathogenic
chr13:32337713:G>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,pathogenic
chr13:32376737:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/27,,1,,,,,,,benign
chr13:32357937:A>G,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,16/26,1,,,,,1,,benign
chr17:43092782:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43061643:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr17:43092155:GA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),benign(0-187),,1,,pathogenic
chr13:32339046:C>CC,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32339938:A>AA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32316435:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,benign
chr17:43091030:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,,,-1,1.0,,,1&1,1&1,,pathogenic
chr13:32316435:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3689 (Asian)| 0.04878 (African)| 0.2282 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,26.3256|10.2587|20.8827,None,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,benign
chr13:32316435:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,benign
chr17:43071069:A>G,,Ambry_Genetics|Invitae,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,,benign
chr17:43091627:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32340274:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32332683:G>-,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/23,,-1,,,,,,,pathogenic
chr13:32338092:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,pathogenic
chr13:32363204:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Austria,1,,N,,,,,,,,stop_gained,HIGH,18/27,,1,,,,,1&1,,pathogenic
chr17:43092510:TGAA>-,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Division_of_Human_Genetics_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/27,,1,,,,,1&1,,pathogenic
chr17:43091474:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western-European|Western Europe|Central/Eastern-European,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43063889:C>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32355152:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,1,,benign
chr13:32322585:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43063359:T>AAA,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/23,,-1,,,,,1,,pathogenic
chr13:32336881:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32363421:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,1,,pathogenic
chr13:32354271:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.5524 (Asian)| 0.561 (African)| 0.5396 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr17:43104249:T>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000105,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0116|0.0|0.0077,probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,6/23,,-1,,tolerated(0-06),,,1&1,,benign
chr13:32338044:C>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,6/23,,-1,,tolerated(0-06),,,1&1,,pathogenic
chr13:32339176:TGA>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32340946:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43050609:A>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1,,benign
chr13:32339789:G>T,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,0&1&1,1&1&1,,pathogenic
chr17:43046070:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01055 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,,benign
chr13:32318738:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04675 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,benign
chr17:43048092:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,benign
chr13:32373331:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02846 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.001,0.0325,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00898562,benign
chr17:43068303:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1504 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,benign
chr13:32336967:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1&1,,pathogenic
chr13:32356580:C>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32354838:TATA>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,17/23,,-1,,,,,,,benign
chr17:43116981:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr17:43094244:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32363293:C>T,,Ambry_Genetics|Invitae,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,,benign
chr13:32337955:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43106549:A>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr17:43094439:AGGATTCTCTG>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,pathogenic
chr13:32340996:C>CC,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32340637:TTCACCTA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,5/27,,1,,,,0&0&1&1&1&1,1&1&1&1&1&1,,pathogenic
chr13:32379895:TC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43093316:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32319587:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02243 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr13:32332925:G>GG,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43094607:GCT>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43091748:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr13:32339837:AAATT>-,,Ambry_Genetics|Biesecker_Laboratory_-_ClinSeq_Project|Sharing_Clinical_Reports_Project_(SCRP)|_NHGRI|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,pathogenic
chr13:32319205:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,3/27,,1,,,,,1,,pathogenic
chr13:32368807:->G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08 (Asian)| 0.02 (African)| 0.04 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32336731:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32332473:->G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,10/27,,1,,,,,,,pathogenic
chr13:32379796:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,,,benign
chr17:43091867:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned),,,,,,,,,,,,Western Europe|-,,Central/Eastern Europe|-|-Central/Eastern-Europe|Western-European|None-Specified|None Specified,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43104157:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,pathogenic
chr13:32339699:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43049164:C>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,deleterious(0),benign(0-031),0&0&0&1&1,1&1&1&1&1,,pathogenic
chr13:32355140:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,,,benign
chr17:43070924:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/22,-1,,,,,1&1,,pathogenic
chr13:32340895:G>C,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-17),probably_damaging(0-994),,1,,benign
chr17:43092471:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.237e-06,benign
chr13:32339184:TG>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,,pathogenic
chr13:32355170:A>G,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,1,3.295e-05,benign
chr17:43071169:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,1,,pathogenic
chr17:43094179:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,0&0&1,1&1&1,,pathogenic
chr13:32340250:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32354267:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06294 (Asian)| 0.3232 (African)| 0.2836 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32345389:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.07343 (Asian)| 0.3049 (African)| 0.2018 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.1938,0.2693,0.2176,0.0794,0.1452,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,0.184505,benign
chr17:43054835:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.4146 (African)| 0.01055 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.007,0.5787,0.0447,0.001,0.0317,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.166733,benign
chr13:32337273:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32339964:TC>AG,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&0,,pathogenic
chr17:43106439:A>G,,Invitae,,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,,benign
chr17:43058399:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.4959 (African)| 0.01319 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32390504:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32376714:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,21/27,,1,,,,,1&1,,pathogenic
chr17:43047641:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,21/21,-1,,,,,1,,pathogenic
chr17:43094628:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43047641:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,21/21,-1,,,,,1,,pathogenic
chr17:43098566:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0121,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,0.00379393,benign
chr17:43093661:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Central/Eastern Europe,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43125086:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43092099:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr13:32346906:GTT>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,benign
chr17:43072263:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.07317 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,benign
chr17:43094578:TGTTG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-011),,,,pathogenic
chr17:43082456:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/22,,-1,,,,,1,,benign
chr17:43050573:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1199 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,benign
chr13:32338724:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,1.648e-05,benign
chr17:43099774:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,6/21,-1,1.0,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43099774:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,6/21,-1,1.0,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43063914:A>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,6/21,-1,1.0,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43094464:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,6/21,-1,1.0,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43099810:A>AA,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr13:32340047:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-043),,1,,pathogenic
chr13:32398679:C>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr13:32398679:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32333048:AT>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32340989:TGTT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43092608:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32377040:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01583 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0159,0.0,0.0072,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.00419329,benign
chr17:43082024:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0212,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.00559105,benign
chr13:32365177:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.5524 (Asian)| 0.5206 (African)| 0.5396 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr17:43102132:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,benign
chr17:43067642:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,pathogenic
chr13:32340609:T>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43064916:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3164 (Asian)| 0.1992 (African)| 0.3588 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3608,0.2073,0.2925,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.339657,benign
chr17:43092648:G>A,,Ambry_Genetics|Invitae,,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32383177:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32321240:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.8902 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr13:32340556:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,pathogenic
chr17:43091848:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1&1&1,,pathogenic
chr13:32339554:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,-|10/1658,,0.5358|0.091|0.3851,None,0.004,0.0,0.0043,0.0,0.001,German|Austria|-,1|0|3|2|-," Asia""""|""""Europe|-",Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,0.00301522,benign
chr13:32341126:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32341171:AAGAG>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,pathogenic
chr17:43093119:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,benign
chr17:43094601:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,,pathogenic
chr13:32316532:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,MODIFIER,,,1,,,,0&1&1,1&1&1,,benign
chr13:32363455:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,1,,pathogenic
chr13:32341109:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43099914:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| 0.219 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,Prevalence in normal controls|-|?,-|141/1658,,24.0698|4.8797|17.5688,None|None|None|None|None,0.2266,0.0098,0.1167,0.0,0.1759,U.S.A.|German|Malaysian|-|Austria|Greek|American|Spanish|Italian|Belgian?,-|1|0|2|5|412|8,Greek|-|Caucasian|Chinese,IVS,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,1,0.1363211,benign
chr17:43091919:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,pathogenic
chr17:43092188:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43094338:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Asian|-South-China,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32315226:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.16 (Asian)| 0.18 (African)| 0.18 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,benign
chr17:43099773:A>T,,Biesecker_Laboratory_-_ClinSeq_Project|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|_NHGRI|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,6/21,-1,1.0,,,,1&1,,pathogenic
chr13:32398536:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43052839:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| 0.1702 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr17:43114980:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03826 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0427,0.0015,0.0115,0.0,0.0143,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.0133786,benign
chr13:32339471:AATA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,1,,pathogenic
chr13:32379765:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,1,,,,,1,,pathogenic
chr13:32345984:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,benign
chr17:43091873:C>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/21,-1,,,,,1&1,,pathogenic
chr17:43094519:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43125170:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.1362 (African)| 0.3694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Counsyl,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr13:32326296:C>T,,GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,1,,benign
chr17:43092197:CTTG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,1,,pathogenic
chr17:43097229:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/21,-1,1.0,,,,1,,benign
chr17:43108791:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3377 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr17:43057610:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06504 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0356,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.00958466,benign
chr13:32337285:TGAATATAGAT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,pathogenic
chr17:43103254:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,benign
chr17:43112347:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3549 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr13:32379894:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,,1,,pathogenic
chr13:32340137:G>T,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32327594:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,benign
chr13:32333109:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,pathogenic
chr17:43082423:TTCT>TTCTTTCT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/22,,-1,,,,,,,pathogenic
chr17:43104926:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,,benign
chr13:32355077:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,1&1,,benign
chr17:43071204:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,,benign
chr13:32337163:ACAA>-,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32362603:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,17/27,,1,,,,,1,,pathogenic
chr17:43090998:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,1,,benign
chr13:32339496:ATTT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43094833:AC>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1,,pathogenic
chr17:43093056:G>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-17),benign(0-001),,1,,pathogenic
chr17:43051983:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02273 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr13:32340955:TT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43071236:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,15/23,,-1,,,,,1,,pathogenic
chr13:32396449:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1923 (Asian)| 0.1037 (African)| 0.248 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32336530:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32323006:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43091860:GGAA>GGAAGGAA,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43104264:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,4/21,-1,,,,,1&1,,pathogenic
chr17:43074226:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,benign
chr17:43067594:G>A,,Invitae,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,1,,benign
chr17:43094304:T>C,,Ambry_Genetics,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,1&1,1&1,,benign
chr13:32394801:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,25/27,,1,,,,,1,,benign
chr13:32386226:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.5427 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.5159,0.5711,0.5375,0.5327,0.4683,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.527556,benign
chr17:43107299:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06504 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr13:32370396:G>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,18/26,1,,,,,1,,benign
chr13:32340799:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,13/26,1,,,,,1,,pathogenic
chr17:43094204:->AC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32338577:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43074328:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,,,,,1,,pathogenic
chr13:32336464:C>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32340262:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43092222:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32338285:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43067696:C>T,,Pathway_Genomics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,15/22,-1,,,,,1,,pathogenic
chr13:32332345:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr13:32340072:AC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,pathogenic
chr13:32376734:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/27,,1,,,,,,,benign
chr17:43093119:CT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-62),benign(0-019),,,,pathogenic
chr17:43092393:TTCATTAATA>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43094870:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43104234:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-15),benign(0-061),,,,pathogenic
chr17:43070445:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3322 (Asian)| 0.2195 (African)| 0.3615 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,benign
chr13:32376710:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,pathogenic
chr13:32339826:A>AA,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32394814:C>T,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,25/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43093738:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1&1,,pathogenic
chr17:43093738:A>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1&1,,pathogenic
chr17:43058379:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3392 (Asian)| 0.4411 (African)| 0.3588 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32332906:TCAT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,pathogenic
chr13:32379747:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,1,,,,,1,,pathogenic
chr13:32356594:G>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,,,benign
chr17:43127281:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.22 (African)| 0.36 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,0&1,,benign
chr13:32356594:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,,,benign
chr17:43092757:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32356237:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,,benign
chr13:32340070:T>TT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43094415:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43063931:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,University_of_Washington_Center_for_Mendelian_Genomics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|_University_of_Washington|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(0-995),,1&1,,pathogenic
chr13:32397002:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,benign
chr13:32397002:G>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,benign
chr17:43091629:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43093343:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43094679:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32337967:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43104104:G>A,,Invitae,,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,benign
chr17:43063954:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/21,-1,,,,,1,,pathogenic
chr13:32340707:GT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,15/21,-1,,,,,1,,pathogenic
chr13:32398195:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,,probably_damaging(0-999),,1,,pathogenic
chr13:32340849:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43091513:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32376690:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/27,,1,,,,,,,benign
chr13:32394671:C>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,1,,benign
chr13:32398404:ATTT>ATTTATTT,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43092845:T>TT,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32394816:->G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,25/27,,1,,,,1&1,1&1,,pathogenic
chr13:32394933:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,25/27,,1,,,,,1,,pathogenic
chr13:32339214:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,-|British,1|-,Caucasian|English,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32317569:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1853 (Asian)| 0.1382 (African)| 0.1794 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,benign
chr13:32337717:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32337717:C>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32325750:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,benign
chr13:32375831:->TTAC,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr17:43045756:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/22,,-1,,,,,,,benign
chr13:32340037:C>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&0,,benign
chr13:32338215:A>AA,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43066355:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05285 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0666,0.0029,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.0179712,benign
chr13:32340037:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&0,,pathogenic
chr13:32340037:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&0,,pathogenic
chr17:43093222:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43091895:T>C,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr13:32357873:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,16/27,,1,,,,,,,benign
chr13:32362235:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01187 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr13:32379318:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,pathogenic
chr17:43093222:G>T,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43064696:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02098 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr13:32319272:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-27),benign(0-099),0&1&1,1&1&1,,pathogenic
chr17:43062603:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0542 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0008,0.0058,0.0456,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.0105831,benign
chr17:43104172:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr17:43099858:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-03),,1,,pathogenic
chr17:43094110:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Western-European,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,0&0&1,1&1&1,,pathogenic
chr13:32340010:->CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43074483:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,,,pathogenic
chr17:43091446:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,pathogenic
chr17:43093492:->GG,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43077840:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.1321 (African)| 0.3668 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr17:43073764:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3182 (Asian)| 0.128 (African)| 0.3377 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,benign
chr17:43094595:G>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,pathogenic
chr17:43106446:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,1,,benign
chr17:43114094:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06504 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr17:43104106:A>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr13:32340128:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43077744:T>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.22 (African)| 0.35 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32347053:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32339621:GTAT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,pathogenic
chr17:43094662:A>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32340737:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European| Dutch,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32341102:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,1&1,1&1,,benign
chr13:32354955:T>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,deleterious(0-05),,,1,0.0001071,benign
chr17:43104919:C>A,,Counsyl|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr13:32355092:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,,,benign
chr17:43099817:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,Western-European|Western European|-|Latin-American/Caribbean|-Hispanic,N,,,,,,,,stop_gained,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr13:32340581:GTTA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr13:32363181:ATGATACGGAAAT>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr17:43092756:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43124052:A>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32370544:C>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,,pathogenic
chr17:43091434:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43071239:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,13/21,-1,,,,0&1&1,1&1&1,,pathogenic
chr13:32340688:GAGAA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,13/21,-1,,,,0&1&1,1&1&1,,pathogenic
chr17:43092611:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.236e-06,benign
chr17:43058377:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03455 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32332277:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,1&1,1&1,,pathogenic
chr17:43093774:G>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,,pathogenic
chr17:43122761:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32399302:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3811 (Asian)| 0.04675 (African)| 0.2177 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32339938:A>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43078965:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0935 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr13:32340999:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32332644:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-21),benign(0-021),,1,,benign
chr17:43058314:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1484 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32332644:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-35),benign(0-169),,1,,benign
chr17:43091599:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,pathogenic
chr17:43097077:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3562 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/21,-1,1.0,,,,,,benign
chr13:32379904:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,,,benign
chr13:32361348:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01224 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr13:32337195:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,1,,pathogenic
chr17:43124017:CAGATGGGACA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(1),benign(0-007),,1,,pathogenic
chr13:32338413:AAACG>-,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(1),benign(0-007),,1,,pathogenic
chr13:32339902:T>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32398735:A>T,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,0&1,,benign
chr13:32370533:T>-,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,pathogenic
chr13:32318532:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,benign
chr17:43106026:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3588 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3579,0.2171,0.3746,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,0.353035,benign
chr17:43093329:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,10/27,,1,,,,,,,pathogenic
chr17:43093138:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32396599:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.502 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43091945:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43092374:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32355232:->G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,14/27,,1,,,,,1&1,,pathogenic
chr13:32339717:T>TT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32376960:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,benign
chr17:43045735:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/22,,-1,,,,,1,,pathogenic
chr17:43076583:G>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr13:32330987:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,9/27,,1,,,,,1,4.942e-05,benign
chr13:32339825:AA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,pathogenic
chr17:43068206:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2175 (African)| 0.3562 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,benign
chr13:32362533:GACA>GACAGACA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,17/27,,1,,,,,,,pathogenic
chr13:32395111:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.229 (Asian)| 0.01626 (African)| 0.2111 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.2336,0.0106,0.0965,0.248,0.2413,,,,,,,,,,,,intron_variant,MODIFIER,,25/26,1,,,,,,0.160144,benign
chr17:43076583:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr13:32337550:TAAT>-,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43094020:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32340982:A>C,,Invitae,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,0&1,,benign
chr13:32340142:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43071223:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000102,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0|0.1362|0.0461,probably-damaging:0.999|probably-damaging:0.999|probably-damaging:0.999|probably-damaging:0.999|probably-damaging:0.999,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,possibly_damaging(0-85),,1&1,,benign
chr17:43057070:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/22,,-1,,,,,1&1,,benign
chr17:43103842:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01187 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0099,0.0023,0.0072,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.00419329,benign
chr13:32363499:C>-,,Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-73),benign(0-011),,1&1,,pathogenic
chr17:43092618:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32335829:A>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43063917:A>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,Not Specified|Western Europe|Western/Central/Eastern Europe|-,,"""""Native American|Central/Eastern European| Central/Eastern European""""|Not Specified|Western European|-|Western-European|Western Europe|None-Specified",N,,,,,,,,stop_gained,HIGH,17/23,,-1,,,,,1&1,,pathogenic
chr17:43076492:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,pathogenic
chr13:32333126:G>GG,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43057070:T>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,pathogenic
chr17:43115780:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,2/22,-1,1.0,,,,1&1&1,,pathogenic
chr17:43092414:GGCT>TC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32333297:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,Western Europe|-,,Western European|-|None Specified|White-NonHispanic,N,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43104105:A>G,,GeneDx|Invitae,,,,,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,1&0,,benign
chr13:32346514:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,benign
chr17:43051085:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,pathogenic
chr13:32379905:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1&1,,pathogenic
chr17:43063351:T>C,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/23,,-1,,,,,1,,benign
chr13:32362572:T>TT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,17/27,,1,,,,,1,,pathogenic
chr17:43094084:TAAT>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,pathogenic
chr13:32337581:GTAGT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&splice_region_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr17:43105222:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05285 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,,benign
chr13:32379335:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western Europe,N,,,,,,,,stop_gained,HIGH,22/27,,1,,,,,1,,pathogenic
chr13:32355064:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,pathogenic
chr17:43051085:C>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,20/23,,-1,,,,,1&0&1,,benign
chr13:32362680:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,17/27,,1,,,,0&0&0&0&1&1,1&1&1&1&1&1,,pathogenic
chr13:32336584:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1031 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,Prevalence in normal controls|-|?,-|57/1658,,3.6977|2.02|3.1293,None,0.0348,0.0325,0.0922,0.0952,0.1329,German|Austria|Sri Lankan|-|Belgian,1|0|-,Global|-|Sinhalese,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,0.0627412,benign
chr13:32350832:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32379513:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,,,1,,,,,1&1,,pathogenic
chr17:43091678:->GT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43076600:G>A,,Ambry_Genetics,,,,,,,,,,,,,-|Hong Kong|Spanish,,Chinese |Caucasian|None-Specified,N,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,pathogenic
chr13:32336398:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,1.647e-05,benign
chr13:32339179:GA>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,4/27,,1,,,,,1,,pathogenic
chr17:43093488:A>AA,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32340264:C>A,,Ambry_Genetics|Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32379502:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,,1,,pathogenic
chr13:32338403:CATA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-51),benign(0-301),,1&1,,pathogenic
chr17:43094265:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32338916:C>T,,Ambry_Genetics,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,,benign
chr13:32338874:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,,,,pathogenic
chr17:43067697:T>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,15/22,-1,,,,,1&1,,pathogenic
chr13:32377459:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06294 (Asian)| 0.3252 (African)| 0.2836 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,benign
chr13:32339931:TTAA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,pathogenic
chr13:32338322:A>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43091457:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr17:43050562:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08217 (Asian)| 0.03862 (African)| 0.07388 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,benign
chr13:32336191:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.07343 (Asian)| 0.2703 (African)| 0.2018 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,benign
chr13:32333120:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32340533:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43093579:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32335965:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,benign
chr13:32340981:TA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,probably_damaging(0-988),,1,,pathogenic
chr13:32379300:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,1,1.647e-05,benign
chr13:32348049:A>AA,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32333630:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1031 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,benign
chr17:43092276:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32337141:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32339708:A>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43040165:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32337617:CC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,7/27,,1,,,,,1,,pathogenic
chr17:43049195:C>T,,Counsyl,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,19/21,-1,,,,0&0&0&1&1,1&1&1&1&1,,pathogenic
chr13:32332552:G>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr13:32319213:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,pathogenic
chr13:32340289:T>TT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43115759:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,pathogenic
chr13:32382033:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr17:43051574:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr17:43061077:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0061,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.00159744,benign
chr13:32339593:T>TT,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43074490:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,13/27,,1,,deleterious(0),probably_damaging(1),,1,,pathogenic
chr17:43081610:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,benign
chr13:32338963:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32360373:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03659 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr13:32337167:GCAA>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1&1,,pathogenic
chr17:43092274:->TC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32332774:GA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,pathogenic
chr13:32336284:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,,pathogenic
chr13:32325765:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03659 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,benign
chr17:43116189:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr13:32340379:G>GG,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43091670:CTCA>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0),probably_damaging(0-956),,1&1&1,,pathogenic
chr17:43092551:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32363421:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),Germline (inherited),,,,FA FANCD1_00011,,,,,,,,,,None Specified,N,,,,,,,,stop_gained,HIGH,18/27,,1,,,,,1&1&0,,pathogenic
chr13:32371432:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr13:32333086:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32326134:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,5/27,,1,,,,,,,benign
chr13:32379305:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,benign
chr13:32363449:GA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,pathogenic
chr13:32346858:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,13/27,,1,,,,,,,benign
chr13:32338132:T>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,pathogenic
chr13:32346825:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,12/26,1,,,,,1,,pathogenic
chr17:43043756:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.22 (African)| 0.36 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32332877:A>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Asian,N,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1&1,8.236e-06,pathogenic
chr13:32340412:C>T,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0|0.4312|0.1461,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1,1&1,,benign
chr13:32356587:->TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/27,,1,,,,1&1,1&1,,pathogenic
chr13:32345879:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.8902 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,benign
chr13:32319236:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,3/27,,1,,,,,1,,pathogenic
chr17:43074720:GGGTT>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.13 (African)| 0.35 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr17:43093122:ACTC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,,pathogenic
chr17:43092593:T>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,probably_damaging(0-95),,,,pathogenic
chr13:32387951:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.502 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43076571:C>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr13:32394865:G>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-15),benign(0-009),,1,,benign
chr13:32355104:CA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,pathogenic
chr17:43094443:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-06),benign(0-001),,,,pathogenic
chr13:32319061:T>TT,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,benign
chr13:32394688:G>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,24/26,1,,,,,1&1&1,,pathogenic
chr13:32339513:T>TT,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32363402:CCTCCCCTCT>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43068755:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01319 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0149,0.0023,0.0086,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.00539137,benign
chr13:32337568:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43094577:->CA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43094608:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,pathogenic
chr13:32331011:AA>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,pathogenic
chr17:43099832:T>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,pathogenic
chr13:32340886:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32340886:T>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32380284:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr17:43076489:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,pathogenic
chr17:43104957:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,4/22,-1,,,,,1&1,,pathogenic
chr17:43106479:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,pathogenic
chr13:32380124:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,pathogenic
chr13:32398608:C>GAATTATATCT,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43094635:AC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43053035:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr17:43076592:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,benign
chr13:32354963:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr17:43092732:ACCA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-12),benign(0-258),,1,,pathogenic
chr13:32329481:GATA>GATAGATA,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,8/27,,1,,,,,,,pathogenic
chr13:32363178:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,17/26,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43092828:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,pathogenic
chr13:32363178:G>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,17/26,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32394858:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,25/27,,1,,,,,,,benign
chr17:43092861:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32339290:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32338148:T>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000881,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),In vitro (cloned)|Unknown,predicted neutral|-,-|Multifactorial likelihood-ratio model,1/1658|-,,,,,,,,,,,,,1 - Not pathogenic or of no clinical significance,0.042,1.0294,,0.00088,0.02,0.02,missense_variant,MODERATE,11/27,,1,,tolerated(0-38),benign(0-128),,,,benign
chr13:32333159:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European| Italian Irish French,N,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43116581:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05285 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr17:43061609:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3588 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3579,0.1573,0.2824,0.371,0.4969,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,0.324281,benign
chr17:43092252:G>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43092861:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,benign
chr13:32339733:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,pathogenic
chr13:32319075:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,2/26,1,,,,,1,,pathogenic
chr13:32333006:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43094846:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43115776:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,0&1&1,1&1&1,,pathogenic
chr17:43092101:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32319231:G>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,,,benign
chr17:43099794:C>T,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0|0.0681|0.0231,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,1,,benign
chr17:43113054:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02439 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr13:32340434:A>AA,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43064327:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04878 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr13:32329687:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,,benign
chr17:43089550:->TC,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.13 (African)| 0.35 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32347801:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr17:43050671:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,benign
chr13:32339320:C>G,,Oregon_Health_and_Sciences_University|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae|Pathway_Genomics|Knight_Diagnostic_Laboratories|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1&1&1,,pathogenic
chr13:32339320:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1&1&1,,pathogenic
chr13:32354180:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.9045 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32356472:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Emory_Genetics_Laboratory|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/27,,1,,,,,1&1,,pathogenic
chr13:32326241:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,5/26,1,,,,0&1,1&1,,pathogenic
chr13:32386851:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0129,0.0,0.0,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00359425,benign
chr13:32332716:T>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr17:43125524:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43093671:A>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,pathogenic
chr17:43092963:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32340558:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,,,pathogenic
chr13:32339320:C>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,,,pathogenic
chr13:32336679:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,,,pathogenic
chr17:43099793:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,,,pathogenic
chr13:32333125:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Malaysian,,Chinese,Syn,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,8.236e-06,benign
chr17:43094404:T>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43041129:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32389570:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.5407 (African)| 0.5356 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43082408:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/22,,-1,,,,,,,benign
chr13:32340823:TC>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/22,,-1,,,,,,,pathogenic
chr13:32340729:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,1,,pathogenic
chr13:32333047:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,8.236e-06,benign
chr17:43093256:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43045749:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),,,1,,pathogenic
chr17:43093814:ATTCT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,10/27,,1,,,,0&0&1,1&1&1,,pathogenic
chr13:32340433:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-13),benign(0-126),,1,,pathogenic
chr17:43067403:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr13:32330993:CAGT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,pathogenic
chr13:32362521:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,16/26,1,,,,,1&1,,pathogenic
chr13:32338524:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32389796:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43093410:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32337333:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43109546:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1484 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr13:32340280:T>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43092809:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1,,pathogenic
chr17:43092205:TTTA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32337663:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43047693:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,pathogenic
chr13:32332625:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-01),probably_damaging(0-996),,1&1,,pathogenic
chr17:43074362:C>T,,Ambry_Genetics|Invitae,,,,,,0.0233|0.0|0.0154,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,,benign
chr17:43063373:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,18/23,,-1,,,,,0&1&1,,pathogenic
chr13:32316490:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,1,,,,,,,benign
chr13:32319179:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,HIGH,3/27,,1,,,,,1,,pathogenic
chr17:43092172:AC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,HIGH,3/27,,1,,,,,1,,pathogenic
chr17:43093426:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32340756:ATAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,pathogenic
chr17:43067684:G>T,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,Germline (inherited),,,1/238 patients,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/22,,-1,,,,,,,pathogenic
chr17:43067684:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/22,,-1,,,,,,,benign
chr17:43065857:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr13:32339847:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32357721:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,1,,benign
chr17:43111066:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr13:32363320:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,,benign
chr13:32379856:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,,pathogenic
chr13:32346835:AAAG>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,,,pathogenic
chr13:32331861:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1066 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,,benign
chr13:32338600:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,0&1&1,,benign
chr17:43090268:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32376793:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,21/26,1,,,,,1,,pathogenic
chr17:43091783:->GGTAGCAACGGTGCTATGCCTAGTAGACTGAGAAGGTATATTG,,Emory_Genetics_Laboratory,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&0&0&1&1,1&1&1&1&1,,pathogenic
chr17:43093125:CA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43093337:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,American|-,,Western-European|Western Europe|-|None-Specified,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32339397:TG>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43107458:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.001,0.0083,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.00299521,benign
chr13:32340746:->T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,,,pathogenic
chr17:43097357:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43091573:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr17:43074482:C>T,,Pathway_Genomics|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,In vitro (cloned),,,,,,,,,,,,,,"-Central/Eastern-Europea|Australia|Not Specified|Western European|Native-American| Native American""""|Ashkenazi|-Italian|Western-European|Western Europe|caucasian|None Specified|""""Western European",N,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,pathogenic
chr13:32339236:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32397919:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02972 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32398733:A>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32394153:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04268 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32398143:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01748 (Asian)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Counsyl|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32338674:AA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43115742:CA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43092841:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32355341:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1031 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,1,,benign
chr17:43094277:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,1,1,,benign
chr13:32325461:AGTC>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,1,1,,benign
chr17:43092186:TTCT>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),benign(0-093),,1,,pathogenic
chr17:43093018:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,1,,,,,,,pathogenic
chr17:43123638:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.002,0.0159,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.00539137,benign
chr13:32340984:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,,pathogenic
chr13:32363534:G>A,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,18/26,1,,,,,1&1&1,,pathogenic
chr17:43094516:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32379896:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,pathogenic
chr17:43067614:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/22,,-1,,,,,1&1,,pathogenic
chr17:43056199:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04268 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr13:32320668:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02639 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43091843:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32337674:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32345093:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03562 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,benign
chr13:32371232:C>CC,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr17:43092910:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,1,,pathogenic
chr17:43093316:->AA,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43070969:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,1,,pathogenic
chr13:32389392:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06119 (Asian)| 0.0343 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32364315:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02448 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32316027:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,benign
chr17:43093836:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32333025:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,pathogenic
chr17:43049114:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,20/21,-1,,,,,1&1,,benign
chr17:43067611:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/22,,-1,,,,,,,pathogenic
chr17:43093633:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,pathogenic
chr17:43049174:G>A,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,-|Central/Eastern Europe,,Western-European|-Greek|-|-Italian,N,,,,,,,,stop_gained,HIGH,21/23,,-1,,,,,1&1,,pathogenic
chr13:32370555:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,19/27,,1,,,,,1,,pathogenic
chr13:32337638:C>T,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43080681:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.07692 (Asian)| 0.02236 (African)| 0.1966 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,benign
chr13:32344666:T>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,1,,benign
chr17:43094141:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,pathogenic
chr17:43092825:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32362094:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0091,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.00239617,benign
chr17:43092018:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43104246:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,pathogenic
chr13:32338596:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0|0.6639|0.2241,benign:0.002,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-004),,1,,benign
chr13:32355088:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,,,1,8.237e-06,pathogenic
chr13:32379045:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0507 (Asian)| 0.1346 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,benign
chr17:43110174:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr13:32336801:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43045450:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0053,0.0,0.0,0.0,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.00078513,benign
chr17:43091829:T>C,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr17:43074394:->C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,,,-1,,,,0&0&1,1&1&1,,pathogenic
chr13:32357938:T>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,8.236e-06,benign
chr13:32338440:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr17:43091752:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),possibly_damaging(0-447),,1,,pathogenic
chr17:43093915:GTTTG>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43092610:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/22,,-1,,,,,,,pathogenic
chr17:43092293:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr17:43092918:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,pathogenic
chr17:43115430:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr13:32326240:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,5/26,1,,,,,1&1,,pathogenic
chr17:43094190:->C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32363524:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,1,,pathogenic
chr13:32376732:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,21/27,,1,,,,,1&1,,pathogenic
chr13:32326303:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,0.0|2.2252|0.7536,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/26,1,,,,,1,,benign
chr17:43091905:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,,pathogenic
chr17:43065363:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05691 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr13:32326257:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,6/27,,1,,,,,1,,pathogenic
chr17:43099410:AC>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr17:43091714:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32394454:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.5427 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32360294:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03659 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.001,0.0461,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,0.0123802,benign
chr17:43096147:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3536 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43094145:C>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,pathogenic
chr17:43094855:A>-,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|Invitae|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32326145:AGTCA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32331015:GA>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,pathogenic
chr13:32340993:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43067607:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned),predicted deleterious,Multifactorial likelihood-ratio model,,,,,,,,,,,,-|Asian,IVS,5 - Definitely pathogenic,1.0,1.22,160.57,1.0,,0.97,splice_donor_variant,HIGH,,15/21,-1,,,,,1&1&1,,pathogenic
chr17:43093320:TG>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,15/21,-1,,,,,1&1&1,,pathogenic
chr17:43067607:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown,predicted deleterious|-|as variant control,Splicing reporter minigene|mRNA analysis (RT-PCR)|-,1/1658|-,,,,,,,,,Western European|-,,-|Asian|None Specified,IVS,,,,,,,,splice_donor_variant,HIGH,,15/21,-1,,,,,1&1&1,,pathogenic
chr13:32346849:G>A,,Ambry_Genetics|GeneDx,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,13/27,,1,,,,,1,,benign
chr17:43091479:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32333969:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.8902 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,benign
chr17:43116451:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03455 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0582,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.0159744,benign
chr13:32332634:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,deleterious(0),,,,,pathogenic
chr17:43097246:G>A,,Emory_Genetics_Laboratory|Ambry_Genetics|Genetic_Services_Laboratory|GeneDx|Counsyl|Invitae|_University_of_Chicago|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.1744|0.0227|0.123,None|None|None|None|None,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,,,-1,1.0,,,0&0&1&1,1&1&1&1,,benign
chr17:43092526:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,,,-1,1.0,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43047661:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,21/22,,-1,,,,,1&1,,pathogenic
chr17:43092000:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,0&1&1,1&1&1,,pathogenic
chr13:32336927:A>G,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-037),,1,,benign
chr13:32338870:CTTCCAGGGAC>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-06),benign(0-037),,1,,pathogenic
chr13:32357771:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Italian,,Caucasian,N,,,,,,,,stop_gained,HIGH,16/27,,1,,,,,1,,pathogenic
chr17:43049120:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,20/21,-1,,,,,1,,pathogenic
chr13:32336530:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32337682:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32319153:A>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,pathogenic
chr17:43045720:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/22,,-1,,,,,,,benign
chr17:43045759:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,Czech|Norwegian,,Caucasian,N,,,,,,,,stop_gained,HIGH,22/22,,-1,,,,,1&1,,pathogenic
chr13:32363549:C>G,,GeneDx|Invitae,In vitro (cloned)|Unknown,no splicing defect|-,splicing reporter minigene|-,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,1,4.119e-05,benign
chr13:32336609:GACT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,1,,pathogenic
chr13:32325307:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,benign
chr17:43094731:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43091847:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32379862:->AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,,,,pathogenic
chr13:32344622:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,12/27,,1,,,,,,,benign
chr13:32340686:AA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,pathogenic
chr13:32337515:GATA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,22/22,,-1,,,,,1&1&1,,pathogenic
chr17:43045711:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/22,,-1,,,,,1&1,,pathogenic
chr17:43073822:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3287 (Asian)| 0.2175 (African)| 0.3536 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3579,0.2239,0.3761,0.371,0.4969,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.354832,benign
chr13:32396909:ACTT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-053),,1,,pathogenic
chr13:32338826:CTGA>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-053),,1,,pathogenic
chr17:43107032:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr17:43091770:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,1,1,,pathogenic
chr13:32370955:G>A,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,19/26,1,,,,,1&1&0,,pathogenic
chr17:43092050:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43094023:TTTAA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,20/27,,1,,,,,,,pathogenic
chr13:32325430:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3864 (Asian)| 0.1646 (African)| 0.2718 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,benign
chr13:32338769:AA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,pathogenic
chr13:32338072:A>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,,,pathogenic
chr17:43092198:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,,,,1,,pathogenic
chr13:32376713:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1&1&1,,pathogenic
chr17:43045789:CATCTGCC>-,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr13:32336586:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32344575:AGAAA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1&1,,pathogenic
chr13:32340151:TA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-004),,1,,pathogenic
chr13:32339969:A>T,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32340146:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32339302:AA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32340301:TGGA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,14/27,,1,,,,,1,,pathogenic
chr17:43092133:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,,pathogenic
chr13:32336214:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1031 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,3.6389|1.9152|3.0556,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,benign
chr13:32355195:AA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32321244:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43104147:T>TT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,pathogenic
chr13:32339041:A>G,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0698|0.0|0.0461,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43092133:A>C,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1&1,,pathogenic
chr13:32394887:AG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-205),,1,,pathogenic
chr17:43081018:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04268 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,benign
chr17:43093389:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,0&1,,pathogenic
chr17:43091951:->A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,0&1,,pathogenic
chr13:32339519:AG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Counsyl|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,0&1,,pathogenic
chr13:32339293:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32362523:->AG,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&splice_region_variant,HIGH,17/27,,1,,,,,,,pathogenic
chr17:43090966:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr17:43093800:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,8.237e-06,benign
chr17:43092179:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32371028:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-2),benign(0-048),,,,pathogenic
chr17:43092522:AA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-39),benign(0-037),,1,,pathogenic
chr13:32333293:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,pathogenic
chr13:32341162:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32393672:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.229 (Asian)| 0.01626 (African)| 0.2111 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43082423:TTCTGGAT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,1,,,,,,,pathogenic
chr17:43051062:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),In vitro (cloned)|Unknown,predicted deleterious|-,Splicing reporter minigene|-,,,,,,,,,,,,Western European|-,IVS,,,,,,,,splice_donor_variant,HIGH,,19/21,-1,,,,,1&1&1&1&1,8.236e-06,pathogenic
chr13:32325331:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06728 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,benign
chr17:43047642:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Counsyl|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown,predicted deleterious|-,Splicing reporter minigene|-,,,,,,,,,,,,African American|-|Caucasian|African,IVS,,,,,,,,splice_donor_variant,HIGH,,21/21,-1,,,,,1&1,,pathogenic
chr13:32396937:ATGCATATACTGCA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-39),benign(0-117),,1&1&1,,pathogenic
chr13:32319282:C>T,,Ambry_Genetics|Invitae,,,,,,0.0|0.0454|0.0154,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,1&1,,benign
chr13:32379783:T>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,1,,,,,,,pathogenic
chr13:32337406:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,inframe_deletion,MODERATE,11/27,,1,,,,,,,pathogenic
chr17:43065497:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08333 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr13:32394694:G>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,pathogenic
chr13:32332743:A>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,pathogenic
chr13:32337406:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&0&1&1,1&1&1&1,,benign
chr17:43127517:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32339409:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43047698:G>A,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/22,,-1,,,,,1,,benign
chr17:43052883:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1678 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr17:43091767:T>TT,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32398462:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32332447:A>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr17:43092918:C>T,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1&1,1&1&1,,benign
chr13:32340883:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32340917:A>AA,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32325155:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,4/27,,1,,,,,1&1,,pathogenic
chr13:32338827:TGAA>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-091),,1,,pathogenic
chr17:43093689:C>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43067763:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3322 (Asian)| 0.2175 (African)| 0.3615 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),In vitro (cloned)|Unknown,-|?,-|?,-|10/1658,,,,0.3598,0.2224,0.3746,0.372,0.4959,Austria|-|American,1|0|2|-|412,,IVS,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,1,0.354633,benign
chr17:43071205:A>AA,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,,,pathogenic
chr13:32338518:CT>A,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32316461:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,start_lost,MODIFIER,,,1,,,,,,,pathogenic
chr17:43063881:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,pathogenic
chr13:32332285:A>G,,Ambry_Genetics,,,,,,0.0117|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,8.239e-06,benign
chr13:32338811:GTTA>-,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,pathogenic
chr13:32333333:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1&1,,pathogenic
chr17:43124030:CT>-,,GeneReviews|_NHGRI|Biesecker_Laboratory_-_ClinSeq_Project|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1&1,,pathogenic
chr13:32344344:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0227,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.00658946,benign
chr17:43094239:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43094737:GAAC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32381652:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03455 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0144,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.00399361,benign
chr13:32325710:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02439 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,,benign
chr17:43094683:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32338669:C>T,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&0&0&1&1,1&1&1&1&1,,benign
chr13:32339707:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,protein_altering_variant,MODERATE,15/23,,-1,,,,,,,pathogenic
chr17:43049192:G>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,,pathogenic
chr13:32316486:C>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,,,pathogenic
chr13:32337409:G>A,,Ambry_Genetics|GeneDx,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32355061:CCAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-18),benign(0-089),,1,,pathogenic
chr13:32332668:->TTAG,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,10/27,,1,,,,,,,pathogenic
chr13:32337954:GT>-,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32384686:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01923 (Asian)| 0.04268 (African)| 0.02243 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43094239:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-03),,,,,pathogenic
chr17:43091466:ATTA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-66),benign(0-311),0&1&1,1&1&1,,pathogenic
chr13:32363167:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,17/26,1,,,,,1,,benign
chr13:32332519:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr17:43094562:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43076579:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,0&1&1,1&1&1,,pathogenic
chr13:32376974:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3811 (Asian)| 0.09756 (African)| 0.2177 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.2078,0.1384,0.196,0.3661,0.1728,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,0.212859,benign
chr13:32351338:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02448 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32398377:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32341070:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32340595:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32341048:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32379401:G>T,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/27,,1,,,,,1,,pathogenic
chr13:32319240:T>G,,Ambry_Genetics|Emory_Genetics_Laboratory|GeneDx|Counsyl|Invitae,,,,,,0.0|0.6809|0.2307,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,1&1,,benign
chr13:32346830:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,pathogenic
chr17:43071071:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,,,pathogenic
chr13:32355111:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,14/27,,1,,,,,1,,pathogenic
chr13:32398663:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,,benign
chr13:32363500:A>G,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,,benign
chr13:32339569:T>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32394783:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,25/27,,1,,,,,1,,benign
chr13:32329473:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr17:43071000:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,,benign
chr17:43048519:->C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.2 (African)| 0.35 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,benign
chr17:43093706:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,pathogenic
chr13:32338099:TGAG>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,pathogenic
chr13:32339908:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,,benign
chr13:32379893:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,,pathogenic
chr13:32370400:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,18/26,1,,,,,1,,pathogenic
chr17:43115730:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/22,,-1,,tolerated(1),benign(0-001),,1,,pathogenic
chr17:43094709:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,African,N,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43091561:TT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43106464:TA>-,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32398458:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,8.236e-06,benign
chr17:43093093:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32338907:G>-,,Pathway_Genomics|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32396896:A>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European,IVS,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43093016:G>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32324497:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05691 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43091916:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr13:32339213:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43068271:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02902 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0278,0.0008,0.0216,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,0.00878594,benign
chr17:43115730:A>AA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr17:43104260:A>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,6/23,,-1,,,,,1&1,,pathogenic
chr13:32337691:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&splice_region_variant,HIGH,,,-1,,,,,,,pathogenic
chr17:43103094:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2175 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3579,0.2179,0.3746,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.353235,benign
chr13:32337358:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32337635:A>T,,Faculty_of_Pharmacy|_Ain_Shams_University,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43092192:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32379466:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/27,,1,,,,,0&1&1,,benign
chr13:32355250:T>C,,Emory_Genetics_Laboratory,,,,,,0.0582|6.4714|2.2304,None,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(1),benign(0),,1&1,,benign
chr17:43082472:G>GG,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/22,,-1,,,,,,,pathogenic
chr13:32339634:C>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,2/1658,,,,,,,,,,,Not Specified,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32333232:A>-,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32379466:C>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,deleterious(0-01),,,,,pathogenic
chr13:32349428:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr17:43047640:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,21/21,-1,,,,,1,,pathogenic
chr17:43111027:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2215 (African)| 0.3562 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr13:32340314:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43094040:G>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43074513:G>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1&1,,pathogenic
chr17:43091904:T>TT,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Counsyl|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32354972:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,,,benign
chr13:32338450:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43110085:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06301 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr17:43093570:T>-,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|Invitae|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32317315:AAGT>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.25 (Asian)| 0.13 (African)| 0.28 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1,,benign
chr17:43124078:->C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43092202:TTTTT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,pathogenic
chr17:43092877:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,deleterious(0),,,1,,pathogenic
chr17:43094195:T>TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43092927:T>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32341079:GA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,pathogenic
chr17:43092274:A>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,Austrian|-,2|-,Western-European|Not Specified|-|Austrian,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43092274:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,None Specified,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43093202:A>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,1,,pathogenic
chr13:32337430:GA>TT,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43092849:TT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43081527:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,benign
chr17:43093475:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32338531:T>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43049164:CCACA>TCACT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,,,,,,pathogenic
chr13:32363440:A>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,benign
chr17:43093202:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,benign
chr17:43093787:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,pathogenic
chr13:32330904:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32336293:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae,Unknown|Germline (inherited),,,4/1658|-,,0.1512|0.0|0.1,None,0.001,0.0,0.0014,0.0,0.0,-|Dutch,,-|Caucasian,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,0.0006568305,benign
chr13:32336293:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Austria,0,,M,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-19),benign(0-108),,1,,benign
chr13:32362595:G>A,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,17/27,,1,,,,,1&1&1&0,,pathogenic
chr13:32339576:AGTAA>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32363270:GT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43082547:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,1,,,,,1,,pathogenic
chr13:32341013:GAAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43074498:G>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,0&0&1,1&1&1,,pathogenic
chr13:32337047:AGGAA>-,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/22,,-1,,,,,1,,pathogenic
chr17:43091924:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|CSER_CC_NCGL._University_of_Washington_Medical_Center|GeneDx|Invitae,Unknown|Germline (inherited),,,2/1658|-,,0.0|0.0227|0.0077,None|None|None|None|None,,,,,,Not Specified|-|British|Greek|Austria|spanish|Republic-of-Turkey,,"Latin American/Caribbean|Mexican|Central/Eastern European|Turkish|Not Specified|Western European|-|Caucasian|Greek|None-Specified|-Central/Eastern-Europe| Italian""""|English|Western-European|Western Europe|caucasian|""""Western European",N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32319070:T>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,1.0,,,,1,,benign
chr13:32339345:AT>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/22,,-1,,deleterious(0),benign(0-276),,1&1,,pathogenic
chr13:32340100:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,1&1,1&1,,benign
chr17:43057078:G>A,,Medical_University_Innsbruck|Ambry_Genetics|GeneDx|Invitae|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/22,,-1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43060788:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2866 (African)| 0.3681 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr17:43100596:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0979 (Asian)| 0.07927 (African)| 0.1557 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,,benign
chr13:32333385:C>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32363212:G>A,,Ambry_Genetics|Invitae,,,,,,0.0349|0.0|0.0231,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,,benign
chr13:32338431:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,,,-1,1.0,,,,,,pathogenic
chr17:43092849:TTTC>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Counsyl|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-31),benign(0-023),,1&1,,pathogenic
chr17:43070969:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43063903:G>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited), exon 18 skipping|very destabilizing|strong functional effect|inconclusive|ESE disruption/ESS creation|-|as variant control|predicted deleterious|Loss of wild type allele|as wildtype control|?,Clonogenic assay|Histopathology|Bayesian statistics|Loss of Heterozygosity|Grantham score|mRNA analysis (RT-PCR)|transcription activation/PS/BA/BS|Centrosome amplification|Multifactorial likelihood-ratio model|structure-based prediction (crystallography etc) BRCA1:BACH1|Transcription activation in yeast (GAL4-fusions)|Peptide binding ability|-| lymphocyte RT-PCR|evolutionary conservation analysis|Recombination rate|Transcription activation in human cells|Structure-based prediction (crystallography etc)|Proteolytic degradation|Survival assay with HCC1937 (after MMS treatment)|co-immunoprecipitation BRCA1-ER|Oncogene expression|Nuclear localisation|?|Thermodynamic stability prediction|ESEfinder/ESRsearch,1/238 patients|-|3/1658,,,,,,,,,Latin American/Caribbean|Not Specified|-|Sweden|Spanish|Western Europe|Italian|Near East/Mid East,,"Latin American/Caribbean| Native American""""| Latin American/Caribbe|Not Specified|Western European|Latin-American/Caribbean|-|Caucasian|Western-European|Western Europe|None-Specified|None Specified|""""Western European",M,5 - Definitely pathogenic,1.0,12.59,1.66e+11,1.0,0.81,0.81,missense_variant,MODERATE,17/23,,-1,,deleterious(0),probably_damaging(1),,1&1&1,2.471e-05,pathogenic
chr17:43093449:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3562 (European)| derived from 1000 genomes (2012-04-30).,Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,32.4419|23.9555|29.5678,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&1,1&1,,benign
chr17:43063369:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/23,,-1,,,,,1,,benign
chr17:43104242:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-36),benign(0-007),0&0&1&1,1&1&1&1,,pathogenic
chr13:32333062:C>T,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr17:43063369:C>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/23,,-1,,,,,1,8.237e-06,benign
chr17:43095845:C>A,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,-1,,,,,1,,pathogenic
chr17:43080891:A>AA,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,benign
chr13:32336735:A>AA,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43091961:AG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32326564:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,N,,,,,,,,stop_gained,HIGH,7/27,,1,,,,,1,,pathogenic
chr13:32341164:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr17:43091493:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,,possibly_damaging(0-487),,1&1,,pathogenic
chr13:32333409:T>-,,Counsyl,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43049448:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04371 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0,0.0,0.0456,0.001,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.00938498,benign
chr17:43045572:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,3_prime_UTR_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32346864:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,13/27,,1,,,,,1,8.238e-06,benign
chr13:32379792:T>TT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,,,,pathogenic
chr13:32332534:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr17:43118218:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08943 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr13:32370971:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,Protein likelihood ratio model|-|?,,,0.0465|0.5901|0.2307,benign:0.012,0.0,0.0045,0.0014,0.0,0.0,Western European|African American|-,,"Latin American/Caribbean| Central/Eastern European""""| Latin American/Caribbean""""|Not Specified|Western European|-|Native American/African American|""""African|African| African|Western Europe|Asian|None Specified|""""Western European",M,,,,,,,,missense_variant,MODERATE,20/27,,1,,tolerated(0-4),benign(0-125),0&0&1&1,1&1&1&1,0.00106128,benign
chr17:43094546:->G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43094514:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,1&1,1&1,,benign
chr17:43057561:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2053 (African)| 0.343 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32326613:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,2/1658,,,,,,,,,,,"Not Specified|Western European| Italian""""|None Specified|""""Western European",M,,,,,,,,missense_variant&splice_region_variant,MODERATE,7/27,,1,,,,,1&1&1,,pathogenic
chr17:43093405:->T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32396919:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32336380:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43106490:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,pathogenic
chr17:43092437:TAATGTTATTA>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,pathogenic
chr13:32367008:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr17:43106525:A>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,0&1&1,1&1&1,,pathogenic
chr17:43047705:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,20/21,-1,,,,,1&1,,pathogenic
chr17:43047705:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,20/21,-1,,,,,1&1,,pathogenic
chr17:43092305:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,20/21,-1,,,,,1&1,,pathogenic
chr13:32349323:A>AA,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08 (Asian)| 0.28 (African)| 0.21 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32336380:A>G,,Ambry_Genetics,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1,2.471e-05,benign
chr13:32338274:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1,,pathogenic
chr13:32339719:C>CC,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43093615:A>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43065535:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04617 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr13:32336567:T>TT,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32336900:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32380046:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,pathogenic
chr13:32337651:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32340956:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32341123:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32353975:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06294 (Asian)| 0.3232 (African)| 0.2836 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32340553:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,14/27,,1,,tolerated(0-86),,0&1&1,1&1&1,,pathogenic
chr17:43066699:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr13:32337766:G>GG,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32376684:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,21/23,,-1,,deleterious(0),benign(0-002),,1&1,,pathogenic
chr13:32339577:GTAA>-,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32316462:T>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,start_lost,MODIFIER,,,1,,,,,1&1,,pathogenic
chr13:32316462:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,start_lost,MODIFIER,,,1,,,,,1&1,,pathogenic
chr13:32381260:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.502 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32316511:AC>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,pathogenic
chr13:32357882:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,16/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43093472:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43091911:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43092482:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43093638:T>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43092809:CTTC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32337708:TAG>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,pathogenic
chr13:32394913:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,-|Italian,,Caucasian|Central/Eastern Europe,N,,,,,,,,stop_gained,HIGH,25/27,,1,,,,,1,,pathogenic
chr17:43045745:A>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,25/27,,1,,,,,1,,pathogenic
chr17:43093128:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43082402:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,11/21,-1,,,,,1&1,,pathogenic
chr17:43082402:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,11/21,-1,,,,,1&1,,pathogenic
chr13:32396462:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32360418:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr17:43070444:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04878 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,,,benign
chr13:32371033:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,20/27,,1,,,,,,,benign
chr13:32385397:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1923 (Asian)| 0.09959 (African)| 0.248 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.2455,0.087,0.2925,0.1984,0.2894,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.209265,benign
chr13:32320185:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01187 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43061301:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr17:43115775:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr13:32337094:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43104928:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,pathogenic
chr13:32339734:T>C,,Ambry_Genetics,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32340392:A>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Counsyl|Invitae,,,,,,,,,,,,,,,"Not Specified|Western European| Italy""""|Western Europe|None Specified|""""Western European",N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32371580:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3811 (Asian)| 0.1362 (African)| 0.2177 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.2078,0.1846,0.1988,0.3661,0.1728,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.225439,benign
chr13:32316496:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32332369:AACAGTTGT>GATACTTCAG,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43093454:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&1,1&1&1,,benign
chr13:32332459:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr13:32339435:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32352807:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1031 (Asian)| 0.03049 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr17:43094460:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43094620:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32346809:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,1,,benign
chr17:43094008:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,pathogenic
chr13:32389810:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08179 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43094275:A>AA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32340890:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,,,pathogenic
chr13:32336767:A>G,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32339202:T>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43094685:TGAG>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,pathogenic
chr13:32366142:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04675 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32332358:G>T,,Counsyl|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43092430:->TTTCTCTAATGTTA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32340802:TA>TATA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43049175:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,21/23,,-1,,,,,,,pathogenic
chr17:43076545:T>TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,12/22,,-1,,,,,,,pathogenic
chr13:32316543:A>G,,Invitae,,,,,,,,0.0,0.0,0.0,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,0.0002738305,benign
chr13:32319131:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,,benign
chr17:43086602:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03166 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr17:43091824:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,pathogenic
chr17:43080359:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,benign
chr13:32379808:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,1,,benign
chr17:43107764:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.1346,0.013,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.0373403,benign
chr13:32338027:C>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32362630:TTCCT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),probably_damaging(0-957),,,,pathogenic
chr17:43093668:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32338579:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32339526:TA>TATA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43106527:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,0&1&1&1,1&1&1&1,,pathogenic
chr17:43092883:GCA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,0&1&1&1,1&1&1&1,,pathogenic
chr13:32350510:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3864 (Asian)| 0.1707 (African)| 0.2929 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32339152:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,pathogenic
chr17:43082511:A>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/26,1,,,,,,,pathogenic
chr17:43063870:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,17/22,-1,,,,,1&1,,pathogenic
chr17:43049113:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Counsyl|Emory_Genetics_Laboratory|Invitae,,,,,,0.0|1.4526|0.4921,None|None|None|None|None,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,20/21,-1,,,,,1,,benign
chr13:32379128:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03659 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,benign
chr17:43090963:CTCT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,pathogenic
chr17:43090946:G>A,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr13:32338693:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43092276:TC>TCTC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32340087:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-2),benign(0-007),,1,,benign
chr17:43093457:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-002),,,,pathogenic
chr13:32340191:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,1,,pathogenic
chr17:43095830:C>T,,Ambry_Genetics,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32332889:G>T,,Ambry_Genetics|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43115781:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32366208:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.5524 (Asian)| 0.5206 (African)| 0.5396 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32383835:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3811 (Asian)| 0.1402 (African)| 0.2177 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32335313:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,benign
chr13:32347399:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,benign
chr13:32374128:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr13:32363288:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,8.236e-06,benign
chr17:43115781:T>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,2/22,-1,1.0,,,,1&1&1&1,,pathogenic
chr13:32376669:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,20/26,1,,,,,1,,pathogenic
chr17:43057136:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,18/22,-1,,,,,1,,pathogenic
chr13:32338162:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Austria,0,,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32338162:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1836 (Asian)| 0.1972 (African)| 0.1794 (European)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,Prevalence in normal controls|-,-|288/1658,,18.7384|19.8366|19.1106,None,0.1998,0.1846,0.1527,0.1726,0.1196,German|Austria|-|USA|Sri Lankan,1|0|2|-|6,Global|-|Caucasian|Sinhalese,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,0.1720655,benign
chr13:32344643:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,12/27,,1,,,,,1,1.648e-05,benign
chr17:43106487:A>C,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),probably_damaging(1),,1&1&1,,pathogenic
chr17:43093321:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),probably_damaging(1),,1&1&1,,pathogenic
chr17:43115524:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr13:32340670:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32336851:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43091784:G>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr13:32328257:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3724 (Asian)| 0.122 (African)| 0.277 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,benign
chr17:43121331:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.1484 (African)| 0.3694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32319154:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,3/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32340557:A>AA,,Ambry_Genetics|Medical_University_Innsbruck|Division_of_Human_Genetics_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43091933:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32340289:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,8.237e-06,benign
chr17:43118401:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1931 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr13:32337810:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32390362:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04021 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32338486:->TGAGGA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43094195:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,possibly_damaging(0-51),,,,pathogenic
chr17:43094602:T>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/27,,1,,,possibly_damaging(0-51),,,,pathogenic
chr17:43048507:TC>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32333303:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32316523:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,pathogenic
chr13:32341274:AATT>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.38 (Asian)| 0.18 (African)| 0.29 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,1&1,,benign
chr17:43094207:AT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,pathogenic
chr13:32339073:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,0.0116|0.0|0.0077,benign:0.002,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-41),benign(0-234),,1,,benign
chr17:43067660:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/22,,-1,,,,,,,benign
chr17:43082565:GT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32398241:C>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr13:32383682:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3811 (Asian)| 0.1402 (African)| 0.219 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32380145:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,,,1,,,,,1,,pathogenic
chr13:32337741:A>AA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43102157:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3269 (Asian)| 0.2215 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,benign
chr13:32322709:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1503 (Asian)| 0.01016 (African)| 0.1781 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43091814:A>T,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,benign
chr17:43088260:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.07517 (Asian)| 0.04878 (African)| 0.1702 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr17:43094486:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32363196:A>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-|?,Protein likelihood ratio model|-|Multifactorial likelihood-ratio model|?,-|3/1658,,0.0698|0.0|0.0461,probably-damaging:1.0,0.001,0.0,0.0,0.0,0.0,Not Specified|-,,Central/Eastern European|Western European| Germany/Ireland|-|Western Europe|None Specified,M,2 - Likely not pathogenic or of little clinical significance,0.0021,1.733,,0.0183,0.81,0.81,missense_variant,MODERATE,18/27,,1,,deleterious(0-02),probably_damaging(1),,1&1,0.0001657405,benign
chr17:43093140:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43091008:CT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43041622:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43063347:T>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/23,,-1,,,,,1&1,,pathogenic
chr13:32338224:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0118|0.8772|0.3042,benign:0.121,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,benign(0-019),,1&1,,benign
chr17:43104145:TCTGTAG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,3/27,,1,,,,,,,pathogenic
chr13:32357751:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,16/27,,1,,,,,1,,pathogenic
chr13:32337649:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,pathogenic
chr13:32332832:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr17:43076498:C>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,,,pathogenic
chr13:32341031:GA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,20/21,-1,,,,,1,,pathogenic
chr13:32339572:TTTAAGTA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,,benign(0-031),,1,,pathogenic
chr13:32339135:A>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,pathogenic
chr13:32333296:G>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr17:43066730:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08566 (Asian)| 0.03862 (African)| 0.07784 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr13:32384750:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06728 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0676,0.003,0.0288,0.0,0.0184,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.0219649,benign
chr17:43094390:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43092597:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32332786:GA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,6/27,,1,,,,,1,,pathogenic
chr17:43085995:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06301 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr17:43106480:A>T,,Pathway_Genomics|Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1&1,,pathogenic
chr13:32315889:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3199 (Asian)| 0.1382 (African)| 0.1939 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,benign
chr17:43051078:T>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.0227|0.0077,probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0|probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,20/23,,-1,,deleterious(0-01),benign(0-089),,1&1,,benign
chr17:43080276:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0008,0.0,0.0079,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,0.00179712,benign
chr13:32337817:C>T,,Ambry_Genetics|Invitae,,,,,,0.0116|0.0227|0.0154,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32365165:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.2535 (Asian)| 0.2012 (African)| 0.215 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr17:43091597:TGTT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/23,,-1,,deleterious(0-02),benign(0-023),,1,,pathogenic
chr17:43077795:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2846 (African)| 0.3641 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr13:32333332:C>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32340458:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(1),benign(0-003),,1,,pathogenic
chr13:32326084:G>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,1,,benign
chr17:43092597:A>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1&1&1,,pathogenic
chr17:43091795:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,1,,pathogenic
chr13:32373524:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03659 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr17:43090947:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,,,benign
chr17:43073638:A>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.12 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,,,benign
chr13:32340820:C>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32378348:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05937 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,benign
chr17:43047691:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr13:32394763:G>T,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,25/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32357946:G>A,,Invitae,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr13:32332631:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1&1,,pathogenic
chr13:32369961:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06294 (Asian)| 0.2215 (African)| 0.2836 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.2734,0.1755,0.2406,0.0704,0.1595,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.179912,benign
chr13:32337900:TT>-,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43091949:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43091749:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32337058:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43092644:T>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-07),possibly_damaging(0-814),,1,,pathogenic
chr13:32338117:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43093951:TT>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-37),benign(0-02),,,,pathogenic
chr13:32354922:CT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-37),benign(0-02),,,,pathogenic
chr13:32332472:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-61),benign(0-004),0&1&1,1&1&1,,pathogenic
chr17:43093605:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43093559:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32336566:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32357807:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,16/27,,1,,,,,,,benign
chr13:32336566:A>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32333226:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1&1&1&1,,pathogenic
chr17:43124741:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02033 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0159,0.0058,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.00499201,benign
chr17:43094365:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,7/26,1,,,,,1,,pathogenic
chr13:32371842:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0333,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00898562,benign
chr13:32379429:A>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0116|0.0|0.0077,probably-damaging:0.996,,,,,,,,,,,,,,,,,missense_variant,MODERATE,22/27,,1,,,,,1,,benign
chr13:32328672:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04065 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.031,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,0.0081869,benign
chr17:43067608:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,15/22,,-1,,deleterious(0),possibly_damaging(0-704),0&0&1,1&1&1,,pathogenic
chr17:43093817:C>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,0&1&1&1&1,1&1&1&1&1,,pathogenic
chr17:43067608:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,15/22,,-1,,deleterious(0),probably_damaging(0-938),0&0&1,1&1&1,,pathogenic
chr17:43094294:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43092096:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43082403:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 0.9999,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Invitae|Pathway_Genomics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned),predicted deleterious,Splicing reporter minigene|Multifactorial likelihood-ratio model,,,,,0.001,0.0,0.0,0.0,0.0,African American|-,,"Bahamas| Latin American/Caribbean""""|Not Specified|Western European|-Native-American|-Native-Americ|-|-Portuguese|African American/Latin American/Caribbea|None Specified|African|Western-European|Western Europe|-African|-Irish|""""Western European",IVS,5 - Definitely pathogenic,1.0,3.98,1230000.0,1.0,,0.97,splice_donor_variant,HIGH,,11/21,-1,,,,,1&1&1&1&1,0.0001039585,pathogenic
chr13:32317168:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.09441 (Asian)| 0.01626 (African)| 0.04749 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0447,0.0333,0.0994,0.0903,0.1207,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.0732827,benign
chr13:32339759:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43091463:TTGA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr17:43067649:TTAG>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32375718:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03455 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr13:32336246:TT>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr13:32391173:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.2587 (Asian)| 0.2195 (African)| 0.2137 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43093284:->TC,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32379412:G>A,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/27,,1,,,,0&0&1&1,1&1&1&1,2.471e-05,benign
chr13:32371075:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,20/27,,1,,,,,,,benign
chr17:43063934:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,20/27,,1,,,,,,,pathogenic
chr13:32332675:C>G,,Ambry_Genetics,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,1,,benign
chr13:32346812:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,1,,benign
chr17:43074529:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,,-1,,,,,1,,benign
chr13:32340957:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,pathogenic
chr13:32380083:TT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,pathogenic
chr13:32337522:AAAA>-,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),probably_damaging(0-921),,,,pathogenic
chr17:43095103:->TAC,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.24 (Asian)| 0.2 (African)| 0.23 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43093637:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32337706:A>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32336449:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,,pathogenic
chr13:32346887:T>TT,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,13/27,,1,,,,,,,pathogenic
chr17:43071115:A>AA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,,,pathogenic
chr17:43092663:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43090381:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43073428:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.07692 (Asian)| 0.03862 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,benign
chr17:43060530:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32398185:A>AA,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&0,,pathogenic
chr17:43091657:A>-,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,pathogenic
chr13:32340377:A>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43092694:AT>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,pathogenic
chr13:32370490:C>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,19/27,,1,,,,,1,,pathogenic
chr13:32340999:ACTCC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,19/27,,1,,,,,1,,pathogenic
chr13:32336266:T>C,,Ambry_Genetics|GeneDx|Emory_Genetics_Laboratory|Invitae,,,,,,0.0|0.4312|0.1462,None,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43094768:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,German|-,2|-,Unknown|Caucasian,N,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,pathogenic
chr13:32341011:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32340868:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.8902 (African)| derived from 1000 genomes (2012-04-30).,Ambry_Genetics|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Emory_Genetics_Laboratory,,,,,,0.0581|7.1266|2.4527,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1,1&1,,benign
chr17:43065086:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04371 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0015,0.0086,0.0536,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.0123802,benign
chr17:43071012:C>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,,benign
chr17:43095848:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,pathogenic
chr17:43092493:TC>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,16/27,,1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr13:32316402:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,1,,benign
chr13:32379316:G>A,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Counsyl|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,21/26,1,,,,,1&1,,pathogenic
chr13:32326150:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,5/27,,1,,,,,1&1&0,,pathogenic
chr17:43063952:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,15/21,-1,,,,,1&1,,pathogenic
chr13:32375530:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02622 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0,0.0014,0.0198,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00419329,benign
chr17:43092052:TTT>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43071164:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,pathogenic
chr13:32341037:G>GG,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32379410:A>CT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,22/27,,1,,,,,1&1&1,,pathogenic
chr17:43070985:T>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/23,,-1,,,,,,,benign
chr13:32362563:T>-,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,pathogenic
chr13:32368578:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03034 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32340367:A>G,,Ambry_Genetics,,,,,,,,0.0,0.0,0.0,0.0,0.001,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,0.000103959,benign
chr13:32338066:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43045778:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,pathogenic
chr13:32373523:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0113,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.00359425,benign
chr17:43104137:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,benign
chr13:32394833:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,pathogenic
chr17:43120810:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43093694:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/21,-1,,,,,,,pathogenic
chr13:32379464:ACCGTGTGGAAG>TCCC,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,22/27,,1,,,,,,,pathogenic
chr17:43124063:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr17:43073750:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1199 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.001,0.1195,0.0058,0.001,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,0.0327476,benign
chr17:43093803:T>TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43104331:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,,,benign
chr17:43094060:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32340276:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-22),benign(0-002),,1,,benign
chr17:43099802:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-96),benign(0),,1,,pathogenic
chr13:32336391:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,pathogenic
chr17:43093530:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43093332:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-29),benign(0-006),,1,,pathogenic
chr17:43105799:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05285 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,,,benign
chr17:43076602:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1,,pathogenic
chr13:32393329:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.549 (Asian)| 0.502 (African)| 0.5383 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43045692:G>GG,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,22/22,,-1,,,,,,,pathogenic
chr17:43070933:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/23,,-1,,,,,1&1&1,,pathogenic
chr13:32337115:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,15/23,,-1,,,,,1&1&1,,pathogenic
chr13:32327930:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.09965 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,benign
chr13:32336414:GATTA>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,pathogenic
chr13:32340309:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,pathogenic
chr17:43057120:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/22,,-1,,,,,1,,pathogenic
chr13:32348067:AAG>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,benign
chr13:32342225:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,benign
chr13:32391943:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43094290:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32339653:T>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Austria,0,,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32332805:G>T,,Counsyl,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43046604:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2114 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,,benign
chr13:32337535:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43115615:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,benign
chr17:43094444:TC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,pathogenic
chr17:43106456:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,,,,,1&1,,pathogenic
chr17:43106456:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,,deleterious(0),,,1&1,,pathogenic
chr13:32337163:A>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,-1,,deleterious(0),,,1&1,,pathogenic
chr17:43090059:AAG>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.21 (African)| 0.35 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43065094:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04545 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,benign
chr13:32333366:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr17:43104967:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,1&1,,pathogenic
chr17:43093677:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/22,-1,,,,,1&1,,pathogenic
chr13:32346707:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.8902 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,benign
chr17:43094523:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32346203:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,benign
chr17:43104197:A>C,,Ambry_Genetics,,,,,,,,0.0,0.0,0.0029,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,6/23,,-1,,,,,,0.0002079155,benign
chr13:32339777:AT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,pathogenic
chr17:43093055:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43093610:T>TT,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43063331:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32339053:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32339095:TG>TGTG,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32339244:C>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32333148:T>G,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1&1&1,,pathogenic
chr13:32336893:A>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|GeneDx|Counsyl|Invitae,,,,,,0.0233|0.0|0.0154,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43051074:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-02),benign(0-017),,1,,pathogenic
chr17:43124022:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,1,,benign
chr13:32338506:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1,,pathogenic
chr13:32394843:T>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,25/27,,1,,,,,1,0.0005189,benign
chr13:32318104:AGT>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-18),benign(0-267),0&0&0&1&1,1&1&1&1&1,,benign
chr13:32346879:TACCT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,pathogenic
chr13:32379749:GTT>AA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant&coding_sequence_variant,HIGH,,,1,,,,,1,,pathogenic
chr17:43094141:TT>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32355094:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,14/27,,1,,,,,1,,pathogenic
chr17:43106529:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,pathogenic
chr17:43041893:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.87 (African)| 0.37 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43092278:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43091981:CT>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr13:32332867:AG>-,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(1),0&1&1,1&1&1,,pathogenic
chr13:32338403:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32318080:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.8902 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.999,0.9047,0.9971,1.0,1.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,0.974241,benign
chr13:32394835:C>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,pathogenic
chr13:32379822:ATCAT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,,pathogenic
chr13:32326151:G>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,5/26,1,,,,,1&1,,pathogenic
chr17:43093626:A>G,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0|0.0454|0.0154,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32326151:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,5/26,1,,,,,1&1,,pathogenic
chr17:43071135:TATGT>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,1,,pathogenic
chr17:43057558:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32339897:A>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1&1,,pathogenic
chr17:43091018:CA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,19/27,,1,,deleterious(0),probably_damaging(1),,1&1,,pathogenic
chr17:43092568:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&1,1&1&1,,pathogenic
chr13:32340842:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43092438:A>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32371492:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03659 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.053,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,0.0141773,benign
chr17:43092292:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43093393:G>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32339269:A>AA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32355033:A>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,14/27,,1,,,,,1&1,,pathogenic
chr13:32390046:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.003,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.000798722,benign
chr13:32340073:CTCT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr13:32340133:TG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32332387:T>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,8.238e-06,benign
chr17:43125979:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32332304:GTAAA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,21/26,1,,,,,,,pathogenic
chr17:43094279:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32326554:AT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32340259:AGTC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,0&1,,pathogenic
chr17:43092020:T>A,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43093650:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32367159:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02846 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32338770:AGAA>-,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr13:32355233:->G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,14/27,,1,,,,,,,pathogenic
chr17:43124935:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0874 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0552,0.0072,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,0.0155751,benign
chr13:32333022:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-07),benign(0-055),,,,benign
chr17:43093844:G>A,,Medical_University_Innsbruck|Ambry_Genetics|GeneDx|Invitae|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32338202:GT>-,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Division_of_Human_Genetics_Innsbruck|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,pathogenic
chr17:43121078:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3339 (Asian)| 0.2114 (African)| 0.3509 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32336325:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32319335:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,1,,benign
chr13:32333274:CTTAT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32339011:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|GeneDx|Counsyl|Invitae,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1&1,,benign
chr13:32357886:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,,pathogenic
chr13:32332375:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr13:32341116:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32334492:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3846 (Asian)| 0.1626 (African)| 0.2929 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,benign
chr13:32396248:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03455 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43094092:T>TT,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43093975:T>-,,Pathway_Genomics|Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,pathogenic
chr17:43093901:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,0&1&1,1&1&1,,pathogenic
chr17:43094567:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,pathogenic
chr17:43095864:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,8.237e-06,benign
chr13:32393109:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43061876:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32357843:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,16/27,,1,,,,,1,,pathogenic
chr17:43074368:A>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,benign
chr17:43102801:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01748 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0,0.0,0.0248,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,0.00499201,benign
chr13:32338789:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,1&1,1&1,,benign
chr13:32319195:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant&stop_lost,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32363263:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,,benign
chr17:43124094:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,start_lost,HIGH,,,-1,1.0,deleterious(0),,,1&1,,pathogenic
chr13:32394146:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43121405:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01187 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43094054:T>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,5/26,1,,,,,1,,pathogenic
chr17:43092765:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,1,,,,,,,pathogenic
chr13:32340322:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32346185:T>TT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04 (African)| 0.02 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,benign
chr13:32338918:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.8902 (African)| derived from 1000 genomes (2012-04-30).,Ambry_Genetics|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Emory_Genetics_Laboratory,,,,,,0.0582|7.0391|2.4227,None,0.999,0.9039,0.9971,1.0,1.0,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,0.983521,benign
chr13:32341191:TA>CTTTGTGGTAAGTTT,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32325701:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0348,0.0325,0.0965,0.0962,0.1329,,,,,,,,,,,,intron_variant,MODIFIER,,4/26,1,,,,,,0.0742812,benign
chr13:32339990:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32395964:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1416 (Asian)| 0.1118 (African)| 0.1979 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,0.0005417,benign
chr17:43097267:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,,,benign
chr17:43097267:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,,,benign
chr13:32336359:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,1.648e-05,benign
chr13:32338215:ATAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,pathogenic
chr17:43094649:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/21,-1,,,,,,,pathogenic
chr17:43092591:T>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,2/22,-1,1.0,,,,1&1,,pathogenic
chr13:32338488:CTCA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,1,,pathogenic
chr13:32336956:T>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32355257:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,1,1.647e-05,benign
chr17:43076585:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,pathogenic
chr17:43074531:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32379391:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/27,,1,,,,,,,benign
chr17:43094234:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,pathogenic
chr13:32339940:TGAA>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,pathogenic
chr13:32338833:AAAG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,,,,1,,pathogenic
chr17:43092586:G>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43093091:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43074330:C>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,,-1,,,,,1&1,,pathogenic
chr17:43127210:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43074330:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),In vitro (cloned)|Germline (inherited),predicted deleterious|-|?,Splicing reporter minigene|-|Multifactorial likelihood-ratio model|?,,,,,,,,,,Czech|-,,Western European|-|Western-European|Western Europe|Caucasian|None Specified,IVS,5 - Definitely pathogenic,1.0,1.55,128.82,1.0,,0.97,splice_donor_variant,HIGH,,,-1,,,,,1&1,,pathogenic
chr17:43127753:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.21 (African)| 0.37 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32318748:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,benign
chr13:32340335:C>T,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,In vitro (cloned),,,,,,,,,,,,,,-|None Specified,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43093153:T>TT,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32332375:->C,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,10/27,,1,,,,,,,pathogenic
chr17:43091907:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43067646:AGATTAGTTAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43094635:->CATT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43104220:GA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,1,,tolerated(1),,,,,pathogenic
chr13:32391627:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0348,0.0303,0.0908,0.0962,0.136,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.0734824,benign
chr13:32319323:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,4/1658,,,,,,,,,,,Western European|Western Europe|None Specified,N,,,,,,,,stop_gained&splice_region_variant,HIGH,3/27,,1,,,,,1&1,,pathogenic
chr17:43123628:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3269 (Asian)| 0.2114 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32337824:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Asian| Samoan,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43094276:C>-,,_University_of_Chicago|Genetic_Services_Laboratory|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-1),benign(0-076),,1,,pathogenic
chr13:32333167:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,0&0&1,1&1&1,,pathogenic
chr13:32380066:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,0&0&1,1&1&1,,pathogenic
chr17:43085936:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3562 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr13:32320807:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0227,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,0.00599042,benign
chr13:32362574:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,17/27,,1,,,,,1,,pathogenic
chr13:32331031:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,9/26,1,,,,,1,,pathogenic
chr13:32340446:A>AA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32326631:G>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,benign
chr17:43093193:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Counsyl|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32337628:ATTT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32368998:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01829 (African)| 0.03958 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32328640:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,benign
chr17:43093295:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43099779:T>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,1,,benign
chr13:32339080:C>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43062062:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06504 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32316090:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3374 (Asian)| 0.128 (African)| 0.2124 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,benign
chr13:32360873:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr13:32336694:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43082403:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,IVS,,,,,,,,splice_donor_variant,HIGH,,11/21,-1,,,,,1&1&1&1&1,,pathogenic
chr13:32363225:A>G,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-01),probably_damaging(0-996),,1&1,,pathogenic
chr17:43051118:C>G,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,18/21,-1,,,,0&0&0&1,1&1&1&1,,pathogenic
chr17:43051118:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,18/21,-1,,,,0&0&0&1,1&1&1&1,,pathogenic
chr17:43051118:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,18/21,-1,,,,0&0&0&1,1&1&1&1,,pathogenic
chr17:43057088:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,18/21,-1,,,,0&0&0&1,1&1&1&1,,pathogenic
chr17:43063926:T>C,,Ambry_Genetics|Invitae,,,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,17/23,,-1,,,,,1,,benign
chr17:43082403:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Central/Eastern-European|-,IVS,,,,,,,,splice_donor_variant,HIGH,,11/21,-1,,,,,1&1&1&1&1,,pathogenic
chr17:43059207:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01049 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr17:43054613:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02243 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr13:32338214:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,1.0,,,,1,,pathogenic
chr17:43094061:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43074353:A>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,,benign
chr13:32363182:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1&1&1,,benign
chr13:32332581:C>A,,GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32323201:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01715 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43067690:G>A,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0|0.1817|0.0615,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/22,,-1,,,,,1,,benign
chr13:32339146:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43094608:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,pathogenic
chr17:43087455:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3287 (Asian)| 0.1321 (African)| 0.3562 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr17:43111413:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01451 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0139,0.0,0.0058,0.0,0.002,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,0.00399361,benign
chr17:43093610:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43078520:A>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2846 (African)| 0.3668 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr13:32338030:A>G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,Malaysian,,Malay,Syn,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,8.237e-06,benign
chr13:32332641:TACC>TACCTACC,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,pathogenic
chr13:32371003:AGAG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,10/27,,1,,,,,,,pathogenic
chr13:32326592:C>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,pathogenic
chr13:32379440:C>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,22/27,,1,,,,,1&1,,pathogenic
chr13:32364238:T>TT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr13:32339572:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,Western European,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1&1&1,,pathogenic
chr13:32342999:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0227,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,0.0061901,benign
chr17:43063872:A>AA,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,17/22,-1,,,,,,,pathogenic
chr17:43100863:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02902 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,,benign
chr17:43094013:C>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,,pathogenic
chr13:32315831:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.8636 (Asian)| 0.5285 (African)| 0.777 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,benign
chr17:43093355:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43092487:C>CC,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32319326:G>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,3/26,1,,,,1&1,1&1,,pathogenic
chr13:32319326:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,3/26,1,,,,1&1,1&1,,pathogenic
chr13:32394708:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,25/27,,1,,,,,1&1,,pathogenic
chr17:43093399:TT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,25/27,,1,,,,,1&1,,pathogenic
chr13:32338523:TT>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr13:32319326:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,3/26,1,,,,1&1,1&1,,pathogenic
chr13:32337720:G>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,3/26,1,,,,1&1,1&1,,pathogenic
chr17:43094090:->T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,,,-1,,,,1&1,1&1,,pathogenic
chr17:43079318:G>A,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,1,,benign
chr13:32362564:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43091771:TA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32338215:A>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),possibly_damaging(0-714),,,,pathogenic
chr13:32340786:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,deleterious(0),,,1&1&1,,pathogenic
chr13:32333479:TATCT>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,tolerated(0-16),benign(0-311),,,,benign
chr17:43093299:A>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr17:43127512:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32337544:GTCA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,,pathogenic
chr13:32339423:AAAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,,pathogenic
chr17:43054080:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03862 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr17:43063913:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,17/23,,-1,,,,,1,,benign
chr17:43097369:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02846 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,benign
chr13:32337527:A>T,,Medical_University_Innsbruck|GeneDx|Division_of_Human_Genetics_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32356561:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,,,benign
chr17:43106473:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,pathogenic
chr13:32340646:G>A,,Ambry_Genetics,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,0&1&1,1&1&1,,benign
chr17:43124057:CATT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-01),possibly_damaging(0-898),,,,pathogenic
chr17:43094582:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32379823:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,21/27,,1,,,,,,,pathogenic
chr13:32363345:A>T,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,18/27,,1,,,,,,,pathogenic
chr17:43099453:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,benign
chr17:43092141:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,pathogenic
chr13:32349553:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06294 (Asian)| 0.3028 (African)| 0.2018 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.1938,0.2693,0.2176,0.0714,0.1472,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.183307,benign
chr13:32338943:A>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,0&1&1,1&1&1,,pathogenic
chr13:32394717:C>T,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,25/27,,1,,,,0&0&1&1&1,1&1&1&1&1,,benign
chr13:32332735:T>-,,Ambry_Genetics|Invitae|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43115736:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(1),0&0&1&1&1,1&1&1&1&1,,pathogenic
chr17:43092479:TCTCA>TCTCATCTCA,,Pathway_Genomics|Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32384015:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0227,0.0043,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,0.00658946,benign
chr17:43100595:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08741 (Asian)| 0.09553 (African)| 0.1675 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.326,0.1581,0.3372,0.2371,0.456,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,1.0,,,,,0.290735,benign
chr13:32340183:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Genetic_Services_Laboratory|GeneDx|Invitae|_University_of_Chicago|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32354913:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,14/27,,1,,,,,1&1,,pathogenic
chr13:32379823:T>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1&1,,pathogenic
chr13:32363436:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,18/27,,1,,,,,1,,pathogenic
chr17:43093698:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32326099:A>G,,GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,4/26,1,,,,,1,,pathogenic
chr13:32370937:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,1,,benign
chr17:43090064:G>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (Asian)| 0.03 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,14/26,1,,,,,,,benign
chr13:32333023:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,benign
chr13:32398321:G>-,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,10/27,,1,,,,,,,pathogenic
chr13:32357775:A>C,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,tolerated(0-05),probably_damaging(0-985),,1,,benign
chr17:43094861:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,,-1,,,,,1,,pathogenic
chr13:32339003:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&0,,pathogenic
chr13:32388548:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04268 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43045793:TGCCCAAT>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr17:43071023:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/23,,-1,,,,,,,pathogenic
chr13:32340052:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43074472:TG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43092044:TATCTTCCTT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32316544:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr17:43074403:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,pathogenic
chr17:43074519:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,,,-1,,,,,1&1,,pathogenic
chr13:32337431:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Czech|Western Europe|-,,Not Specified|Western European|-|Caucasian,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43074519:G>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained&splice_region_variant,HIGH,,,-1,,,,,1&1,,pathogenic
chr13:32333073:AAACT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,pathogenic
chr13:32338656:A>T,,Ambry_Genetics,In vitro (cloned)|Unknown|Germline (inherited),predicted neutral|-,Histopathology|-,,,,,,,,,,,,,,2 - Likely not pathogenic or of little clinical significance,,,2.07,0.0405,0.02,0.02,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(0-985),,1,,benign
chr13:32380096:T>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),Germline (inherited),,,,FA FANCD1_00003,,,,,,,,,,Ashkenazi|None Specified,N,,,,,,,,stop_gained,HIGH,,,1,,,,,1&1&0,,pathogenic
chr13:32358885:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.4476 (Asian)| 0.3435 (African)| 0.4604 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,16/26,1,,,,,,,benign
chr13:32340760:CTTA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,,,pathogenic
chr13:32337241:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,1&1,1&1,,benign
chr13:32341040:G>T,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43099629:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3562 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,13/1658,,,,0.3549,0.2179,0.3746,0.371,0.498,,1|-,,IVS,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,1,0.352636,benign
chr17:43063372:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,Not Specified|-,N,,,,,,,,stop_gained&splice_region_variant,HIGH,18/23,,-1,,,,,1&1,,pathogenic
chr17:43063931:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,17/23,,-1,,,,,1&1,,benign
chr13:32331491:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.03694 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0348,0.0325,0.0908,0.0962,0.1319,,,,,,,,,,,,intron_variant,MODIFIER,,9/26,1,,,,,,0.0732827,benign
chr13:32326796:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.4895 (Asian)| 0.1992 (African)| 0.3298 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,benign
chr17:43063372:C>A,,Ambry_Genetics,In vitro (cloned)|Unknown,predicted deleterious|-|as variant control|strong functional effect,Peptide binding ability|Bayesian statistics|Structure-based prediction (crystallography etc)|-|transcription activation/PS/BA/BS|Proteolytic degradation|Co-segregation in families,,,,,,,,,,,2,,M,,,,,,,,missense_variant&splice_region_variant,MODERATE,18/23,,-1,,deleterious(0),probably_damaging(0-99),,1&1,,pathogenic
chr13:32338507:G>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32370444:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,pathogenic
chr13:32334210:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.4878 (Asian)| 0.1951 (African)| 0.3285 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,benign
chr17:43077891:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3269 (Asian)| 0.128 (African)| 0.3681 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr13:32385103:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1253 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.1143,0.0008,0.0533,0.002,0.0358,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.0379393,benign
chr17:43092628:->GA,,Sharing_Clinical_Reports_Project_(SCRP)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43092732:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr13:32339054:C>T,,Ambry_Genetics,,,,1/1658|-,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,1.647e-05,benign
chr13:32392531:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.0343 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr13:32367964:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02375 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr17:43093074:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Invitae|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr13:32336447:C>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,pathogenic
chr13:32340055:A>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,8.237e-06,benign
chr13:32366755:->AGGT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr17:43093460:T>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43092165:TG>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,pathogenic
chr17:43119034:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05691 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,benign
chr13:32339568:CTTA>-,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,pathogenic
chr17:43092822:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,tolerated(0-15),benign(0-027),,,,pathogenic
chr13:32316477:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_lost,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43106464:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,,,pathogenic
chr13:32366751:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06294 (Asian)| 0.3232 (African)| 0.2836 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,,benign
chr17:43094604:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1&1&1,,benign
chr17:43089157:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr17:43092051:CTTT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-4),benign(0-01),,1,,pathogenic
chr17:43094472:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43099865:TG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,,,-1,,,,,1,,pathogenic
chr13:32336943:A>AA,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1&0,,pathogenic
chr17:43093654:ACTA>ACTAACTA,,Medical_University_Innsbruck|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Invitae|Division_of_Human_Genetics_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32336972:A>AA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43104233:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,pathogenic
chr13:32336835:A>AA,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32340922:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43049195:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,19/21,-1,,,,0&0&0&1&1,1&1&1&1&1,,pathogenic
chr17:43093145:T>TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43104143:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,8.236e-06,benign
chr13:32339829:C>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-93),benign(0-059),,1,,benign
chr13:32332471:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,,,pathogenic
chr17:43095038:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02902 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,1/1658,,,,0.0268,0.0,0.0115,0.0,0.0031,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,0.00758786,benign
chr17:43074394:G>A,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,0&0&1,1&1&1,,pathogenic
chr13:32339429:->A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,,,pathogenic
chr17:43051690:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0083,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,0.00219649,benign
chr17:43093514:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,0&0&1&1,1&1&1&1,,pathogenic
chr17:43070927:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,15/22,-1,,,,,1,,pathogenic
chr13:32337158:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0931|0.0227|0.0692,benign:0.055,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),,,1&1,,benign
chr17:43045842:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,IVS,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,1,,pathogenic
chr17:43085677:A>AA,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.08 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr17:43093514:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/26,1,,,,,,,pathogenic
chr13:32317793:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03049 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/26,1,,,,,,,benign
chr17:43093533:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32379510:ATTCAGGTAAG>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32337355:T>A,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32355213:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,5/21,-1,,,,,,,pathogenic
chr13:32346914:T>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,1.648e-05,benign
chr17:43061979:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3575 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32338566:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,pathogenic
chr13:32382146:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.06294 (Asian)| 0.2866 (African)| 0.2836 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr17:43067787:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3322 (Asian)| 0.2175 (African)| 0.3615 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/22,-1,,,,,1,,benign
chr13:32338467:A>AA,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43092872:->T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,1&1,1&1,,pathogenic
chr17:43093639:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32319115:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,3/27,,1,,,,,1,,pathogenic
chr17:43077369:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.3588,0.2194,0.3746,0.371,0.498,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,0.353834,benign
chr17:43093980:A>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,pathogenic
chr13:32379463:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,22/27,,1,,,,,,,benign
chr17:43092699:A>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32332989:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32396976:CC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,pathogenic
chr17:43094477:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr17:43059351:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01626 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr13:32396886:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1&1,,benign
chr13:32393031:G>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.04 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32357774:A>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,16/27,,1,,,,0&1&1,1&1&1,,benign
chr17:43097582:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01451 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,benign
chr13:32340219:C>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Counsyl|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1,,pathogenic
chr13:32340219:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1,,pathogenic
chr17:43092201:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43066788:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3801 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.005,0.3956,0.0274,0.0,0.0317,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,0.115415,benign
chr17:43082503:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/22,,-1,,,,,1&1,,pathogenic
chr17:43057051:C>T,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,18/21,-1,,,,0&0&0&0&1&1,1&1&1&1&1&1,,pathogenic
chr13:32338753:ACATT>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32316463:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,start_lost,MODIFIER,,,1,,,,0&0&0&1&1,1&1&1&1&1,,pathogenic
chr17:43104937:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0-02),benign(0-311),0&1&1,1&1&1,,pathogenic
chr13:32316463:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,start_lost,MODIFIER,,,1,,,,0&0&0&1&1,1&1&1&1&1,,pathogenic
chr17:43093081:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-23),benign(0-081),,,,pathogenic
chr17:43094043:A>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-23),benign(0-081),,,,pathogenic
chr17:43088898:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.05409 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr13:32316463:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,pathogenic
chr17:43076579:TAG>AA,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,,,,,1,,pathogenic
chr17:43057051:C>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,pathogenic
chr17:43082560:G>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/22,,-1,,,,,1&1,,pathogenic
chr13:32363197:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,benign
chr13:32371874:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.909 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,20/26,1,,,,,,,benign
chr13:32340837:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-1),benign(0-117),,,,benign
chr17:43082534:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/22,,-1,,,,,,,benign
chr17:43091737:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,,,pathogenic
chr17:43094190:AA>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32337546:C>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,1&1,1&1,,pathogenic
chr13:32371046:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,tolerated(0-47),benign(0-02),,1,,pathogenic
chr17:43091688:CTGAG>GCCT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr17:43078973:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2886 (African)| 0.3681 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,12/22,-1,,,,,,,benign
chr13:32336500:A>G,,Ambry_Genetics|GeneDx|Invitae,Unknown|Germline (inherited),,,,,0.0|0.1589|0.0538,None,0.0,0.0015,0.0,0.0,0.0,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,0.0002573305,benign
chr13:32399143:A>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03 (Asian)| 0.04 (African)| 0.02 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43092579:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,,pathogenic
chr17:43091870:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|CSER_CC_NCGL._University_of_Washington_Medical_Center|GeneDx,Unknown|Germline (inherited),,,,,0.0116|0.0|0.0077,None|None|None|None|None,,,,,,-|Belgian,1|-,Caucasian|Western European|-|None-Specified|Asian,N,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,8.236e-06,pathogenic
chr13:32394822:A>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,25/27,,1,,,,,1,8.236e-06,benign
chr17:43087474:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3287 (Asian)| 0.2154 (African)| 0.3549 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,,benign
chr13:32340079:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,upstream_gene_variant,MODIFIER,,,1,,,,,,,pathogenic
chr17:43051115:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,20/23,,-1,,,,,1,,benign
chr13:32319109:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,3/27,,1,,,,,1&1,,pathogenic
chr13:32332287:C>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,10/27,,1,,,,,1,,pathogenic
chr13:32336849:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,1&1,1&1,,pathogenic
chr13:32338601:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43106544:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,,,,,,,benign
chr13:32337646:T>TT,,Faculty_of_Pharmacy|_Ain_Shams_University,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43091012:->AA,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr17:43106485:AC>-,,Counsyl,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,-1,1.0,,,,1&1,,pathogenic
chr17:43050881:T>TT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,,benign
chr17:43093903:C>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,pathogenic
chr13:32330945:T>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,1,,,,,1,,benign
chr17:43092588:T>A,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32398716:G>A,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0233|0.0454|0.0308,None,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,4.942e-05,benign
chr13:32337189:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,21/26,1,,,,,1&1,,pathogenic
chr13:32380016:G>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,pathogenic
chr17:43093920:GTTA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,1,,,,,1,,pathogenic
chr17:43093121:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32329701:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.02642 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,8/26,1,,,,,,,benign
chr13:32339933:A>T,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43092200:G>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32340524:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32340886:TCAT>-,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,pathogenic
chr17:43045758:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,deleterious(0),probably_damaging(0-998),,1&1,,pathogenic
chr13:32337172:C>T,,Ambry_Genetics|Invitae,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32336315:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43051061:A>C,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,19/21,-1,,,,,1,,pathogenic
chr17:43049119:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,15/23,,-1,,,benign(0-036),,1,,pathogenic
chr13:32328310:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01583 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,7/26,1,,,,,,,benign
chr13:32379893:A>AA,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,,1&1,,pathogenic
chr13:32362671:G>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,,pathogenic
chr13:32330978:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,9/27,,1,,,,,1,,benign
chr17:43122889:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3129 (Asian)| 0.1768 (African)| 0.3522 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,benign
chr13:32379856:->TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,,,1,,,,,1,,pathogenic
chr17:43104911:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,8.237e-06,benign
chr17:43122889:G>-,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.31 (Asian)| 0.8 (African)| 0.34 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,18/27,,1,,,,,1,,benign
chr17:43045759:CCACTCTCGGGTCA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,16/27,,1,,deleterious(0-03),,,1,,pathogenic
chr13:32340197:T>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32319099:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,3/27,,1,,,,,1,,benign
chr13:32338940:G>A,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000000000166,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|CSER_CC_NCGL._University_of_Washington_Medical_Center|Ambry_Genetics|GeneDx|Counsyl|Invitae|Pathway_Genomics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0698|0.0|0.0461,probably-damaging:1.0,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0),probably_damaging(1),0&0&1&1,1&1&1&1,,benign
chr17:43063371:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43091706:T>TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr13:32322539:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1049 (Asian)| 0.01423 (African)| 0.04354 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr13:32344538:T>C,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,1,,benign
chr13:32340574:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32340622:GCA>C,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43094198:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1&1,,pathogenic
chr13:32326250:G>-,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,,,,1,,pathogenic
chr17:43094748:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,,,-1,,,,,1&1,,pathogenic
chr13:32356548:C>CC,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,15/27,,1,,,,,1,,pathogenic
chr13:32337817:C>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43093827:A>C,,Ambry_Genetics|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32340484:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43049415:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0212,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,19/21,-1,,,,,,0.00559105,benign
chr17:43045712:T>TT,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained&frameshift_variant,HIGH,22/22,,-1,,,,,,,pathogenic
chr13:32333240:A>G,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,10/27,,1,,deleterious(0),benign(0-19),,1,,benign
chr17:43093238:C>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,Latin-American/Caribbean,N,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32341028:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32340561:T>G,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1&1,,pathogenic
chr13:32341105:A>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32338618:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32356498:C>T,,Ambry_Genetics|GeneDx|Invitae,,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,15/27,,1,,,,,1,,benign
chr17:43093130:ATTT>-,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0),probably_damaging(1),,,,pathogenic
chr13:32337583:AG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-23),,1,,pathogenic
chr13:32363359:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,1,,benign
chr17:43091479:A>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1&1,,pathogenic
chr17:43104914:C>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,,benign
chr13:32340804:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,,,-1,,,,,1,,pathogenic
chr17:43092938:T>A,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32349673:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0098,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,0.00259585,benign
chr13:32356588:CTCTGCGTGTTCTC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/26,1,,,,,,,pathogenic
chr13:32340210:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,0.0|0.0227|0.0077,None,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32340805:A>AA,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32387447:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0106,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00299521,benign
chr13:32336794:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32337160:TAAA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32333388:G>A,,Ambry_Genetics|GeneDx|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,10/26,1,,,,,1,,pathogenic
chr17:43046931:G>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0113,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,21/21,-1,,,,,,0.00299521,benign
chr17:43094800:T>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32338880:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43085058:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0219,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,10/21,-1,,,,,,0.00579073,benign
chr13:32339371:C>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32316482:AG>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,pathogenic
chr13:32339698:->A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,,,pathogenic
chr13:32336826:TAAATG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,pathogenic
chr13:32371005:AG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,,,pathogenic
chr17:43049186:C>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,,,pathogenic
chr17:43082453:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3588 (European)| derived from 1000 genomes (2012-04-30).,Emory_Genetics_Laboratory|Ambry_Genetics|GeneDx|Counsyl|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,32.6047|18.8833|27.9563,None|None|None|None|None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/22,,-1,,,,0&1,1&1,,benign
chr13:32338203:T>TT,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,1,,pathogenic
chr17:43094438:T>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43118065:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01016 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0008,0.0,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,2/22,-1,1.0,,,,,0.000199681,benign
chr17:43049186:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,21/23,,-1,,,,,1&1&1,,pathogenic
chr13:32337871:G>A,,Ambry_Genetics|Emory_Genetics_Laboratory|GeneDx|Counsyl|Invitae,,,,,,0.407|0.0227|0.2768,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr13:32379474:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43093290:G>GG,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32337775:T>C,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|GeneDx|Counsyl|Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43063375:T>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODIFIER,,,-1,,,,,1&1&1,,pathogenic
chr13:32398350:A>G,,Ambry_Genetics|GeneDx,,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,benign
chr13:32371101:G>T,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,20/26,1,,,,,1&1,,pathogenic
chr17:43091689:TG>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr17:43091477:C>A,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,1,,pathogenic
chr13:32331031:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,splice_donor_variant,HIGH,,9/26,1,,,,,1,,pathogenic
chr13:32338048:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr17:43104849:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,4/21,-1,,,,,,,benign
chr13:32338195:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,,,benign
chr13:32337312:->G,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,coding_sequence_variant,MODIFIER,11/27,,1,,,,,1,,pathogenic
chr17:43045790:->TC,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,22/22,,-1,,,,,,,pathogenic
chr13:32363416:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,benign
chr17:43094212:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,18/27,,1,,,,,,,pathogenic
chr17:43063375:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,17/22,-1,,,,,1&1,,pathogenic
chr13:32356513:A>G,IARC class based on posterior probability from multifactorial likelihood analysis| thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.0000989,Ambry_Genetics|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|Invitae,,,,1/1658,,,,,,,,,,,,,1 - Not pathogenic or of no clinical significance,0.01,,,0.0,0.02,0.02,synonymous_variant,LOW,15/27,,1,,,,,1,4.118e-05,benign
chr13:32323405:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01829 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43094255:A>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32336790:A>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,15/21,-1,,,,,,,pathogenic
chr17:43095105:->CCT,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.32 (African)| 0.35 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43093532:G>A,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32357862:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,Brazilian,,,N,,,,,,,,stop_gained,HIGH,16/27,,1,,,,,1&1,,pathogenic
chr17:43092246:T>-,,Counsyl,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43104262:CT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43094382:AT>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,11/27,,1,,deleterious(0-01),benign(0-196),,1,,pathogenic
chr17:43043008:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.33 (Asian)| 0.22 (African)| 0.36 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,benign
chr13:32398396:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr13:32370398:C>G,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,18/26,1,,,,,,,benign
chr17:43092783:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&intron_variant,LOW,,18/26,1,,,,,,,pathogenic
chr13:32340902:G>T,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr13:32394925:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,25/27,,1,,tolerated(0-54),benign(0-006),,1,,benign
chr17:43067625:T>C,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,Unknown|Germline (inherited),,,1/238 patients|-,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,15/22,,-1,,deleterious(0),probably_damaging(0-992),,1,,pathogenic
chr17:43073768:T>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01423 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,13/21,-1,,,,,,,benign
chr13:32330992:ACAG>-,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,pathogenic
chr13:32319686:A>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,3/26,1,,,,,,,benign
chr17:43113938:G>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.4919 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.005,0.5136,0.0317,0.0,0.0317,,,,,,,,,,,,intron_variant,MODIFIER,,3/22,-1,1.0,,,,,0.147165,benign
chr13:32338191:A>AA,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr13:32341098:ATGCCACACATTC>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,frameshift_variant,HIGH,11/27,,1,,,,,,,pathogenic
chr17:43093572:T>C,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,8.237e-06,benign
chr17:43091661:TT>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43124015:A>C,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,None-Specified,IVS,,,,,,,,splice_donor_variant,HIGH,,,-1,1.0,,,,1,,pathogenic
chr17:43091883:T>TT,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,1.0,,,,,,pathogenic
chr17:43090944:C>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,Czech|-,,Western-European|Western Europe|-|Caucasian,Syn,,,,,,,,splice_region_variant&synonymous_variant,LOW,,,-1,1.0,,,,1&1&1,,pathogenic
chr13:32380158:A>G,,GeneDx,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,,benign
chr17:43092769:T>-,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,1,,pathogenic
chr17:43074416:CTTA>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,synonymous_variant,LOW,14/27,,1,,,,,,,pathogenic
chr13:32326563:G>A,,Sharing_Clinical_Reports_Project_(SCRP)|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,In vitro (cloned)|Unknown,partial rescue lethality  HR as wt|-, RNA analysis|-|Mouse ES cell assay,,,,,,,,,,,,Western European|-|Caucasian,N,,,,,,,,stop_gained,HIGH,7/27,,1,,,,,1&1,,pathogenic
chr13:32341387:C>A,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3846 (Asian)| 0.1626 (African)| 0.2929 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,11/26,1,,,,,,,benign
chr17:43093059:A>G,,Ambry_Genetics,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,benign
chr17:43053615:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/21,-1,,,,,,,benign
chr17:43060321:A>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.2154 (African)| 0.3602 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,18/22,-1,,,,,,,benign
chr17:43094732:AA>-,,Breast_Cancer_Information_Core_(BIC)_(BRCA1)|Ambry_Genetics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant&splice_region_variant,MODERATE,,,1,,,,,1&1,,pathogenic
chr13:32380775:C>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.01573 (Asian)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,,,benign
chr13:32385907:T>C,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.03252 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0,0.0333,0.0014,0.0,0.0,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,0.00898562,benign
chr13:32379913:G>A,,Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,,,,,,,,,,splice_region_variant&synonymous_variant,LOW,,,1,,,,,1&1,,pathogenic
chr17:43099478:C>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3304 (Asian)| 0.128 (African)| 0.3562 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,6/21,-1,1.0,,,,,,benign
chr13:32330952:A>-,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,downstream_gene_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32337173:C>T,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,," Phillipines""""|""""Asian|Asian| filipino",N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32340010:C>A,,Sharing_Clinical_Reports_Project_(SCRP)|GeneDx|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae,,,,,,,,,,,,,,,Western European,N,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1,,pathogenic
chr13:32333409:T>TT,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,10/26,1,,,,,,,benign
chr13:32363216:A>G,,Ambry_Genetics|GeneDx|Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,missense_variant,MODERATE,18/27,,1,,deleterious(0-01),possibly_damaging(0-654),,1,,benign
chr13:32368300:T>G,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.1731 (Asian)| 0.02033 (African)| 0.03826 (European)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,0.0338,0.0325,0.2061,0.1478,0.1411,,,,,,,,,,,,intron_variant,MODIFIER,,18/26,1,,,,,,0.101238,benign
chr13:32355119:T>A,,Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck,,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,14/27,,1,,,,0&1&1,1&1&1,,pathogenic
chr13:32336845:C>T,,Ambry_Genetics|Invitae,,,,,,0.0116|0.0|0.0077,None,,,,,,,,,,,,,,,,,synonymous_variant,LOW,11/27,,1,,,,,1,,benign
chr17:43093258:A>AA,,Ambry_Genetics|Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
chr13:32370567:A>G,,Sharing_Clinical_Reports_Project_(SCRP),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,19/26,1,,,,,1,,benign
chr13:32379613:T>C,,Invitae,,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,1,,,,,1,,benign
chr13:32390265:G>T,Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.0122 (African)| derived from 1000 genomes (2012-04-30).,Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,24/26,1,,,,,,,benign
chr17:43104262:C>A,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,splice_acceptor_variant,HIGH,,4/21,-1,,,,,1&1,,pathogenic
chr13:32339462:G>T,,Breast_Cancer_Information_Core_(BIC)_(BRCA2),,,,,,,,,,,,,,,,,,,,,,,,stop_gained,HIGH,11/27,,1,,,,,1&1,,pathogenic
chr17:43093274:->TA,,Breast_Cancer_Information_Core_(BIC)_(BRCA1),,,,,,,,,,,,,,,,,,,,,,,,intron_variant,MODIFIER,,,-1,,,,,,,pathogenic
